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ABSTRACT 
 
Background  
 
The National Radiation Protection Authority (NRPA) of Namibia was tasked in 2005 by the IAEA 
under the project RAF9/033 to develop diagnostic reference levels for conventional radiographic 
examinations. To date, no study that examines the radiation dose in diagnostic radiology has 
been undertaken in Namibia and radiation protection of patients may not be optimised. 
Diagnostic reference levels acts as a quality assurance tool that identifies procedures or 
activities where patient doses are high. 
 
Objectives 
 
The purpose of the study was to develop local Diagnostic Reference Levels (LDRL’s) for 
commonly performed conventional radiography projections in Windhoek, Namibia. 
The objectives of the study were to: 
 
• Measure KAP (Kerma Area Product) for postero-anterior (PA) and lateral (LAT) chest, 
antero-posterior (AP) and LAT lumbar spine, AP pelvis, and PA and LAT skull 
projections. 
• Calculate entrance skin and effective doses from the recorded KAP values. 
• To compare the KAP, entrance skin doses and effective doses with internationally 
established reference levels for the same procedure as well as similar studies in Africa. 
• Develop conversion coefficients from KAP values for estimation of effective and skin 
doses in clinical practice. 
 
 
Method 
 
In this study, three (3) hospitals located in Windhoek, Khomas region were selected and KAP 
measurements were recorded on 218 patients with a mean weight of 70±5kg.The entrance skin, 
and effective doses were calculated through Monto Carlo simulations by entering the geometric 
data, exposure parameters and equipment specifications and KAP values into PCXMC 2.0 
software (Finland). Diagnostic Reference levels (75th percentile), entrance skin doses (ESDs) 
and effective doses were calculated for anterior (PA) and lateral (LAT) chest, antero-posterior 
(AP) and LAT lumbar spine, AP pelvis, and PA and LAT skull projections. 
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Results 
 
The 75th percentiles of the entrance skin doses combined for PA and LAT chest, AP and LAT 
Lumbar spine, AP Pelvis and PA and LAT skull were, 0.0333 mSv, 0.0663 mSv, 0.1970 mSv, 
0.2740 mSv, 0.2497 mSv, 0.0922 mSv, and 0.0584 mSv respectively. The effective doses for 
the same procedures were 0.0545 mSv, 0.0942, 0.3792, 0.2970 mSv, 0.3061 mSv, 0.0267 and 
0.0283 respectively. The highest skin dose was recorded for the lateral lumbar spine projection 
while the highest effective dose was measured for AP lumbar spine projection. 
 
 
Conclusion 
 
The ESD’s in this study were much lower than previously reported values. However the effective 
doses were generally similar and compare well with previous studies. On the basis of the results 
it can be concluded that the effective dose is a better dosimetry quantity than ESD to determine 
deterministic effects of radiation.  
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CHAPTER 1 
1.1 Background and rationale 
Over the past century, ionising radiation has been readily applied in medicine and has now 
become an indispensable diagnostic tool to evaluate patient’s health (UNSCEAR, 2000). Since 
the discovery of x-rays in 1895, x-ray equipment has undergone various changes with computed 
and digital imaging systems been introduced and having replaced traditional film-screen 
systems. It is therefore not surprising that radiation exposure from x-ray examinations has 
become the largest artificial source of radiation exposure (Sonowane et al., 2010). In the year 
2000 it was reported that, medical radiation exposure in developed countries constituted about 
50% of global exposure (UNSCEAR, 2000).  
 
The benefits resulting from medical imaging cannot be overstated. However, exposure to 
ionising radiation has the potential to cause detrimental health effects. These effects are 
classified as either stochastic or non-stochastic (Kamiya et al., 2015). Stochastic effects are also 
known as probabilistic, where the incidence, but not severity of appearance, is proportional to 
the radiation dose received. These effects occur at low doses and are related to the damage to 
the genetic material at cellular level. Stochastic effects have no threshold dose; examples 
include heredity diseases (Kamiya et al., 2015). Non stochastic effects are also referred to as 
deterministic effects and occur once a threshold radiation dose is received. The degree of injury 
depends on three factors; absorbed dose, dose rate and the quality of radiation. These effects 
can have either a linear or exponential response to the radiation dose received. Non stochastic 
effects are further divided into early and late effects. Examples of early effects include 
haemorrhagic diarrhoea, anaemia, leucopoenia, erythema, and epilation. Late effects comprises 
cataracts, cardiovascular disorders and necrosis (Kamiya et al., 2015). 
 
In a universal effort to protect patients as well as health professionals against the harmful effects 
of ionizing radiation, the International Atomic Energy Agency (IAEA) published its Basic Safety 
Standards (BSS) in 1996 (IAEA, 1996). The BSS is based on three cardinal principles, namely, 
justification, optimisation and dose limitation (IAEA, 1996). 
 
In radiography, justification is the process where radiological requests are evaluated to ascertain 
the diagnostic efficacy of the procedure based on the clinical history of the patient. (Vom & 
Williams, 2017). Optimisation of radiation protection comprises the application of different 
radiographic techniques and imaging parameters in an effort to minimize radiation dose to 
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patients without compromising image quality. Clinically this implies that radiographers adjust and 
select imaging parameters with reference to the patient’s body habitus while maintaining 
diagnostic quality (Freitas & Yoshimura, 2009). A quality diagnostic radiograph therefore 
represents a visual appreciation of the patient’s anatomy under examination sufficient to make a 
clinical diagnosis (Vom & Williams, 2017). 
 
In radiography dose limitation is guided by the As Low As Reasonably Achievable (ALARA) 
principle. According to the Dosimetry Working Party (DWP) of the Institute of Physical Sciences 
in Medicine of the College of Radiographers in the United Kingdom (UK), radiographers are 
responsible for the comfort of patients during radiological procedures (DWP, 1992). As a result, 
radiographers should be concerned about radiation protection and radiation dose when selecting 
exposure parameters during radiological procedures. Therefore, radiographers should keep 
radiation doses as low as reasonably achievable (ALARA) during radiological procedures. It is 
against this background that diagnostic reference levels were introduced as an indicator for 
medical exposure (IAEA, 2006), encouraging radiographers to minimise radiation dose and 
optimise the effects of ionising radiation.  
 
Diagnostic reference levels (DRLs) are defined as “dose levels in medical radiodiagnostic 
practices for typical examinations for groups of standard-sized patients or standard phantoms for 
broadly defined types of equipment” (European Commission, 1999:6). DRLs measure radiation 
doses to patients for a defined set of procedures and act as a quality assurance tool that 
determines whether or not radiation exposure to patients are optimized.  DRLs therefore serve 
as an indicator of good radiographic practice. If radiation doses delivered to patients are 
consistently unsually high then there is a need to investigate radiation practices in order to apply 
corrective measures (Edmonds, 2009; Seeram & Brennan, 2017).  
  
In order to comply with the BSS for medical exposure, authorities that regulate x-ray equipment 
should determine radiation doses for typical sized adult patients (IAEA, 2006). It is for this 
reason that the IAEA requested the National Radiation Protection Authority (NRPA) of Namibia 
in, 2005, to develop diagnostic reference levels for conventional radiographic examinations 
(Appendix 1). The concept of diagnostic reference levels has now been formally adopted by the 
Ministry of Health and Social Services (MOHSS) of Namibia and is gazetted in the Atomic 
Energy and Radiation Protection Act of 2005 (Republic of Namibia, 2005). With the 
implementation of the Atomic Energy and Radiation Protection Act of 2005, there is a statutory 
requirement for all radiology departments to establish diagnostic reference levels. It is against 
this background that the researcher measured the Kerma Area Product (KAP) for conventional 
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postero-anterior (PA) and lateral (LAT) chest, antero-posterior (AP) and LAT lumbar spine, AP 
pelvis, and PA and LAT skull x-ray examinations as recommended by the Atomic Energy and 
Radiation Protection Act, IAEA and ICRP.  
 
1.2 Statement of the problem 
 
The NRPA of Namibia was tasked in 2005 by the IAEA under the project RAF9/033 to develop 
diagnostic reference levels for conventional radiographic examinations (Appendix 1). To date, no 
study that examines the radiation dose in diagnostic radiology has been undertaken in Namibia 
and radiation protection of patients may not be optimised. According to the International 
Commission on Radiological Protection (ICRP), diagnostic reference levels acts as a quality 
assurance tool that identifies procedures or activities where patient doses are high (ICRP, 1996). 
With the implementation of the Atomic Energy and Radiation Protection Act of 2005 (Republic of 
Namibia, 2005), there is a legal requirement for all radiology departments to establish diagnostic 
reference levels. Although various international diagnostic reference levels (DRLs) exist, these 
levels cannot be directly applied to Namibia, as DRLs are context dependent and vary according 
to the radiographic equipment, technique and exposure factors. Hence, there is a need for 
country or region specific diagnostic reference levels (ICRP, 1996; Johnston & Brennan, 2000; 
Seeram & Brennan, 2006). As such, the study measured radiation doses at three (3) different 
radiology practices in Windhoek for four commonly performed conventional radiographic 
examinations and established diagnostic reference levels for these procedures. The research 
was guided by the following research question.  
 
 What are the radiation doses received by patients undergoing conventional x-ray 
examinations in Windhoek, Namibia? 
 
The purpose of the study was to develop (Local Diagnostic Reference Levels (LDRL’s) for 
commonly performed conventional radiography projections in Windhoek, Namibia. 
The objectives of the study were to: 
 
• Measure KAP for postero-anterior (PA) and lateral (LAT) chest, antero-posterior (AP) and 
LAT lumbar spine, AP pelvis, and PA and LAT skull projections. 
• Calculate entrance skin and effective doses from the recorded KAP values. 
• To compare the KAP, entrance skin doses and effective doses with internationally 
established reference levels for the same procedure as well as similar studies in Africa. 
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• Develop conversion coefficients from KAP values for estimation of effective and skin 
doses in clinical practice. 
 
1.2.1 Null hypothesis: 
 
DRL’s determined for conventional radiography projections used in Windhoek, Namibia are in 
agreement with international levels. 
1.3 Significance of the study 
 
 
To the best of the researcher’s knowledge, no local diagnostic reference dose levels existed in 
Namibia, and as a result, radiography procedures may not be optimised with regard to radiation 
dose. Therefore, the local diagnostic reference levels which have been established in this study 
can be used as baseline data for future studies, until such a time that national diagnostic 
reference levels are determined.  
 
1.4 Overview of the methodology 
 
The study was conducted in three (3) hospitals located in Windhoek, Namibia. Hospital one (1) 
was a national referral hospital with a total capacity of 964 beds. Hospital two (2) was a private 
radiology practice attached to a private hospital with a total capacity of 1024 beds. Hospital three 
(3) was an intermediate hospital with a capacity of 955 beds. All three hospitals utilise computed 
or digital radiography x-ray imaging systems and are affiliated to the University of Namibia. 
Ethical approval was gained from the research ethics committee (REC) of the Cape Peninsula 
University of Technology as well as the Permanent Secretary of the Ministry of Health and Social 
Services (Namibia), Director of the National Radiation Protection Authority (NRPA) and 
permission to conduct the study received from the principal radiographers of the hospitals in the 
study. 
 
Geometric data, exposure parameters as well as KAP measurements were obtained from 218 
patients referred for seven projections that is; PA and LAT chest, AP and LAT lumbar spine, AP 
Pelvis, PA and LAT skull.  Specifications concerning the x-ray equipment for each hospital were 
obtained from the manufacturer’s manual available at each hospital.  The information recorded 
included generator type, name of the manufacturer, type of x-ray tube, anode angle, and total 
tube filtration.  
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Entrance skin, and effective doses were calculated through Monto Carlo simulations by entering 
the geometric data, exposure parameters and equipment specifications and KAP values into 
PCXMC (2008) 2.0 software (Finland). 
 
Microsoft excel 2016 was used to analyse data. Third (3rd) quartile values for KAP, ESD and ED 
were calculated. The research question was answered by means of inferential statistical 
analysis. The correlation between the ESD, ED and KAP were determined using Pearson’s 
tests. The third quartile values of the ESD and KAP obtained were also compared with that 
published in the literature.  
 
1.5 Delimitations 
 
 Only hospitals affiliated to the University of Namibia, located in Windhoek using 
computed or digital radiography were included. 
 In addition KAP measurements were obtained only on adult patients referred for 
conventional radiographic projections; PA and LAT chest, AP and LAT lumbar spine, AP 
pelvis, and PA and LAT skull  that  had a mean weight of 70kg ± 5kg. 
 
1.6 Introduction to the structure of the Thesis 
 
In order to understand the radiation doses delivered to patients referred for conventional 
radiographic projections that is; PA and lateral LAT chest, AP and LAT lumbar spine,  AP pelvis; 
and PA and LAT skull in Windhoek, Namibia, the thesis is structured as follows:   
 
Chapter 2 Literature review 
 
This chapter provides a synopsis for radiation protection as well as the concepts related to 
radiation dosimetry. This chapter discusses the concept of diagnostic reference levels and dose 
measurements in radiography. The chapter similarly highlights the factors that affect radiation 
dose in radiography as well as legislation governing radiation dose measurements. 
 
Chapter 3 Research Methodology 
 
This chapter describes the methodology used in the study. It includes the design, population, 
sampling as well as ethical principles and procedures for data collection. The measures used to 
ensure validity and reliability of the research process are also described. 
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Chapter 4 Research findings 
 
This chapter outlines the research findings from data analysis based on the research question. 
 
Chapter 5 Discussion and conclusion 
 
In this chapter, the results of study are discussed and compared to existing literature. The 
chapter is concluded with recommendations for future research. It further identifies the 
limitations experienced during the study. 
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CHAPTER 2: LITERATURE REVIEW 
 
Ionising radiation plays a vital role in the imaging of the human body. However, it is evident from 
the literature that radiation has the potential to ionise matter, causing potential harmful effects.  
In order to protect patients from harmful effects of ionising radiation, radiation dose as a result of 
medical exposure should be minimised. In order to protect patients against the harmful effects of 
ionising radiation, the IAEA introduced the three principles of radiation protection, namely 
justification, optimisation and dose limitation (IAEA, 2006). Diagnostic reference levels (DRLs) 
are an important quality assurance tool that can be used to minimise radiation doses delivered to 
patients. Over the past decades, various researchers have investigated radiation doses to 
patients and have identified the factors that cause dose variation. Factors that affect radiation 
dose are type of filtration, generator type and the application of manual exposure techniques 
amongst others (Ng et al., 1998; Johnston & Brennan, 2000; Nyathi et al., 2009; Sonowane, et 
al., 2010; Abdelhalim, 2011). In this chapter the principles of radiation protection and dosimetry 
will be discussed. In addition the chapter describes; the legislation regarding DRLs, different 
methods used to obtain DRLs, comparisons of DRLs in different countries and explains the 
factors that cause dose variation.  
 
2.1 Principles of radiation protection  
2.1.1 Justification 
 
Justification in radiography is the process where radiographers and radiologist evaluate the x-ray 
request for x-ray examinations by comparing it with the patient’s clinical history to determine its 
validity. In practice justification involves the usage of correct exposure techniques while 
maintaining diagnostic image quality. Therefore, the principle of justification in radiology means 
that the risk of exposure to ionizing radiation should be balanced, against the benefits derived 
from the procedure. A procedure is justified when the benefits of undergoing a procedure 
outweigh the risk (Von & Williams, 2017). 
 
 
2.1.2 Optimisation 
 
In radiography optimisation is the process where radiographers minimize the amount of radiation 
delivered to patients through selection of correct exposure factors (kVp and mAs) (Martin, 2007). 
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The quality of radiation is dependent on the applied tube potential and the amount of filtration of 
the x-ray beam. Therefore optimisation of radiation protection comprises the application of 
different radiographic techniques and imaging parameters in an effort to minimize radiation dose 
to patients without compromising image quality. Clinically this implies that radiographers adjust 
and select exposure factors with reference to the patient’s body habitus while maintaining 
diagnostic quality (Freitas & Yoshimura, 2009). A quality diagnostic radiograph therefore 
represents a visual appreciation of the patient’s anatomy under examination sufficient to make a 
clinical diagnosis (Vom & Williams, 2017). 
 
2.1.3 Dose limitation 
 
Dose limitation applies to occupational exposure of radiation workers and therefore is not 
applicable to medical radiography procedures (ICRP, 2007).  However, the principle of radiation 
protection in radiography is guided by the As Low As Reasonably Achievable (ALARA) principle. 
According to the Dosimetry Working Party (DWP) of the Institute of Physical Sciences in 
Medicine of the College of Radiographers in the United Kingdom (UK), radiographers are 
responsible for the comfort of patients during radiological procedures (DWP, 1992). As a result, 
radiographers should be concerned about radiation protection and radiation dose when selecting 
exposure parameters during radiological procedures. Therefore, radiographers should keep 
radiation doses as low as reasonably achievable (ALARA) during radiological procedures. 
Diagnostic reference levels were introduced as quality assurance tool for medical exposure 
(IAEA, 2006), encouraging radiographers to minimise radiation dose and optimise the effects of 
ionising radiation.  
 
2.2 Biological effects of radiation 
 
2.2.1 Stochastic effects 
Stochastic effects are also known as probabilistic effects, where the incidence, but not severity 
of appearance, is proportional to the radiation dose received. These effects occur at low doses 
and are related to the damage to the genetic material at cellular level. Stochastic effects have no 
threshold dose; examples include heredity diseases (Kamiya et al., 2015).  
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2.2.2 Non stochastic effects  
 
Non stochastic effects are also referred to as deterministic effects and occur once a threshold 
radiation dose is received. The degree of injury depends on three factors; absorbed dose, dose 
rate and the quality of radiation. These effects can have either a linear or exponential response 
to the radiation dose received. Non stochastic effects are further divided into early and late 
effects. Examples of early effects include haemorrhagic diarrhoea, anaemia, leucopoenia, 
erythema, epilation. Late effects comprises of cataracts, cardiovascular disorders and necrosis 
(Kamiya et al., 2015). 
 
2.3 Quantities for patient dosimetry 
 
Various quantities have been documented in the literature that can be used during patient 
dosimetry studies, namely absorbed dose, entrance skin dose, and entrance surface dose 
(Heggie, 2008; Kron, 2008; Lee et al., 2013). These quantities play a pivotal role in the 
assessment of radiation exposure to humans and are of great importance for radiation protection 
due to the potential harmful effects of ionising radiation (ICRP, 2005). 
2.3.1 Absorbed dose (D) 
 
The energy absorbed per unit mass of the patient is known as the absorbed dose and is 
measured in joule per kilogram (J/kg).  This quantity is specific for all types of ionising radiation. 
The international system (SI) unit for absorbed dose is Gray (Gy).  Absorbed dose was 
previously measured in “rad”, where 100 rad is equal to 1 Gy (Kron, 2008). Mathematically the 
absorbed dose can be expressed as: 
 
dm
d
D

                                                                      
 
Where, dm  is mass of the subject and d is the average energy absorbed (IAEA, 2007). 
 
2.3.2 Entrance skin dose (ESD) 
 
The entrance skin dose (ESD) also known as entrance surface dose ,is defined by (Heggie, 
2008) as the absorbed dose in air in the centre of the x-ray beam and the entrance surface of 
the patient’s skin including backscatter radiation. The ESD is expressed in milligray (mGy). The 
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ESD is measured by means of thermoluminescent dosimeters placed on the patient skin. 
Additionally it can be calculated by multiplying the entrance surface air kerma (ESAK) with a 
backscatter factor (BSF) (Sonowane et al., 2010; European Commission, 1996).  Mathematically 
the entrance skin dose can be expressed as: 
 
ESD (mGy) = ESAK (mGy) x BSF     
 
The magnitude of ESD is dependent on the focal skin distance, for example it decreases as the 
distance from the x-ray source to the skin is increased (Sonowane et al., 2010). 
 
2.3.3 Effective dose (E)  
 
The effective dose is an indicator of harmful effects of exposure to ionising radiation. The 
effective dose is measured in Sieverts (Sv). It is the product of the tissue weight (WT) factors of 
the IRCP, the applicable radiation weighting factor and organ doses (Lee et al., 2013). 
 
2.4 Legislation on diagnostic reference levels (DRL’s) 
 
 
The International Commission on Radiological Protection (ICRP) defines diagnostic reference 
levels (DRL’s) as “a form of investigation level, applied to an easily measured quantity, usually 
the absorbed dose in air, or tissue-equivalent material at the surface of a simple phantom or a 
representative patient”. Furthermore, the ICRP recommends the establishment of diagnostic 
reference levels to optimise the radiation dose delivered to patients during radiological 
procedures (ICRP, 1996). 
 
 As previously mentioned, the concept of diagnostic reference levels has  now been formally 
adopted by the Ministry of Health and Social Services (MOHSS) and is gazetted in the Atomic 
Energy and Radiation Protection Act of 2005 (Republic of Namibia, 2005). With the 
implementation of the Atomic Energy and Radiation Protection Act of 2005 (Republic of Namibia, 
2005), there is now a legal requirement for every radiology department to establish diagnostic 
reference levels. 
 
The Atomic Energy and Radiation Protection Act of Namibia, sub regulation 38 states that 
(1) The director general may determine diagnostic reference levels as a condition of registration 
and ensure that:  
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(2) Diagnostic reference levels are used during radiological procedures using radiation as well 
as during optimisation of radiation protection of patients.  
(3)  X-ray equipment is evaluated in order to compare with diagnostic reference levels. 
(4)  Radiation doses or activities do not fall significantly below the diagnostic reference levels 
and if the need arise start an investigation to avoid loss of image quality. 
(5) Corrective actions are initiated when diagnostic reference levels are exceeded to ensure 
optimisation of radiographic practice. 
(6) Diagnostic reference levels are applied with flexibility and adjusted to allow for higher 
exposures if necessary, and should be revised as technological and scientific advancements 
take place (Republic of Namibia, 2005). 
 
 A diagnostic reference level can be described as a reference level of dose. The dose descriptor 
used to establish DRL’s is dependent on the radiographic examination and is usually expressed 
in either entrance skin doses (ESD) or kerma area product (KAP) for conventional radiographic 
examinations, KAP for fluoroscopic examinations and the dose length product (DLP) for 
computed radiography (CT) examinations. Dose descriptors selected for DRL’s should be an 
easily measurable quantity of radiation exposure (DWP, 1992; Heggie, 2008; Verdun et al., 
2008). 
 
Diagnostic reference values are usually determined by the regulatory authorities in consultation 
with the various professional bodies and should be established for frequently performed 
examinations or those that have a high radiation dose (ICRP, 1996). Regardless of the fact that 
technology has advanced, diagnostic imaging by means of conventional radiography remains 
the most common method of imaging in Namibia due to its availability and affordability.  
 
Diagnostic reference levels are usually selected by means of the 75th percentile of dose 
distributions and assist radiographers with the optimisation of radiation protection to patients. 
This means that 25% of the facilities will surpass the diagnostic reference levels and therefore, 
the reasons for variation should be investigated (Johnston & Brennan, 2000; Gray et al., 2005). 
 
2.5 Tools used to measure radiation dose 
 
The Dosimetry Working Party (DWP) of the National Radiation Protection Board (NRPB) of the 
Institute of Physical Sciences in Medicine (IPSM) in the United Kingdom (UK)  proposes three 
methods to measure radiation doses, namely thermoluminescent dosimeters (TLDs) for 
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measurement of entrance skin doses (ESDs), Kerma area product (KAP) meters for 
measurement of absorbed dose and the mathematical method using an ionisation chamber and 
computing absorbed dose from known exposure factors (DWP, 1992). These methods have 
been well accepted by the International Atomic Energy Agency (IAEA) as well as the European 
commission and have been applied in various dosimetry studies worldwide. According to 
Roberts (1995), dosimetry techniques are dependent on the type of examination, whether digital 
or analogue.   
 
2.5.1 Kerma Area Product (KAP) meter 
 
The KAP is the product of the area of the x-ray beam and the absorbed dose in air at a point in a 
plane perpendicular to the central axis of the beam also known as the Dose Area Product (DAP) 
(IAEA, 2007). According to the Dosimetry Working Party (DWP) of the National Radiation 
Protection Board (NRPB) in the United Kingdom (UK), the KAP is a useful dosimetric quantity 
that can be used for both conventional and fluoroscopic x-ray examinations (DWP, 1992). KAP 
can be measured by means of a KAP meter or calculated by means of tube output (Akinlade et 
al., 2012). 
 
KAP (mGycm2) = L(mAs)DO(mGy/mAs)A(cm
2) (FSD)      
 
Where L is the tube current, DO is the beam output at 1 meter (m), FSD is the focus to skin 
distance and A (FSD) is the cross-sectional area of the beam on the patient’s skin.  
 
The KAP is a dose descriptor that describes the total amount of radiation used in an 
examination. It is measured by means of a KAP meter. The KAP meter consist of a radiolucent, 
flat ionisation chamber with square plates and is used to monitor radiation exposure to patients 
(Dowsett et al., 2006; Allisay-Roberts & Williams, 2008; Ball et al., 2008).  KAP values are 
usually expressed in Gycm2 or mGycm2 and are a good indicator of stochastic effects of 
radiation. Due to its small size, usually 15 cm2, it can be easily be retrofitted on the x-ray tube 
collimator without any interference with the x-ray procedure (DWP, 1992). According to Ball et 
al., (2008); and Dowsett et al., (2008) kerma area product measurements are dependent on the 
radiographic technique employed by the radiographer. Factors that affect the KAP reading are; 
applied tube potential (KVp), tube current (mA), amount of filtration (mm Al), exposure time (in 
milliseconds) as well as the area exposed to radiation (cm2).  Hence, the KAP is a good indicator 
for monitoring the effect of radiographic technique on radiation dose (Ball et al., 2008; & Dowsett 
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et al., 2008). KAP meters do not measure backscatter radiation due to their attachment on the 
tube housing; however, they offer instant display of radiation used in an examination and 
eliminate the need for patient specific dosimeters (Seeram & Brennan, 2006).  South African 
legislation requiring all fluoroscopy x-ray units to be fitted with KAP meters have not been 
implemented in Namibia (Department of Health South Africa, 2006). For this study, the 
researcher used a portable KAP meter. 
 
 
 
 
Figure 2.1 KAP meter mounted on the x-ray collimator at one of the research sites. 
 
2.5.2 Themoluminescent dosimeters 
 
Thermoluminescent dosimeters (TLD’s) are widely accepted tools used to measure entrance 
surface or entrance skin doses during conventional radiography. They are made from dielectric 
material doped with lithium fluoride (LiF) or lithium borate (Li2B4O7) phosphors (Seeram & 
Brennan, 2006; Hobbie & Roth, 2007). The dosimeters are small in size, approximately 3 mm2 
with a thickness of 0.9 mm, and have an atomic number close to normal body tissue, and 
therefore, do not appear on radiographs (Abdelhalim, 2011). Usually the dosimeters are 
attached on the patient’s skin in such a manner that it coincides with the centre of the x-ray 
beam (IAEA, 2006). When the TLD’s are exposed to ionising radiation, electrons are trapped 
and stored in the conduction band of the phosphors (Hobbie & Roth, 2007).  Thereafter, the 
TLD’s are placed in a TLD reader and are heated to a temperature of approximately 250ºC 
(Seeram & Brennan, 2006). The trapped electrons of the conduction band overcome the binding 
energy and fall back to their normal state and gives off light (Hobbie & Roth, 2007). The light is 
read by means of a photocathode and photomultiplier tube and the signal emitted by the TLD is 
recorded. The advantage of this method is that it includes backscatter radiation (Seeram & 
Brennan, 2006). However, the dosimeters require precision and accuracy during handling and 
needs to be calibrated against predetermined energy levels before dosimetry studies 
(Abdelhalim, 2011). This makes the process expensive and cumbersome. Another disadvantage 
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is that the dosimeters have to be read in a laboratory, which may cause variations in the 
recorded signal due to variation in TLD reader performance (Seeram & Brennan, 2006).  In 
addition, there is no immediate record of the dose received. Furthermore, TLD’s are also known 
for signal fade (Seeram & Brennan, 2006). The dose values obtained with TLD’s are expressed 
in milligray (mGy). Radiation dose measurements by means of TLD’s for patient dosimetry 
during conventional radiography have been a well-established method to measure entrance skin 
doses during radiological procedures, however, the use of TLD’s was not suitable for this 
research project, as it may cause patient discomfort and irritation, since the dosimeter is placed 
in direct contact with the patient’s skin (Johnston & Brennan, 2000). 
 
2.5.3 Mathematical method using an ionisation chamber 
 
The ionisation chamber was introduced by Behnken in 1924 and is used to measure radiation 
(Ghom, 2008). It is cylindrical in form and consists of collecting electrodes, negative electrodes, 
an insulator, an air volume and an outer wall.  According to Aird (1988), the chambers contain air 
at atmospheric pressure. When the ionisation chamber is exposed to ionising radiation, the x-ray 
photons interact with the air and the walls of the chamber and release secondary electrons. The 
secondary electrons ionise the air in the chamber. The total charge produced is proportional to 
the radiation dose imparted on the chamber (Aird, 1988). According to Roberts (1995), this 
method is used to measure the absorbed dose in air or air kerma at a specific distance from the 
x-ray source. The Entrance skin dose (ESD) is then computed with reference to the relevant 
exposure factors. 
 
2.5.4 Monto Carlo Simulations 
 
The Monto Carlo Simulations is a PCXMC (2008) version 2.0 computer programme, developed 
by the Finish Radiation and Nuclear Safety Authority. A hermaphrodite MIRD5 phantom is used 
and scaling factors are applied to modify the size of the phantom. Monto Carlo simulations are 
performed based on the technique factors applied in the clinical setting. The programme 
calculates effective and organ doses for 29 organs based on ICRP 60 and 103 tissue weighing 
factors (Sermovaa & Tapiovaara, 1998; Kramer et al., 2008).  
 
The PCXMC (2008) version 2.0 programme simulates how x-ray photons are spread through 
tissue during exposure. These simulations are based on the interaction of x-ray photons as they 
pass through tissue. The simulations are completed when all particles are annihilated and drop 
below a specific threshold level. The organ and effective doses are calculated from the sampling 
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histories generated and the mean values of the energy deposits. The programme considers the 
following organs, adrenal glands, brain, breast, colon, gall bladder, heart, kidneys, liver, lungs, 
lymph nodes, muscle, oesophagus, oral mucosa, ovaries, prostate, pancreas, salivary glands, 
skeleton, skin , small intestine, spleen, stomach, testicles, thymus, thyroid, urinary bladder , 
uterus and active bone marrow (Sermovaa & Tapiovaara, 1998; Trap & Johnston, 2008). 
2.6 Diagnostic reference levels comparison 
 
As previously mentioned, diagnostic reference levels can be described as a reference level of 
dose. The dose descriptor used to establish DRL’s is dependent on the radiographic 
examination and is usually expressed in either entrance skin doses (ESDs) or Kerma area 
product (KAP) for conventional radiographic examinations (DWP, 1992; Heggie, 2008; Verdun et 
al., 2008). 
 
Table 2.1 shows the entrance skin doses for conventional x-ray examinations. Some report the 
mean (Aliasgharzadeh et al., 2015), median (Ng et al., 1998; Ofori et al., 2014) and 75th 
percentile (Osibote & de Azevedo, 2008; Nyati et al., 2009; Sonowane et al., 2010). The table 
demonstrates ESD’s for six countries and shows that values ranged from 0.10 mGy to 0.68 mGy 
for PA chest. In addition the table also shows that the 75th percentile radiation doses for AP 
pelvis range from 2.98 mGy to 10mGy. It can be noted from the table that there’s a variation in 
radiation doses, thereby justifying the need of country specific DRLs (ICRP, 1996). 
 
Table 2.1 Comparison of Entrance Skin Doses (ESDs) for the seven projections  
 
Exam IAEA 
(1996) 
 
Ng et 
al., 
(1998) 
Osibote 
& de 
Azevedo 
(2008) 
Sonowane 
et al., 
(2010) 
Nyati et 
al., 
(2009)  
Ofori et 
al, 
(2014) 
Aliasgharzadeh 
et al., (2015)  
PA 
chest 
(mGy) 
0.4 0.3 0.24 0.68 0.10 0.27 0.37 
LAT 
chest 
(mGy) 
1.5 1.2 0.62 1.74 0.22 0.43 0.99 
AP 
lumbar 
spine 
(mGy) 
10 9.1 2.60 8.39 5.30 3.25 2.18 
LAT 
lumbar 
spine 
30 14.0 4.75 15.66 NR NR 5.36 
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(mGy) 
AP 
Pelvis 
(mGy) 
10 5.3 NR 8.03 2.98 1.31 1.76 
PA Skull 
(mGy) 
5 4.7 1.55 6.89 NR NR 1.39 
LAT 
Skull  
(mGy) 
3 3.0 NR 5.16 NR NR 1.01 
NR- not reported 
 
 
Some factors that cause dose variations are applied kilovoltage (kV), type of screens used, type 
of imaging whether digital or analogue and focus-to-skin distance (Ng et al., 1998; Compagnone 
et al., 2006; Nyati et al., 2009). For example the setting of manual exposures instead of 
automatic exposures resulted in dose variations in the study by Nyati et al., (2009), whereas 
poor collimation practices and short focus film distance resulted in dose variations in the study 
by Ng et al., (1998). Similar to Ng et al., (1998), a study conducted by Olowookere et al., (2011), 
found that radiographers fail to adjust the radiographic technique and exposure factors based on 
the patient’s body habitus. Olowookere et al., (2011) found that radiographers used a constant 
tube potential of 80kVp for patients of different mass and body habitus. In addition, the 
radiographers used a short focus-to-skin-distance (FSD) for imaging of chest projections. The 
use of low kVp and constant tube current without adjustment to patient body habitus indicates 
that patients are exposed to high radiation doses in order to obtain good quality image. This is 
contrary to the ALARA principle that states that radiographers should obtain radiographs at the 
lowest possible dose without compromising image quality. Olowookere et al., (2011) concluded 
that radiographers are unaware of the radiation doses during radiography procedures. 
 
2.7 Dose optimising strategies  
 
The exposure factors selected is directly controlled by the radiographer. These are tube potential 
energy, tube current, exposure time and quantity of radiation produced. 
 
2.7.1 Tube potential energy (kVp) 
 
The tube potential, also known as the kVp, controls the penetrating ability of the x-ray beam, 
where high kVp x-ray beams are more penetrating then low kVp beams. When radiographers 
use low kVp techniques, it results in higher patient doses as some x-ray photons may not have 
enough energy to penetrate the patient (Seeram & Brennan, 2017). A study on ESD’s conducted 
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by Nyathi, et al., (2009) for chest, pelvis, abdomen, lumbar spine in two x-ray rooms found 
ESD’s to be well within internationally established reference levels. It was also noted that 
radiographers used a high kV technique for chest radiography (109kV to 125kV for PA chest 
examinations). This is consistent with international standards.  
 
2.7.2 Tube current (mA) 
 
The tube current controls the quantity of radiation released from the x-ray tube and is directly 
proportional to the mA.  The patient dose is increased by high tube current (mA) (Seeram & 
Brennan, 2017).  
 
2.7.3 Exposure time.  
 
When exposure times are long the radiation dose to the patient is increased (Seeram & 
Brennan, 2017) 
 
2.7.4 Radiation quantity (mAs) 
 
The quantity of radiation is equal to the product of exposure time and tube current. When the 
mAs increases, the radiation dose to the patient increases (Seeram & Brennan, 2017). In a 
study conducted my Sonowane et al., (2010), dose variations were due to high mA set by 
radiographers, ranging from 17 to 32 for PA and lateral chest. The mA values were 
approximately 50% more than the study by Ng et al., (1998). Similar to Ng et al., (1998), a study 
conducted by Olowookere et al., (2011) indicate that radiographers used a constant tube current 
of 15 mA and 9 mA for PA chest dependent on patient body habitus. A high mA technique 
necessitates a lower kVp resulting in higher radiation doses in order to obtain a good quality 
image.  
 
2.7.5 Collimation 
 
Collimation is the process where radiographers select and restrict the x-ray beam to the area of 
interest. Collimation therefore determines the field size that will be exposed to radiation. When 
radiographers apply correct collimation, patient radiation doses may be reduced between 27% to 
60% (Fauber & Dempsey, 2013). 
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2.7.6 Source to image distance (SID) 
  
The minimum recommended SID is usually 100 cm, and is changed based on the anatomical 
area that need to be imaged (Seeram & Brennan, 2017). The shorter the SID, the higher the 
dose to the patient and vice versa. When the SID is increased it may significantly reduce the 
effective doses of up to factor of 23 (Joyce et al., 2013). This finding is consistent with 
Olowookere et al., (2011), who found that the ESD’s may be dependent on the focus-to-skin-
distance (FSD). In their study Olowookere et al., (2011) noticed that dose variations was a result 
of the short FSD (105cm) that was used for PA chest projections instead of the 150-180cm 
recommended (European Commission, 1996). 
 
2.7.7 Automatic Exposure Control (AEC) 
 
AEC are electronic devices that terminate the radiation exposure once the programmed radiation 
reaches the image receptor. AEC devices eliminate problems where patients may be 
overexposed due to different patient body habitus; patient pathology and the wear and tear of 
the x-ray tube. In order to effectively operate AEC devices, there is a need to train radiographers 
on how to operate these devices in clinical practice (Seeram & Brennan, 2017).   
 
2.7.8 Equipment type  
 
The type of radiographic equipment whether conventional film-screen, computed radiography or 
digital radiography will also have an effect on the dose delivered to patients. In a study 
conducted by Compagnone et al., (2006), computed radiography contributed to higher entrance 
skin doses when compared to conventional film screen radiography and direct digital 
radiography.  The authors noted that direct digital radiography techniques resulted in lower 
effective doses up to 43% lower than when film screen radiography were used. Overall, the 
effective dose calculated for AP and LAT lumbar spine projections was 54% higher when 
computed radiography systems was used compared to film screen radiography.   
 
2.8 Conversion coefficients 
 
Conversion coefficients are constants that explain the relationship between two dosimetric 
quantities.  Estimation of effective dose by means of the PCXMC programme could be laborious. 
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Therefore conversion coefficients may be used to estimate entrance skin dose (ESD) or effective 
dose (E) from KAP values in the radiology department. The conversion coefficients for 
radiographic procedures can be obtained by dividing  the entrance skin dose (ESD) or effective 
dose (E) by the KAP value and is given E/KAP and skin dose (ESD/KAP) (Hansson & 
Karambatsakidou, 2000; Compagnone et al., 2005). 
  
The literature review above highlights the importance of diagnostic reference levels in the 
optimisation of radiation protection to patients.  Factors that may cause dose variation and more 
importantly the need for country specific and region specific diagnostic reference levels were 
found to be: exposure parameters used such as the tube potential and or mA selected, the 
radiographic technique selected and source to image distance. In order to minimise the harmful 
effects of ionising radiation and to keep radiation doses aligned with the ALARA principle it is 
evident that diagnostic reference levels are an inexpensive tool that can be used to monitor 
radiation doses to patients. The next chapter will describe the methodology used in the research 
process.  
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CHAPTER 3: METHODOLOGY 
3. Introduction 
 
The purpose of the study was to develop LDRL’s for commonly performed conventional 
radiography projections in Windhoek, Namibia. 
The objectives of the study were to: 
 
• Measure KAP for PA and lateral LAT chest, AP and LAT lumbar spine, AP pelvis, and PA 
and LAT skull projections. 
• Calculate entrance skin and effective doses from the recorded KAP values. 
• To compare the KAP, entrance skin doses and effective doses with internationally 
established reference levels for the same procedure as well as similar studies in Africa. 
• Develop conversion coefficients from KAP values for estimation of effective and skin 
doses in clinical practice. 
 
This chapter describes the research design, sampling strategies, scope, research instrument 
and procedures that were followed to collect data as well as ethical considerations applied 
during the study. 
 
3.1 Research design 
 
A prospective, quantitative research design was adopted to measure the KAP values, and 
calculate ESD, ED and develop conversion factors for four conventional radiographic 
examinations. The study was divided into two phases. Phase one involved a quantitative 
approach where KAP measurements were obtained and phase two was a correlational approach 
to calculate ESD and ED using the PCXMC (2008) 2.0 Monto Carlo Software.  
 
 
3.1.1 Site Selection: 
The sampling frame for selecting the research sites was the geographical location of Windhoek 
Namibia (Figure 3.1). 
 
 21 
 
 
Source: (Hitchcock, 2015) 
 
Figure 3.1 Map of Namibia illustrating, the research site  
 
Two public and one private hospital located in Windhoek registered with the National Radiation 
Protection Authority were approached to participate in the study through a letter of invitation 
(refer to appendix 2 to 4). The letter of invitation explained the purpose and motivation of the 
study. Windhoek is located in the Khomas region of Namibia and consists of one (1) national 
referral hospital, one (1) Intermediate hospital, and one (1) health centre that provide radiological 
services to patients. In addition, there are approximately seven private radiology facilities that 
also provide x-ray services to patients. The three hospitals in Windhoek were selected because 
they employ computed radiography and digital radiography in their radiology departments 
whereas the other regions still employ analogue systems. In addition, they are the three training 
hospitals affiliated to the University of Namibia, and are the largest hospitals in Namibia. The 
researcher is employed as an assistant lecturer at the University of Namibia and could therefore 
gain access to the selected research sites. 
  
These hospitals were purposefully selected in the geographical area of Windhoek as they are 
representative of radiography practices in the area thus increasing the reliability and validity of 
the results for radiation dosimetry studies (Hart et al., 2000). 
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3.1.2 Equipment selection 
 
From each hospital, the x-ray room dedicated for conventional radiographic examinations was 
identified using a purposeful sampling method.  Information regarding the x-ray equipment was 
recorded. This included;  type of generator, type of x-ray tube, filtration, waveform, presence of a 
anti scatter grid and the ratio, focal spot size, automatic exposure control (AEC), and presence 
of quality assurance programmes. Refer to (appendix 5) for a copy of the data collection sheet 
(DWP, 1992; Council of European Commission, 1996; Johnston & Brennan, 2000; Abdelhalim, 
2009). Specifications regarding the x-ray equipment are given in table 3.1 below. 
 
Table 3.1 Specifications regarding x-ray equipment at different study sites 
 
Hospital 1 2 3 
Type of x-ray unit Computed (CR) Direct Digital (DR) Direct Digital (DR) 
Manufacturer Philips Siemens Philips 
X-ray tube Ceiling-suspended Ceiling-suspended Floor mounted 
Generator  Optimus 50kW HV  50kW generator M cabinet CXA Pro 50kW 
Total filtration ≥2.5mm Al at 100 kV ≥2.5mm Al at 80 kV ≥2.5mm Al at 100 kV 
Inherent filtration ≤0.30mm Al ≤0.60 mm Al ≤0.30mm Al 
Motorized filters 2mm Al 
1mm Al + 0.1 Cu 
1mm Al + 0.2 Cu 
2mm Al 
1mm Al + 0.1 Cu 
1mm Al + 0.2 Cu 
2mm Al 
1mm Al + 0.1 Cu 
1mm Al + 0.2 Cu 
Anode angle 13º 12º 13º 
 
 
 
Information regarding the anode angle was collected retrospectively as this was not included 
during the initial phase of the data collection process. This information was used as input data 
for Monto Carlo Simulations in phase two of the research project. 
 The x-ray unit at hospital 1 was a Philips Duradiagnost.  It consisted of a 50kW Optimus 
generator, with a ceiling suspension (Figures 3.2 and 3.3). 
 The x-ray unit at hospital 2 was a Siemens Multix Fution Max RF 80. It consisted of 
50kW generator with ceiling suspension (Figures 3.4 and 3.5).  
 23 
 
 The x-ray unit at hospital 3 was a Philips Duradiagnost 4. It was a floor mounted x-ray 
tube with a CXA Pro 50kW generator (Figures 3.6 and 3.7). 
 
 
Figure 3.2 Philips Duradiagnost at research site 1 
 
 
 
Figure 3.3 Philips Duradiagnost controls and display monitor at research site 1 
 
 
Figure 3.4 Siemens Multix Fution Max RF 80 at research site 2 
 
 24 
 
 
Figure 3.5 Siemens Multix Fution Max RF 80 controls and display at research site 2 
 
 
Figure 3.6 Philips Duradiagnost 4 at research site 3 
 
 
Figure 3.7 Philips Duradiagnost 4 controls and display at research site 3 
 
KAP values were obtained from a portable KAP meter (VACUDAP, Germany) (Figure 2.1) that 
was retrofitted onto the collimator of each of the x-ray machines. The KAP values was obtained 
by the research assistant and recorded on the research instrument (refer to appendix 6). The 
KAP meter was reset after each exposure. The KAP meter was calibrated prior to 
commencement of the study (see appendix 7). There was only one KAP meter available to the 
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researcher, therefore data could not be collected concurrently. It was initially anticipated that 
KAP values be obtained on a sample of 20 patients for each examination at each hospital. 
However, for some examinations a minimum of 10 patients were recruited. This was consistent 
with international guidelines which recommend that 10 patients be included for each examination 
(DWP, 1992; European Commission, 1996; IAEA, 2007).  
 
3.1.3 Study population 
 
The population was all adult patients that underwent chest PA and LAT, lumbar spine AP and 
LAT, pelvis AP, and skull PA and LAT at the different study sites from June 2014 to July 2017. 
 
3.1.4 Sampling of conventional radiography procedures 
 
A purposive sampling method was used to select research participants.  Chest examinations 
were included because they are most commonly performed procedure, whilst lumbar spine 
examinations have a high radiation dose and low diagnostic yield (Khoo et al., 2003; IAEA, 
2009). The ICRP recommends that diagnostic reference levels be established on the most 
frequently performed examinations or examinations with high radiation doses (ICRP, 1996). 
However, the IAEA request in 2005 suggested the establishment of diagnostic reference levels 
for common radiographic examinations. Extremity radiographs have not been considered, as the 
exposure factors employed during these procedures are usually relatively low. According to 
(Ofori et al., 2012), it is important to include pelvic radiographs in patient dosimetry studies. The 
pelvis contains both male and female sex organs, which are highly sensitive to ionising radiation 
and should always be protected during radiography examinations hence it was included as part 
of establishing DRLs for this study. 
 
3.1.5 Inclusion criteria 
 
It is known that the patient’s weight may affect radiation dose results. Therefore only adults that 
underwent chest, lumbar spine, skull and pelvis x-ray examinations aged ≥18 years and that 
weighed ≥ 65 kg and ≤ 75 kg were included in this study. Guidelines provided by the dosimetry 
working party, European commission, and IAEA states that patients must weigh more than 60 kg 
but less than 80 kg (DWP, 1992; European Commission, 1996; IAEA, 2007). The weight 
restriction in this study ensured that the mean weight of patients were in the range of 65-75kg 
which is indicative of an average patient of 70kg (Hart et al., 2000). The study followed 
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guidelines on direct dose measurements as established by the dosimetry working party (1992) of 
the National Radiological Protection Board (NRPB) of the College of Radiographers in the 
United Kingdom, European commission (1996) and International Atomic Energy Agency (IAEA, 
2007).The NRPB recommends that dose measurement studies be performed on a minimum of 
10 patients, rather than phantoms or free air in order to provide a true measurement of clinical 
practice. In order to meet the objectives, KAP measurements were obtained from 218 
participants undergoing conventional radiography examinations. 
 
3.1.6 Exclusion criteria 
 
All patients that were younger than 18 years and whose weight was outside the recommended 
range of 65kg to 75 kg were excluded. Similarly all vulnerable population such as mentally, 
physically challenged, imprisoned patients or critically ill patients were excluded from the study. 
 
3.1.7 Data collection procedure 
 
Data was collected by the researcher and a trained research assistant at each research site. 
The research assistants were all qualified diagnostic radiographers.  Data was collected on 218 
patients and 7 projections (379 examinations).  A total of 61 participants were recruited for chest 
examinations (mean weight =69.86 kg), 48 for lumbar spine examinations (mean weight = 
69.51kg), 57 for pelvis examinations (mean weight =70.59 kg) and 52 for skull examinations 
(mean weight =69.77 kg) refer to Table 3.2 below. 
 
Table 3.2 Summary of the sample size and exposure parameters used at the different 
study sites 
Examinati
on 
PA 
Chest 
LAT 
Chest 
AP 
Lumbar 
Spine 
LAT 
Lumbar 
Spine 
AP 
Pelvis 
PA Skull  LAT 
Skull 
Hospital 1 CR unit 
No of 
patients 
20 20 20 20 26 21 21 
Mean age 33 (20-
73) 
33 (20-
73) 
42(23-81) 42(23-81) 44(18-73) 30(20-44) 30(20-44) 
Mean 
mass (kg) 
69.51(65.
3-74.6) 
69.51(65.
3-74.6) 
69.45(65.
1-75) 
69.45 
(65.1-75) 
69.74(65.
1-75) 
69.03(65.
1-74.8) 
69.03(65.
1-74.8) 
Mean kVp 109 
(102-117) 
113 
(109-117) 
77.8 
(70-85) 
83.5 
(73-96) 
76.2 
(73-81) 
72.8 
(63-77) 
71 
(66-73) 
Mean mAs 
 
4.6 (4-
6.3) 
5.4(4-6.3) 34.5 (25-
50) 
42.95(32-
63) 
26.06 
(10.7-
40.0) 
27.03 
(16-40) 
24.3 
(10.1-32) 
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Image 
receptor 
size 
35X43 35X43 35X43 35X43 35X43 24X30 24X30 
Mean SID 
(cm) 
150 150 100 100 102 103 103 
AEC used No No No No No No No 
Hospital 2 DR Unit 
No of 
patients 
21 21 17 17 13 12 12 
Mean age 42 
(19-75) 
42 
(19-75) 
46 
(31-75) 
46  
(31-75) 
46 
(27-74) 
33 
(18-51) 
33 
(18-51) 
Mean 
mass (kg) 
71.4 
(65.5-
75.0) 
71.4 
(65.5-
75.0) 
70.57 
(65.1-75) 
70.57 
(65.1-75) 
71.80 
(65.6-75) 
70.43 
(65.3-75) 
70.43 
(65.3-75) 
Mean kVp 118  
(105-125) 
118 
(117-125) 
73.7  
(69-87) 
86.6 
(81-90) 
77.7 
(70-81) 
68.4 
(66-73) 
70.5 
(66-73) 
Mean mAs 1.9 (0.7-
4.7) 
8.01 (1.3-
16.6) 
50.57 
(17.9-
87.25) 
58.6 
(21.6-
100.8) 
76.3 
(17.9-
183) 
34.6 
(10.9-
59.8) 
19.3 (7.5-
64.8) 
Image 
receptor 
size 
35X43 35X43 35X43 35X43 35X43 24X30 24X30 
Mean SID 
(cm) 
176 176 119 119 117 1150 129 
AEC used Yes Yes Yes Yes Yes Yes Yes  
Hospital 3 DR unit 
No of 
patients 
20 20 11 11 18 19 19 
Mean age  36(18-54) 36( 18-
54) 
47 (22-
79) 
47 (22-
79) 
44(25-60) 34(21-53) 34(21-53) 
Mean 
mass (kg) 
68.67  
(65.1-
74.8) 
68.67 
(65.1-
74.8) 
68.50 
(65.9-75) 
68.50(65.
9-75) 
70.82(65.
1-75) 
69.85 
(65.1-
74.4) 
69.85 
(65.1-
74.4) 
Mean kVp 125 125 77 88.8  
(77-90) 
79.5  
(77-80) 
77.5 
(77-80) 
73.8  
(73-80) 
Mean mAs 1.5 (0.8-
6.3) 
3.8 (1.4-
9.6) 
18.66 
(7.4-33.7) 
13.7 (8.2-
23.4) 
13.72 
(7.2-27.1) 
17.9 (7-
20.1) 
10.4 (7-
10.1) 
Image 
receptor 
size 
35X43 35X43 35X43 35X43 35X43 24X30 24X30 
Mean SID 
(cm) 
150 152 104 104 108 103 103 
AEC used Yes Yes Yes Yes Yes Yes Yes 
*ranges are shown in parenthesis () 
 
The researcher and trained research assistant recorded the participants weight, height, x-ray 
number, anatomical thickness of part under investigation, age, gender, hospital, applied 
kilovoltage (kV), exposure time, source to image distance (SID), tube current (mA or mAs), 
automatic exposure control (AEC) settings if applied as well as KAP meter values for each 
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radiographic examination. [Refer to appendix 6. (European Commission, 1996; Johnston and 
Brennan, 2000; IAEA, 2004)]. 
 
The participants’ weights were measured inside the x-ray room, with a digital bathroom scale. 
Height measurements were obtained by means of a measuring tape that was attached on the 
wall. The patient thickness (PT) in the centre of the x-ray beam was measured by means of a 
measuring tape running from the x-ray tube to the table top. Once the distance from the x-ray 
source to the table top has been measured, the thickness of the anatomical part was measured 
by measuring the distance from the x-ray source to the patient (STP) where the beam is centred. 
Therefore, patient thickness was calculated for each projection by subtracting the source to 
patient distance from the source to table top distance. 
 
In order to determine patient thickness: the source to patient thickness was measured as 
follows: 
 
PA Chest projection: distance from the x-ray source to the surface of the patient in the midline at 
the level of the 7th thoracic vertebra where the radiographer centres the x-ray beam (Bontrager 
& Lampignano, 2013). 
LAT Chest projection: distance from the x-ray source to the surface of the patient in the 
midaxillary region at the level of the 7th thoracic vertebra where the radiographer centres the 
beam (Bontrager & Lampignano, 2013). 
AP Pelvis: distance from the x-ray source to the surface of the patient in the midline 5 cm below 
the level of the Anterior Superior Iliac Spine (ASIS) where the radiographer centres the beam 
(Bontrager & Lampignano, 2013). 
AP Lumbar spine: distance from the x-ray source to the surface of the patient in the midline at 
the level of the iliac crest where the radiographer centres the beam (Bontrager & Lampignano, 
2013). 
LAT Lumbar spine: distance from the x-ray source to surface of the patient at the level of the 
iliac crest where the radiographer centres the beam (Bontrager & Lampignano, 2013). 
PA skull: distance from the x-ray source to the surface of the patient, in the midline midway 
between the External Auditory Meatuses to exit at the Glabella (Bontrager & Lampignano, 2013). 
LAT skull: distance from the x-ray source to the surface of the patients’ skin at a point midway 
between the Glabella and inion where the radiographer centres the beam (Bontrager & 
Lampignano, 2013). 
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3.2 Research assumptions  
 
The research was based on the following assumptions: 
 
 KAP values were consistently and accurately recorded. 
 The research assistant and researcher adhered to the data collection procedure when 
recruiting research participants. 
 All equipment was properly calibrated and working properly. 
 The x-ray equipment underwent the mandatory periodic quality assurance checks.  
 
3.3 Dose calculations 
 
During the second phase a correlational approach was adopted to calculate the effective and 
entrance skin doses from the KAP measurements using PCXMC 2.0 software programme. The 
Monto Carlo programme was developed in 1997. It calculates organ and effective doses based 
on the ICRP (60) and ICRP (103) using the different tissue weighting factors of patients. The 
physical parameters for patients (height, weight, as well as the exposure data (focal to skin 
distance (FSD), x-ray field size, filtration material and anode angle, projection (AP, PA or LAT), 
KAP value, kilovoltage (kVp), source to detector distance (SID) was entered into the Monto 
Carlo PCXMC 2.0 (Finland, 2008) software programme (Bor, et al, 2004). Refer to appendix (8-
28) 
 
The PCXMC (2008) 2.0 programme simulates how x-ray photons are spread through tissue. The 
simulation is based on different attenuations and interactions that the photons experience as 
they pass through the different body tissues (Sermomaa & Topiovaara, 1998).  In this study 
simulations were performed with 20000 histories for each radiographic projection using the 
exposure factors for each patient. A study conducted by (Behardien Peters, 2017) shows that 
using more interactions only slows the computer while the effective and skin doses may not 
differ significantly (1%). The energy deposited was used to calculate effective and entrance skin 
doses for each projection. The x-ray field size for some projections was not recorded. It was 
assumed that the collimated field size was spread over the maximum area of the image receptor 
(refer to table 3.3). 
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Table 3.3 Estimated field size of image receptors for the different x-ray examinations 
 
Examination Field size (cm x cm) 
Chest (PA) 35 x 43 
Chest (LAT) 35 x 43 
Lumbar Spine (AP) 35 x 43 
Lumbar Spine (LAT) 35 x 43 
Pelvis (AP) 35 x 43 
Skull (PA) 24 x 30 
Skull (LAT) 24 x 30 
 
Additional parameters entered into the Monto Carlo programme is shown in the table 3.4 below. 
 
Table 3.4 Parameters selected for the Monto Carlo programme for the different 
radiographic projections. 
 
Parameters Chest 
(PA) 
Chest 
(LAT) 
Lumbar 
Spine 
(AP) 
Lumbar 
Spine 
(LAT) 
Pelvis 
(AP) 
Skull 
(PA) 
Skull 
(LAT) 
X ref and Y ref 0 0 0 0 0 0 0 
Z ref 50 50 20 20 10 83 83 
Projection angle 90o 0o 270o 0o 270o 90o 0o 
Cranio-caudal 
angle 
0o 0o 0o 0o 0o 0o 0o 
Maximum 
energy 
150 kV 150 kV 150 kV 150 kV 150 kV 150 kV 150 kV 
Number of 
photons 
20000 20000 20000 20000 20000 20000 20000 
Anode angle 
Hospital 1 
13o 13o 13o 13o 13o 13o 13o 
Anode angle 
Hospital 2 
12o 12o 12o 12o 12o 12o 12o 
Anode angle 
Hospital 3 
13o 13o 13o 13o 13o 13o 13o 
Filtration 2.5mm 
Al 
2.5mm Al 2.5mm 
Al 
2.5mm Al 2.5mm 
Al 
2.5mm 
Al 
2.5mm 
Al 
 
 
3.4 Delimitation of the research 
 
 Only hospitals affiliated to the University of Namibia, located in Windhoek using 
computed or digital radiography were included. 
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 In addition KAP measurements were obtained only on adult patients referred for 
conventional radiographic projections; PA and LAT chest, AP and LAT lumbar spine, AP 
pelvis, and PA and LAT skull  that  had a mean weight of 70kg ± 5kg. 
 
3.5 Reliability and validity of the research instrument 
 
Reliability of a research instrument can be described as the extent to which the research 
instruments yields the same results over time. In other words, the ability to consistently and 
accurately reproduce the data needed for analysis (Schneider et al., 2003). For the purpose of 
this research, digital bathroom scales were used to obtain patients’ weights. This eliminated 
inter-reader variability when obtaining patients’ weights.  Similarly measuring tapes attached to 
the x-ray tube marked in millimetres (mm) were used to measure participants’ thickness, as well 
as the participants’ height. These measurements were verified by the radiographer positioning 
the patient. The KAP meter (VACUDAP, Germany) was calibrated at the manufacturer (refer to 
appendix 7).  It is recommended that KAP meters be calibrated annually. A medical physicist 
employed at the National Radiation Protection services of Namibia was consulted to calibrate 
the KAP meter upon installation at each research site.  In order to ensure that data were 
collected in a consistent manner, the researcher provided training to the research assistants 
regarding the research protocol.  
 
3.6 Sources of uncertainty 
 
 The KAP meter was calibrated against a reference instrument IEC 60580 and has a combined 
uncertainty of ±25%. Therefore the KAP meter might overestimate the KAP values (refer to 
appendix 29).  The KAP meter values were corrected using the correction factor for kilovoltage 
 ≥ 70 kVp (refer to appendices 30 and 31).The digital scale was calibrated by placing it on a flat 
surface; it was reset to zero before weight measurement were obtained, only patients whose 
weight has been obtained by the researcher or research assistant was included in the study. 
 
3.7 Pilot study 
 
Uys and Basson (1985) describe piloting as a small study that helps the researcher to refine the 
data collection plans with reference to the data collection procedure and equipment. In addition, 
it helps with conceptual clarification of the research design as well. A pilot study was conducted 
on five patients at one of the selected hospitals using the methodology described in the research 
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proposal. This allowed for adjustments in the data collection sheet and allowed the researcher to 
accustom himself with the research instruments and research participants (Uys & Basson, 
1985). The data obtained during the piloting of the instrument was not included in the final data 
analysis. 
 
3.8 Research Ethics 
 
Ethical approval was sought from the Health and Wellness Research Ethics committee of the 
Cape Peninsula University of Technology (appendices 32-34). Permission to conduct the study 
was granted by the; Permanent Secretary of the Ministry of Health and Social Services 
(MOHSS) in Namibia (appendix 35), the Director of the Radiation Protection Services (appendix 
36), as well as the principal radiographers and practice managers at the research sites (refer to 
appendix 37).   
 
The ethical principles of non-maleficence, beneficence, justice and respects for autonomy were 
followed throughout the research process (Pera & van Tonder, 2011).The objectives of the 
research were explained to participants upon arrival at the x-ray department. The risk of the 
study was negligible, as it only recorded the patient’s weight, height and anatomical thickness as 
well as the kerma area product values of patients referred for the selected examinations without 
changing the protocol or positioning technique and did not interfere with the management or 
diagnosis of the patient. Patients were also not exposed to any additional radiation during the 
research process. In order to respect the patient’s right to privacy, all measurements were 
obtained inside the x-ray room. Patients were included in the study on a voluntary basis after 
careful explanation of the research objectives and after informed consent had been obtained. 
Consent letters was in English and a translator was used in cases were the participant could not 
converse in English. The patient information leaflet and consent form is found in appendix 38.  
The translator was a qualified radiographer or student as not to breach patient confidentiality. 
The data obtained was stored and locked in the researcher’s office, where only the researcher 
had access. The data collection form was also coded in order to protect the identity of research 
participants and to maintain anonymity. The data recorded from the patient was limited to the 
patients’ weight, height, and anatomical thickness, age, gender and exposure factors and x-ray 
number (refer to appendix 6). No names or hospital number was required for this study. The 
hospitals were each assigned a study code so that the identity of participants were not be 
revealed during publication of the results. 
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3.9 Data analysis 
 
The raw data obtained in this study was entered into a computer using Microsoft Excel 2016, 
and was analysed by using descriptive and inferential statistics (Marshall & Jonker, 2010).  The 
data analysed included the patient’s height, weight, equipment was well as exposure 
parameters. The researcher used the 3rd quartile of KAP meter values to set DRL’s for the four 
conventional x-ray examinations (7 projections) (DWP, 1992). Six statistical tests were used 
during data analysis, correlation, regression analysis, linear correlation co-efficient, Co-efficient 
of determination (R2), Chauvenet’s criterion test as well as Pearson’s co-efficient of skewness. In 
this study a regression line was drawn to correlate entrance skin doses with KAP values for each 
radiographic examination.  
 
3.9.1 Linear regression 
 
In this study linear regression was used to assess the relationship between the KAP values and 
the calculated skin dose for the four conventional (7 projections) examinations. A straight 
(regression) line was drawn to join all data points on the scatter plots. The regression line was 
used to quantify the relationship been the KAP and ESD’s.  When there is a linear relationship 
between two variables, the linear regression model is applied to predict the effect on the 
independent variable on dependant variable (De Muth, 2006).  
 
3.9.2 Correlation 
This is a statistical technique that determines the relationship between two variables (Machin et 
al., 2007). The strength and direction of the relationship is denoted by the correlation coefficient 
abbreviated r. The correlation coefficient ranges from -1 to +1, and demonstrate the relationship 
between variables. A positive relationship is demonstrated by a linear correlation where negative 
relationship is depicted by an inverse proportional correlation. Therefore when one value 
increases the other value decreases (Machin et al., 2007). A linear relationship is therefore 
between (-1≤ or +1).  
3.9.3  Co-efficient of determination, R² 
The co-efficient of determination, R², is a statistical measure that is used to evaluate the 
relationship between the independent and dependant variable. R2 is applied to explain how one 
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variable influences the other and ranges from (0≥R2≤1). In addition R2 illustrates the strength of 
the relationship between the independent and dependant variable. On a scatter plot diagram, R2 
is used to determine how data is scattered around the mean of y values. R2, is therefore 
described as the ratio of explained variation to the total variation expressed as percentage.  R2 
describes data adjacent to the regression line. For example if r=0.91, then R2=0.8281.This 
suggests that 82.81% of the difference in y values can be explained by the linear relationship 
between x and y whereas the residual 17.79% remains unexplained (De Muth, 2006; Mckillup, 
2006; Mathbits, 2019). 
 
3.9.4 Chauvenet’s criterion test 
The Chauvenet’s criterion test is a test used in the rejection of outliers (Harris & Taylor, 2006; 
Lin & Sherman, 2007; Reddy, 2011). Knowledge of the standard deviation and mean of the 
sample under investigation is required. It is used to a reject a data point for small data sets up to 
a 1000, and is applied to samples that are either normally distributed, skew or multi-modal 
(Harris & Taylor, 2006; Lin & Sherman, 2007; Reddy, 2011). 
The formula for data rejection were 
𝑑𝑚𝑎𝑥
𝑆𝑥
= 0.819 + 0.544. 𝐼𝑛(𝑛) − 0.02346. 𝐼𝑛(𝑛2) 
Where, Sx, is the standard deviation of the data set and n is the number of data points. Data can 
be rejected by comparing a specific data point to the mean of the data by using a normal 
probability table (Harris & Taylor, 2006; Lin & Sherman, 2007; Reddy, 2011). 
The KAP values for each of the projections that were very different from the means were 
investigated to see if they influenced the results. The data points were retained as they did not 
have a significant effect on the results.  
 
3.9.5 Pearson’s Co-efficient of skewness  
The Pearson’s co-efficient of skewness was used to determine how data was distributed around 
the mean.  
Co-efficient of skewness = 
𝟑(𝑴𝒆𝒂𝒏−𝑴𝒆𝒅𝒊𝒂𝒏)
𝛔
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The coefficient of skewness ranges from -3 to 3 and indicates whether data is positively or 
negatively skewed. When data is positively skewed the mean is greater than the median, 
whereas negatively skewed data is presented when the mean is smaller than the median. If the 
data is greatly skewed, one has to be cautious when removing outliers (Arulmozhi & 
Muthulakshmi, 2009; Statistics How To, 2019). 
 
3.10 Summary of Chapter  
 
This chapter described the methodology used to measure KAP for PA and lateral LAT chest, AP 
and LAT lumbar spine, AP pelvis, and PA and LAT skull projections. The chapter also highlights 
the statistical measures employed to execute the research study. In the following chapter the 
results of the study will be presented. 
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CHAPTER 4: RESULTS 
 
The research study measured KAP for PA and lateral LAT chest, AP and LAT lumbar spine, AP 
pelvis, and PA and LAT skull projections. The 75th percentile of KAP values were used to 
establish  local DRLs for the seven projections using a protocol established by the dosimetry 
working party (1992), which recommends that radiation dose measurements be obtained on a 
minimum of 10 patient whose weight lies between 65 and 75 kg. This method ensured that the 
mean weight of the study sample was between (65kg-75kg) which is considered the average 
weight of an adult (70 kg).  
 
The relationship between the recorded KAP values and the patient’s estimated skin dose was 
assessed using regression analysis, correlation coefficient, R as well as coefficient of 
determination, R2.  
 
This chapter presents the mean, median and 75th percentile KAP values of entrance skin doses 
and effective doses recorded for PA and, AP and LAT lumbar spine, AP pelvis AP, PA and LAT 
skull at the three study sites. 
 
4.1 Chest projections 
 
Table 4.1 shows the mean, median and 75th percentile KAP values, skin and effective doses for 
the PA and lateral chest projections at each hospital separately and then the combined values 
for PA and lateral chest projections (refer to appendices 8-13).  The 75th KAP value for PA chest 
projections was 38.2 cGy.cm2, 10.4 cGy.cm2, and 7.6 cGy.cm2 at hospitals 1, 2 and 3 
respectively (appendices 8-13). The combined 75th percentile of KAP was 26.3 cGy.cm2. The 
median effective dose calculated by the PCXMC 2.0 programme was 0.0687 mSv, 0.0208 mSv, 
and 0.0169 mSv respectively, with a combined effective dose of 0.0220 mSv. The 75th percentile 
KAP value for hospital 1 was considerably higher than the combined KAP value, while the KAP 
values for hospital 2 and 3 were considerably lower.   
 
For the LAT chest projections, the 75th KAP value was 51.6 cGy.cm2, 52.9 cGy.cm2, and 26.7 
cGy.cm2 at hospitals 1, 2 and 3 respectively. The combined 75th percentile of KAP was 47.0 
cGy.cm2. The median effective dose calculated by the PCXMC 2.0 programme was 0.0793 
mSv, 0.0855 mSv, and 0.0474 mSv respectively, with a combined effective dose of 0.0687 mSv. 
The 75th percentile KAP value for hospital 1 and 2 was considerably higher than the combined 
KAP value, while the KAP values for hospital 2 and 3 were considerably lower.   
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A regression line was drawn to correlate skin dose with KAP. There was a linear correlation for 
both PA (R=0.9936) and LAT (R=0.9295) chest projections combined (refer to table 4.1 and 
figure 4.1 and 4.2). Similarly a linear correlation was observed for both PA and LAT chest at 
hospitals 1, 2 and 3 respectively (refer to appendices 8-13, and 39-44).   
 
Table 4.1: KAP, skin and effective doses for Chest projections 
 
 
 
Hospital 1 Hospital 2 Hospital 3 Combined  
Radiographic 
projection 
PA LAT PA  LAT PA  LAT PA LAT 
Mean KAP 
(cGy.cm2) 
34.3 
 
44.9 9.4 
 
44.3 
 
7.2 22.5 17.0 
 
37.4 
Median KAP 
(cGy.cm2) 
31.9 38.7 9.0 41.5 7.1 20.8 9.5 33.8 
DRL (75th 
percentile KAP) 
(cGy.cm2) 
38.2 51.6 10.4 52.9 7.6 26.7 26.3 47.0 
Skin dose 
(mSv) (75th 
percentile)  
0.0496 0.0702 0.0140 0.0799 0.0104 0.0386 0.0333 0.0663 
Accuracy of fit 
(R2)# 
0.9715 0.9451 0.9717 0.9415 0.9423 0.8686 0.9936 0.9295 
Effective dose 
(mSv)* 
0.0687 0.0793 0.0208 
 
0.0855 0.0169 0.0474 0.0220 0.0687 
Effective dose 
(mSv) 75th 
percentile 
0.0759 0.1056 0.0229 0.1086 0.0202 0.0616 0.0545 0.0942 
*Median values 
# Values are for linear fit unless otherwise stated. 
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Figure 4.1 Linear fit for PA chest projections comparing skin dose and KAP values at 
the three research sites. 
 
 
Figure 4.2 Linear fit for LAT chest projections comparing skin dose and KAP values 
at the three research sites. 
 
 
4.2 Lumbar spine projections 
 
Table 4.2 shows the mean, median and 75th percentile KAP values, skin and effective doses for 
the AP and lateral lumbar spine projections at each hospital separately and then the combined 
values for AP and lateral lumbar spine projections (refer to appendices 14 -19).  
 
The 75th KAP value for AP lumbar spine projections was 129.7 cGy.cm2, 307.1 cGy.cm2, and 
124.6 cGy.cm2 at hospitals 1, 2 and 3 respectively (refer to appendices 14 – 19). The combined 
75th percentile of KAP was 175.2 cGy.cm2. The median effective dose calculated by the PCXMC 
2.0 programme was 0.2017 mSv, 0.3771 mSv, and 0.1176 mSv respectively, with a combined 
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effective dose of 0.2248 mSv. The 75th percentile KAP value for hospital 2 was considerably 
higher than the combined KAP value, while the KAP values for hospital 1 and 3 were 
considerably lower.   
 
For the LAT lumbar projections, the 75th KAP value was 231.7 cGy.cm2, 279.7 cGy.cm2, and 
130.0 cGy.cm2 at hospitals 1, 2 and 3 respectively. The combined 75th percentile of KAP was 
235.5 cGy.cm2. The median effective dose calculated by the PCXMC 2.0 programme was 
0.1593 mSv, 0.3273 mSv, and 0.1245 mSv respectively, with a combined effective dose of 
0.1864 mSv. The 75th percentile KAP value for hospital 2 was considerably higher than the 
combined KAP value, while the KAP values for hospital 1 and 3 were considerably lower.   
 
A regression line was drawn to correlate skin dose with KAP. There was a linear correlation for 
both AP (R=0.9938) and LAT (R=0.7085) lumbar spine projections combined (refer to table 4.2 
and figure 4.3 and 4.4). Similarly, a linear correlation was observed for both AP and LAT Lumbar 
spine projections at hospitals 1, 2 and 3 respectively (refer to appendices 14-19, and 45-50).  
 
Table 4.2: KAP, skin and effective doses for Lumbar spine projections 
 
 
 
Hospital 1 Hospital 2 Hospital 3 Combined  
Radiographic 
projection 
AP LAT AP LAT AP  LAT AP LAT 
Mean KAP 
(cGy.cm2) 
117.3 192.0 240.4 250.1 90.5 94.6 154.7 190.2 
Median KAP 
(cGy.cm2) 
93.1 181.6 175.6 234.1 68.8 80.1 124.9 182.6 
DRL (75th 
percentile) 
129.7 231.7 307.1 279.7 124.6 130.0 175.2 235.5 
Skin dose 
(mSv) (75th 
percentile) 
0.1439 0.2749 0.3198 0.3007 0.1415 0.1310 0.1970 0.2740 
Accuracy of fit 
(R2)# 
0.9952 0.8888 0.9941 0.5575 0.9753 0.6127 0.9938 0.7085 
Effective dose 
(mSv)* 
0.2017 0.1593 0.3771 0.3273 0.1176 0.1245 0.2488 0.1864 
Effective dose 
(mSv) 75th 
percentile 
0.2617 0.2161 0.5783 0.4285 0.2704 0.1792 0.3792 0.2970 
*Median values 
# Values are for linear fit unless otherwise stated. 
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Figure 4.3 Linear fit for AP Lumbar spine projections comparing skin dose and KAP  
values at the three research sites. 
 
 
 
Figure 4.4 Linear fit for LAT Lumbar spine projections comparing skin dose and KAP  
values at the three research sites. 
 
 
4.3 Pelvis projections 
 
Table 4.3 shows the mean, median and 75th percentile KAP values, skin and effective doses for 
the AP pelvis projections at each hospital separately and then the combined values for AP pelvis 
projections (refer to appendices 20-22).  
 
The 75th KAP value for AP pelvis projections was 194.9 cGy.cm2, 328.8 cGy.cm2, and 137.7 
cGy.cm2 at hospitals 1, 2 and 3 respectively (refer to appendices 20-22). The combined 75th 
percentile of KAP was 209.5  cGy.cm2. The median effective dose calculated by the PCXMC 2.0 
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programme was 0.2220 mSv, 0.3386 mSv, and 0.1562 mSv respectively, with a combined 
effective dose of  0.2186 mSv. The 75th percentile KAP value for hospital 2 was considerably 
higher than the combined KAP value, while the KAP values for hospital 1 and 3 were 
considerably lower.   
 
A regression line was drawn to correlate skin dose with KAP. There was linear correlation for AP 
Pelvis (R=0.9913) projections combined (refer to table 4.3 and figure 4.5).  Similarly a linear 
correlation was observed for AP pelvis projections at hospitals 1, 2 and 3 respectively (refer to 
appendices 20-22, and 51-53).  
 
Table 4.3: KAP, skin and effective doses for Pelvis projections 
 
 
 
Hospital 1 Hospital 2 Hospital 3 Combined 
Radiographic 
projection 
AP 
 
AP AP AP 
Mean KAP 
(cGy.cm2) 
155.7 260.2 122.1 168.9 
Median KAP 
(cGy.cm2) 
155.1 223.4 96.9 147.9 
DRL (75th 
percentile) 
194.9 
 
328.8 134.7 209.5 
 
Skin dose 
(mSv) (75th 
percentile) 
0.2246 0.3510 0.1500 0.2497 
Accuracy of fit 
(R2)# 
0.9911 0.9875 0.9930 0.9913 
Effective dose 
(mSv)* 
0.2220 0.3386 0.1562 0.2186 
Effective dose 
(mSv) 75th 
percentile  
0.2605 0.4832 0.2149 0.3061 
*Median values 
# Values are for linear fit unless otherwise stated. 
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Figure 4.5 Linear fit for AP Pelvis projections comparing skin dose and KAP values at 
the three research sites. 
 
 
 
4.4 Skull projections 
 
Table 4.4 shows the mean, median and 75th percentile KAP values, skin and effective doses for 
the PA and lateral skull projections at each hospital separately and then the combined values for 
PA and skull projections (refer to appendices 23-28).  
 
The 75th KAP value for PA skull projections was 70.9 cGy.cm2, 103.7 cGy.cm2, and 77.1 
cGy.cm2 at hospitals 1, 2 and 3 respectively (refer to appendices 23-28). The combined 75th 
percentile of KAP was 86.7 cGy.cm2. The median effective dose calculated by the PCXMC 2.0 
programme was 0.0156 mSv, 0.0271 mSv, and 0.0223 mSv respectively, with a combined 
effective dose of 0.0197 mSv. The 75th percentile KAP value for hospital 2 was considerably 
higher than the combined KAP value, while the KAP values for hospital 1 and 3 were 
considerably lower.   
 
For the LAT skull projections, the 75th KAP value was 62.8 cGy.cm2, 80.4 cGy.cm2, and 47.6 
cGy.cm2 at hospitals 1, 2 and 3 respectively. The combined 75th percentile of KAP was 62.3 
cGy.cm2. The median effective dose calculated by the PCXMC 2.0 programme was 0.0204 mSv, 
0.0220 mSv, and 0.0155 mSv respectively, with a combined effective dose of 0.0178 mSv. The 
75th percentile KAP value for hospital 2 was considerably higher than the combined KAP value, 
while the KAP values for hospital 1 and 3 were considerably lower.   
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A regression line was drawn to correlate skin dose with KAP. There was a linear correlation for 
both PA (R=0.8454) and LAT (R=0.7949) skull projections combined. Refer to (table 4.4 and 
figure 4.7 and 4.8). Similarly a strong linear correlation was observed for both PA and LAT 
Lumbar skull projections at hospitals 1, 2 and 3 respectively (refer to appendces 23-28 and 54-
59).  
 
Table 4.4: KAP, skin and effective doses for Skull projections 
 
 
 
Hospital 1 Hospital 2 Hospital 3 Combined  
Radiographic 
projection 
PA LAT PA LAT PA  LAT PA LAT 
Mean KAP 
(cGy.cm2) 
55.9 56.5 82.0 54.8 63.0 40.6 64.5 50.3 
Median KAP 
(cGy.cm2) 
50.1 49.4 92.5 52.8 60.7 36.2 61.4 46.4 
DRL (75th 
percentile) 
70.9 62.8 103.7 80.4 77.1 47.6 86.7 62.3 
Skin dose 
(mSv) (75th 
percentile) 
0.0736 0.0639 0.1233 0.0673 0.0894 0.0446 0.0922 0.0584 
Accuracy of fit 
(R2)# 
0.8007 0.7578 0.8890 0.8453 0.7065 0.7508 0.8454 0.7949 
Effective dose 
(mSv)* 
0.0156 0.0204 0.0271 0.0220 0.0223 0.0155 0.0197 0.0178 
Effective dose 
(mSv) 75th 
percentile 
0.0195 0.0283 0.0328 0.0338 0.0271 0.0224 0.0267 0.0283 
*Median values 
# Values are for linear fit unless otherwise stated. 
 
 
 
Figure 4.6 Linear fit for PA skull projections comparing skin dose and KAP  
values at the three research sites. 
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Figure 4.7 Linear fit for LAT Skull projections comparing skin dose and KAP  
values at the three research sites. 
 
In this study the exposure factors and equipment parameters were entered into the PCXMC 2.0 
software programme and entrance and effective doses were calculated. The 75th percentile KAP 
values were used to calculate conversion coefficients for the different radiographic examinations. 
The conversion coefficients for effective dose (E) were calculated with the following formulae 
(E/KAP) and skin dose (ESD/KAP) (Hansson & Karambatsakidou, 2000; Compagnone et al, 
2005). 
(Refer to table 4.5 below) 
 
Table 4.5 Conversion coefficients for PA and lateral LAT chest, AP and LAT lumbar 
spine, AP pelvis, and PA and LAT skull projections 
Research site  75th 
percentile 
(DRL) 
KAP 
cGy.cm2 
Skin dose 
(mSv) 75th 
percentile 
(ESD) 
Effective dose 
(mSv) 75th  
percentile 
(E) 
Conversion 
coefficient  
(ESD/KAP) 
Conversion 
coefficient 
(E/KAP) 
PA Chest 
Hospital 1 38.2 0.0496 0.0759 0.0013 0.0020 
Hospital 2 10.4 0.0140 0.0229 0.0013 0.0022 
Hospital 3 7.6 0.0104 0.0202 0.0014 0.0027 
LAT Chest 
Hospital 1 51.6 0.0702 0.1056 0.0014 0.0020 
Hospital 2 52.9 0.0799 0.1086 0.0015 0.0021 
y = 0.000723502904851x + 0.008204860094902 
R² = 0.794854812623010 
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Hospital 3 26.7 0.0386 0.0616 0.0014 0.0023 
AP Lumbar Spine 
Hospital 1 129.7 0.1439 0.2617 0.0011 0.0020 
Hospital 2 307.1 0.3198 0.5783 0.0010 0.0019 
Hospital 3 124.6 0.1415 0.2704 0.0011 0.0022 
LAT Lumbar Spine 
Hospital 1 231.7 0.2749 0.2161 0.0012 0.0009 
Hospital 2 279.7 0.3007 0.4285 0.0011 0.0015 
Hospital 3 130.0 0.1310 0.1792 0.0010 0.0014 
AP Pelvis 
Hospital 1 194.9 0.2246 0.2605 0.0012 0.0013 
Hospital 2 328.8 0.3510 0.4832 0.0011 0.0014 
Hospital 3 134.7 0.1500 0.2149 0.0011 0.0016 
PA Skull 
Hospital 1 70.9 0.0736 0.0195 0.0010 0.0003 
Hospital 2 103.7 0.1233 0.0328 0.0012 0.0003 
Hospital 3 77.1 0.0894 0.0271 0.0012 0.0004 
LAT Skull 
Hospital 1 62.8 0.0639 0.0283 0.0010 0.0005 
Hospital 2 80.4 0.0673 0.0338 0.0008 0.0004 
Hospital 3 47.6 0.0446 0.0224 0.0009 0.0005 
 
 
The results of the study were presented in this Chapter. The 75th percentile of KAP values were 
used to establish local DRLs and develop conversion coefficients for the conventional 
radiography examinations. The next chapter will discuss the results and make recommendations 
surrounding the research study. 
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CHAPTER 5: DISCUSSION 
This study developed LDRL’s for ESD and E from measured KAP values for four conventional x-
ray examinations (AP and LAT chest, AP and LAT lumbar spine, AP pelvis, and PA and LAT 
skull) in three hospitals in Windhoek Namibia. Additionally conversion factors were derived from 
3rd quartile values in order to have a simple indicator of patient dose in clinical practice.  This 
chapter discusses our findings in relationship to similar studies in literature, and makes 
recommendations for future research.  
5.1 Diagnostic reference levels (DRLs) 
It is recommended that 3rd quartile of KAP measurements be used to establish DRLs (Edmonds, 
2009; Seeram & Brennan, 2017). 
 
5.1.1 LDRL’s for Chest radiography 
 
The LDRL’s for Chest examinations in this study are presented in table 5.1. (combined values). 
 
Table 5.1 Local DRLs for chest projections 
 
 75th percentile 
KAP (cGy.cm2) 
75th percentile 
ESD (mGy) 
75th percentile 
E (mSv) 
This study: PA 
chest 
26.3 0.0333 0.0545 
IAEA (1996) NR 0.4 NR 
Ng et al., (1998) NR 0.3 (median) NR 
Osibote & de 
Azevedo (2008) 
NR 0.24 NR 
Sonowane et al., 
(2010) 
NR 0.68 NR 
Nyati et al., 
(2009) 
NR 0.10 NR 
Ofori et al, 
(2014) 
NR 0.27 (median) 0.02 
Aliasgharzadeh 
et al., (2015) 
NR 0.37(mean) 0.04 
This study  
Lat chest 
47.0 0.0663 0.0942 
IAEA (1996) NR 1.5 NR 
Ng et al., (1998) NR 1.2 (median) NR 
Osibote & de 
Azevedo (2008) 
NR 0.62 NR 
Sonowane et al., 
(2010) 
NR 1.74 NR 
Nyati et al., NR 0.22 NR 
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(2009) 
Ofori et al, 
(2014) 
NR 0.43 (median) 0.01  
Aliasgharzadeh 
et al., (2015) 
NR 0.99 (mean)  0.10 
NR-not reported 
 
In this study, the local DRLs value for PA and LAT chest was 0.0333 mSv and 0.0663 mSv 
respectively by combining the skin dose measurements from the three research sites (refer to 
table 5.1).  The ESDs for PA chest in hospital 2 and 3 were below the third quartile value but in 
hospital 1 was found to be higher (refer to table 4.1). The reason for the high ESD in hospital 1 
could be attributed to the high mAs used at hospital 1 when compared to hospital 2 and 3. It is 
known that higher mAs with lower kVp will result in higher radiation dose to patients (Seeram & 
Brennan, 2017).  
 
5.1.2 Lumbar spine radiography 
 
The LDRL’s for lumbar spine examinations in this study are presented in table 5.2. (combined 
values). 
 
Table 5.2 Local DRLs for lumbar spine projections 
 
 75th percentile 
KAP (cGy.cm2) 
75th percentile 
ESD (mGy) 
75th percentile 
E (mSv) 
This study: AP 
lumbar spine 
175.2 0.1970 0.3792 
IAEA (1996) NR 10 NR 
Ng et al., (1998) NR 9.1 (median) NR 
Osibote & de 
Azevedo (2008) 
NR 2.60 NR 
Sonowane et al., 
(2010) 
NR 8.39 NR 
Nyati et al., 
(2009) 
NR 5.30 NR 
Ofori et al, 
(2014) 
NR 3.25 (median) 0.02 
Aliasgharzadeh 
et al., (2015) 
NR 2.18 (mean) 0.04 
This study  
Lat lumbar 
spine 
235.5 0.2740 0.2970 
IAEA (1996) NR 30 NR 
Ng et al., (1998) NR 14 (median) NR 
Osibote & de 
Azevedo (2008) 
NR 4.75 NR 
 48 
 
Sonowane et al., 
(2010) 
NR 15.66 NR 
Nyati et al., 
(2009) 
NR NR NR 
Ofori et al, 
(2014) 
NR NR (median) 0.01 
Aliasgharzadeh 
et al., (2015) 
NR 5.36 (mean) 0.10 
NR-not reported 
 
 
In this study, the local DRLs value for AP and LAT lumbar spine was 0.1970 mSv and 0.2740 
mSv respectively by combining the skin dose measurements from the three research sites (refer 
to table 5.2).  The ESDs for AP lumbar spine in hospital 1 and 3 were below the third quartile 
value but in hospital 2 was found to be higher (refer table 4.2). The reason for the high ESD in 
hospital 2 could be attributed to the high mAs used at hospital 2 when compared to hospital 1 
and 3 (Seeram & Brennan, 2017).  
.   
5.1.3 Pelvis  
 
The LDRL’s for pelvis examinations in this study are presented in table 5.3. (combined values). 
 
Table 5.3 Local DRLs for pelvis projections 
 
 
 75th percentile 
KAP (cGy.cm2) 
75th percentile 
ESD (mGy) 
75th percentile 
E (mSv) 
This study: AP 
pelvis  
209.5 0.2497 0.3061 
IAEA (1996) NR 10 NR 
Ng et al., (1998) NR 5.3 (median) NR 
Osibote & de 
Azevedo (2008) 
NR NR NR 
Sonowane et al., 
(2010) 
NR 8.03 NR 
Nyati et al., 
(2009) 
NR 2.98 NR 
Ofori et al, 
(2014) 
NR 1.31 (median) NR 
Aliasgharzadeh 
et al., (2015) 
NR 1.76 (mean) 0.13 
NR-not reported 
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In this study, the local DRLs value for AP Pelvis was 0.2497 mSv by combining the skin dose 
measurements from the three research sites (refer to table 5.3).  The ESDs for AP Pelvis in 
hospital 1 and 3 were below the third quartile value but in hospital 2 was found to be higher 
(refer to table 4.3). The reason for the high ESD in hospital 2 could be attributed to the high mAs 
used at hospital 2 when compared to hospital 1 and 3 (Seeram & Brennan, 2017).   .   
 
5.1.4 Skull 
 
The LDRL’s for skull examinations in this study are presented in table 5.4. (combined values). 
 
Table 5.4 Local DRLs for skull projections 
 
 75th percentile 
KAP (cGy.cm2) 
75th percentile 
ESD (mGy) 
75th percentile 
E (mSv) 
This study: PA  
skull  
86.7 0.922 0.0267 
IAEA (1996) NR 5 NR 
Ng et al., (1998) NR 4.7 (median) NR 
Osibote & de 
Azevedo (2008) 
NR 1.55 NR 
Sonowane et al., 
(2010) 
NR 6.89 NR 
Nyati et al., 
(2009) 
NR NR NR 
Ofori et al, 
(2014) 
NR NR (median) NR 
Aliasgharzadeh 
et al., (2015) 
NR 1.39 (mean) 0.01 
This study  
Lat skull 
62.3 0.584 0.0283 
IAEA (1996) NR 3 NR 
Ng et al., (1998) NR 3 (median) NR 
Osibote & de 
Azevedo (2008) 
NR NR NR 
Sonowane et al., 
(2010) 
NR 5.86 NR 
Nyati et al., 
(2009) 
NR NR NR 
Ofori et al, 
(2014) 
NR NR (median) NR 
Aliasgharzadeh 
et al., (2015) 
NR 1.01 (mean) 0.01 
NR-not reported 
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In this study, the local DRLs value for AP and LAT skull was 0.0922mSv and 0.0584 respectively 
by combining the skin dose measurements from the three research sites (refer to table 5.4).  The 
ESDs for PA and LAT lumbar spine in hospital 1 and 3 were below the third quartile value but in 
hospital 2 was found to be higher (refer to table 4.2). The reason for the high ESD in hospital 2 
could be attributed to the high mAs used at hospital 2 when compared to hospital 1 and 3.   
 
A comparison was done between hospital 1 and 3 because they both had equipment from the 
same manufacturer. Entrance skin doses were higher in hospital 1 than in hospital 3. This could 
be attributed to the fact that hospital 3 employed direct digital radiographic systems with 
automatic exposure control devices while hospital 1 employed computed radiography systems 
with manual exposures (Nyati et al, 2009; Seeram & Brennan, 2017). 
5.1.5 Comparison of local DRLs with international values 
The ESD’s in this study was lower than those reported in the literature (IAEA, 1996; Ng et al., 
1998; Osibote & Azevedo, 2008; Nyathi et al., 2009; Sonowane et al., 2009; Ofori et al., 2014; 
Aliasgharzadeh et al., 2015) refer to tables (5.1 to 5.4).  In this study the lateral chest, lateral 
lumbar spine and lateral skull had higher skin doses when compared to the AP or PA projections 
of the same examination. This could be attributed to the shorter focus to skin distance for lateral 
examinations when compared to PA or AP examinations (Olowookere et al., 2011; Joyce et al, 
2013).  
5.2 Effective doses 
In radiation protection effective dose is used to calculate annual dose limits to members of the 
public as well as radiation workers.  It is used to maintain standards (Fisher & Fahey, 2017).  In 
this study the highest effective dose recorded was for AP lumbar spine (0.3792 mSv) and the 
lowest (0.0267 mSv) for PA skull (refer to tables 5.2 and 5.4) respectively. The high dose 
reported for lumbar spine examinations is consistent with the literature (Khoo et al., 2003; IAEA, 
2009). It can be noted from this study that the effective doses for (PA and LAT chest, AP and 
LAT lumbar spine, AP pelvis, and PA and LAT skull) are similar than those reported in the 
literature (refer to tables 5.1 to 5.4). The high effective doses in this study could be as a result of 
the adjustment of some of the tissue weighing factors (Obed et al., 2015). 
5.3 Conversion Factors 
The conversion factors established in this study can be used as a simple means to calculate 
entrance skin and effective doses from KAP values, thereby creating awareness amongst 
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radiology staff in the department. This can be achieved by multiplying the conversion factor with 
the displayed KAP value as indicated on table 4.5 in chapter 4. 
5.4  Limitations of the study   
 Possible limitations of the study was that the total field size (collimation) may not have 
been a true indication of the area exposed to radiation as some field sizes was not 
recorded. This may have affected the KAP values. 
5.5 Conclusion and recommendations 
The 75th percentile ESD’s for (PA and LAT chest, AP and LAT lumbar spine, AP pelvis, and PA 
and LAT skull) in this study were lower than those reported in the literature, while the effective 
doses generally compared well with those reported in the literature.  
The following are recommendations from the study: 
It was noticed in this study that radiographers use manual exposures even though AEC devices 
were available.Therefore it is recommended that radiographers should undergo training on how 
to effectively use AEC devices during radiological examinations so that lower exposure factors 
can be achieved.  
A national dose management programme should be established to create awareness of 
radiation doses amongst radiographers.  
Radiographers in the clinical area should use the conversion coefficients (ESD/KAP) to convert 
KAP to ESD to get an immediate indication of patient doses. Similarly departmental managers 
and radiation safety officers (RSOs) should use the conversion coefficients (E/KAP) to calculate 
effective doses for the different radiographic projections.  
The results of the study will be forwarded to the NRPA to be endorsed as initial local DRLs for 
Windhoek, Namibia.  
It is further recommended that the study be repeated at five (5) year intervals in order to comply 
with Namibian legislation and as a means towards implementation of national diagnostic 
reference levels. 
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APPENDIX 2: 
 
 
Letter of permission: Permanent Secretary 
 
       
         P O Box 20323 
         Windhoek   
         Namibia 
         29 May 2013 
To:  The Permanent Secretary 
Ministry of Health and Social Services 
Private Bag 13301 
Windhoek 
 
Dear Sir/Madam 
 
RE: Request for permission to carry out a research study at Windhoek Central and Katutura 
Intermediate hospitals. 
 
I am registered for a Masters Degree in Technology - Radiography (Diagnostic), at the Cape Peninsula 
University of Technology, (student number 213009641). 
 
As a course requirement I am expected to complete a research project. The title of the study is 
“Measurement of radiation doses to patients undergoing routine x-ray examinations in Windhoek 
Namibia to develop diagnostic reference levels”. 
 
As part of a global effort to minimise radiation doses delivered to patients radiographers are obliged to 
keep radiation doses as low as reasonably achievable. The study intends to measure radiation doses 
delivered to patients during routine x-ray examinations. A portable Dose Area Product (DAP) meter will 
be attached to the x-ray tube housing of the collimator and will be used to measure the radiation doses 
delivered to some patients. The study will involve patients referred for the Chest, Lumbar Spine, Pelvis 
and Skull radiographs. Participants will be asked to participate voluntarily after the research objectives 
have been explained to them thoroughly. After consenting to the study, the patients’ weight, height, age, 
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gender and thickness of anatomical part under investigation will be recorded along with the exposure 
factors used during the examination. Besides these measurements there will be no difference to what is 
routinely done in the department and there will be no interference with the management of patients as well 
as the daily duties of radiographers employed at these hospitals.  
 
I have selected the departments at Windhoek Central Hospital (WCH) and Katutura Intermediate Hospital 
(KIH) to conduct my research as it is the largest public hospitals and utilise computed radiography 
techniques which may be associated with higher radiation doses. It is anticipated that the research may 
contribute towards the optimisation of radiation doses delivered to patients.  
 
In addition I am also an employee at the University of Namibia (Assistant Lecturer) responsible for 
Clinical Practice at Windhoek Central Hospital and Katutura Intermediate Hospital respectively; on staff 
development leave to pursue this qualification.  I am therefore familiar with the radiography department 
and management of radiographic matters. 
 
The data obtained in this study will be strictly confidential. In order to respect the patient’s right to 
privacy, all measurements will be taken inside the x-ray room. Patients will be included in the study on a 
voluntary basis after careful explanation of the research and after informed consent has been obtained. 
Consent letters will be in English and will be translated into indigenous languages by means of a 
translator. The data obtained will be stored and locked in the researcher’s office, where only the researcher 
has access. The data collection form will be coded in order to protect the identity of the research 
participants and maintain anonymity. The data recorded from the patient will be limited to the patients’ 
weight, height, and anatomical thickness, age, gender and exposure factors (Appendix 13). Please see the 
attached patient information leaflet and consent form (Appendix 12).  
 
It is anticipated that the proposed study will have the following advancement in knowledge and benefits: 
 Development of preliminary diagnostic reference levels values for chest posterior-anterior (PA) 
and lateral (LAT) lumbar spine anterior-posterior (AP) and LAT pelvis AP and skull PA and LAT 
which may aid in the optimisation of radiographic technique. 
 The insight from this study may create awareness of radiation doses and provide knowledge about 
diagnostic reference levels amongst radiographers in Windhoek, Namibia. 
 The results will contribute to research knowledge about radiation doses in Windhoek. 
 The diagnostic reference levels can be used as a benchmark to support the need for legislative 
measures to implement diagnostic reference levels at national level. 
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 The data obtained may inform whether radiographic practices in Windhoek conform or differ to 
that of international norms. 
 
The proposed study will have no financial implication for your Ministry and no consumables of the 
hospital will be used. 
 
I hereby request your support in granting me permission to carry out this proposed study at the above 
mentioned hospitals. Please find attached a copy of my full proposal and data collection instruments for 
further reference. Should you have any enquiries regarding this research do not hesitate to contact me or 
my supervisors. 
 
I trust that my request will receive your approval. 
 
Yours faithfully  
 
Edwin Ralph Daniels 
edwindaniels2003@yahoo.com / edaniels@unam.na  
Cell: 0027 721374566 
Supervisor: Mrs F Davidson, Lecturer: Radiography, Groote Schuur Hospital 
Tel: 0027 21 442 6174 
Co-supervisor: Mr A Speelman, Lecturer: Radiography, Groote Schuur Hospital 
Tel: 0027 21 442 6170 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 61 
 
 
APPENDIX 3: 
 
Letter of permission: Medical Imaging Windhoek 
 
         P O Box 20323 
         Windhoek   
         Namibia 
         29 May 2013 
To:  Dr. JA van Rooyen and partners 
Medical Imaging Windhoek 
P. O. Box 9471 
Eros 
Windhoek 
 
Dear Dr. JA van Rooyen and partners 
 
RE: Request for permission to carry out a research study at Medical Imaging Windhoek Branches 
(Roman Catholic, Eros and Rhino Park). 
 
I am registered for a Masters Degree in Technology - Radiography (Diagnostic), at the Cape Peninsula 
University of Technology, (student number 213009641). 
 
As a course requirement I am expected to complete a research project. The title of the study is 
“Measurement of radiation doses to patients undergoing routine x-ray examinations in Windhoek 
Namibia to develop diagnostic reference levels”. 
 
As part of a global effort to minimise radiation doses delivered to patients radiographers are obliged to 
keep radiation doses as low as reasonably achievable. The study intends to measure radiation doses 
delivered to patients during routine x-ray examinations. A portable Dose Area Product (DAP) meter will 
be attached to the x-ray tube housing of the collimator and will be used to measure the radiation doses 
delivered to some patients. The study will involve patients referred for the Chest, Lumbar Spine, Pelvis 
and Skull radiographs. Participants will be asked to participate voluntarily after the research objectives 
have been explained to them thoroughly. After consenting to the study, the patients’ weight, height, age, 
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gender and thickness of anatomical part under investigation will be recorded along with the exposure 
factors used during the examination. Besides these measurements there will be no difference to what is 
routinely done in the department and there will be no interference with the management of patients as well 
as the daily duties of radiographers employed at these hospitals.  
 
I have selected the departments at Medical Imaging (Roman Catholic, Eros and Rhino Park) to conduct 
my research as it is located in Windhoek and utilise computed radiography techniques which may be 
associated with higher radiation doses. It is anticipated that the research may contribute towards the 
optimisation of radiation doses delivered to patients.  
 
In addition I am also an employee at the University of Namibia (Assistant Lecturer) responsible for 
Clinical Practice at Windhoek Central Hospital and Katutura Intermediate Hospital respectively; on staff 
development leave to pursue this qualification. I am therefore familiar with the radiography department 
and management of radiographic matters. 
 
The data obtained in this study will be strictly confidential. In order to respect the patient’s right to 
privacy, all measurements will be taken inside the x-ray room. Patients will be included in the study on a 
voluntary basis after careful explanation of the research and after informed consent has been obtained. 
Consent letters will be in English and will be translated into indigenous languages by means of a 
translator. The data obtained will be stored and locked in the researcher’s office, where only the researcher 
has access. The data collection form will be coded in order to protect the identity of the research 
participants and maintain anonymity. The data recorded from the patient will be limited to the patients’ 
weight, height, and anatomical thickness, age, gender and exposure factors (Appendix 13). Please see the 
attached patient information leaflet and consent form (Appendix 12).  
 
It is anticipated that the proposed study will have the following advancement in knowledge and benefits: 
 Development of preliminary diagnostic reference levels values for chest posterior-anterior (PA) 
and lateral (LAT) lumbar spine anterior-posterior (AP) and LAT pelvis AP and skull PA and LAT 
which may aid in the optimisation of radiographic technique. 
 The insight from this study may create awareness of radiation doses and provide knowledge about 
diagnostic reference levels amongst radiographers in Windhoek, Namibia. 
 The results will contribute to research knowledge about radiation doses in Windhoek. 
 The diagnostic reference levels can be used as a benchmark to support the need for legislative 
measures to implement diagnostic reference levels at national level. 
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 The data obtained may inform whether radiographic practices in Windhoek conform or differ to 
that of international norms. 
 
The proposed study will have no financial implication for your departments and no consumables of the 
department will be used. 
 
I hereby request your support in granting me permission to carry out this proposed study at the above 
mentioned hospitals. Please find attached a copy of my full proposal and data collection instruments for 
further reference. Should you have any enquiries regarding this research do not hesitate to contact me or 
my supervisors. 
 
I trust that my request will receive your approval. 
 
Yours faithfully   
 
Edwin Ralph Daniels 
edwindaniels2003@yahoo.com / edaniels@unam.na  
Cell: 0027 721374566 
Supervisor: Mrs F Davidson, Lecturer: Radiography, Groote Schuur Hospital 
Tel: 0027 21 442 6174 
Co-supervisor: Mr A Speelman, Lecturer: Radiography, Groote Schuur Hospital 
Tel: 0027 21 442 6170 
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APPENDIX 4: 
 
Letter of permission: National Radiation Protection Authority 
 
         P.O. Box 20323 
         Windhoek   
         Namibia 
         29 May 2013 
       
To:  The Director 
National Radiation Protection Authority (NRPA) 
Ministry of Health and Social Services 
P/Bag 13198 
Windhoek 
 
Dear Mr. A Tibinyane. 
 
RE: Request for permission to carry out a research study. 
 
 
I am registered for a Masters Degree in Technology - Radiography (Diagnostic), at the Cape Peninsula 
University of Technology, (student number 213009641). 
 
As a course requirement I am expected to complete a research project. The title of the study is 
“Measurement of radiation doses to patients undergoing routine x-ray examinations in Windhoek 
Namibia to develop diagnostic reference levels”. 
 
As part of a global effort to minimise radiation doses delivered to patients radiographers are obliged to 
keep radiation doses as low as reasonably achievable. The study intends to measure radiation doses 
delivered to patients during routine x-ray examinations. A portable Dose Area Product (DAP) meter will 
be attached to the x-ray tube housing of the collimator and will be used to measure the radiation doses 
delivered to some patients. The study will involve patients referred for the Chest, Lumbar Spine, Pelvis 
and  Skull radiographs. Participants will be asked to participate voluntarily after the research objectives 
have been explained to them thoroughly. After consenting to the study, the patients’ weight, height, age, 
gender and thickness of anatomical part under investigation will be recorded along with the exposure 
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factors used during the examination. Besides these measurements there will be no difference to what is 
routinely done in the department and there will be no interference with the management of patients as well 
as the daily duties of radiographers employed at these hospitals.  
 
I have selected the departments at Windhoek Central Hospital (WCH) and Katutura Intermediate Hospital 
(KIH) to conduct my research as it is the largest public hospitals and utilise computed radiography 
techniques which may be associated with higher radiation doses. It is anticipated that the research may 
contribute towards the optimisation of radiation doses delivered to patients.  
 
In addition I am also an employee at the University of Namibia (Assistant Lecturer) responsible for 
Clinical Practice at Windhoek Central Hospital and Katutura Intermediate Hospital respectively; on staff 
development leave to pursue this qualification.  I am therefore familiar with the radiography department 
and management of radiographic matters. 
 
The data obtained in this study will be strictly confidential. In order to respect the patient’s right to 
privacy, all measurements will be taken inside the x-ray room. Patients will be included in the study on a 
voluntary basis after careful explanation of the research and after informed consent has been obtained. 
Consent letters will be in English and will be translated into indigenous languages by means of a 
translator. The data obtained will be stored and locked in the researcher’s office, where only the researcher 
has access. The data collection form will be coded in order to protect the identity of the research 
participants and maintain anonymity. The data recorded from the patient will be limited to the patients’ 
weight, height, and anatomical thickness, age, gender and exposure factors (Appendix 13). Please see the 
attached patient information leaflet and consent form (Appendix 12).  
 
It is anticipated that the proposed study will have the following advancement in knowledge and benefits: 
 Development of preliminary diagnostic reference levels values for chest posterior-anterior (PA) 
and lateral (LAT) lumbar spine anterior-posterior (AP) and LAT pelvis AP and skull PA and LAT 
which may aid in the optimisation of radiographic technique. 
 The insight from this study may create awareness of radiation doses and provide knowledge about 
diagnostic reference levels amongst radiographers in Windhoek, Namibia. 
 The results will contribute to research knowledge about radiation doses in Windhoek. 
 The diagnostic reference levels can be used as a benchmark to support the need for legislative 
measures to implement diagnostic reference levels at national level. 
 The data obtained may inform whether radiographic practices in Windhoek conform or differ to 
that of international norms. 
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The proposed study will have no financial implication for your Ministry and no consumables of the 
hospital will be used. 
 
I hereby request your support in granting me permission to carry out this proposed study at the above 
mentioned hospitals. Please find attached a copy of my full proposal and data collection instruments for 
further reference. Should you have any enquiries regarding this research do not hesitate to contact me or 
my supervisors. 
 
I trust that my request will receive your approval. 
 
Yours faithfully  
 
Edwin Ralph Daniels 
edwindaniels2003@yahoo.com / edaniels@unam.na  
Cell: 0027 721374566 
Supervisor: Mrs F Davidson, Lecturer: Radiography, Groote Schuur Hospital 
Tel: 0027 21 442 6174 
Co-supervisor: Mr A Speelman, Lecturer: Radiography, Groote Schuur Hospital 
Tel: 0027 21 442 6170 
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APPENDIX 5: 
 
Equipment related data to for each x-ray room. 
 
 
Date: __________________    Hospital: _____________________ 
 
X-ray room: ____________________ 
 
X-ray generator: 
 
Manufacturer / Type: _____________________ / ________________________ 
 
Waveform: Please tick one 
 
Six (6) pulse: _______________  Twelve (12) pulse: __________________ 
Constant potential: __________   
Other: Please specify   __________________________________ 
 
X-ray tube:  
 
Manufacturer / Type:  ________________ / _________________  
 
Inherent Filtration:   __________ mm Al equivalent 
 
     __________ mm Cu equivalent 
 
     _________ mm other equivalent 
 
 Focal spot values:   _____________ to ___________ 
 
  
 
 Is the x-ray unit equipped with Automatic Exposure Control (AEC)  
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     Yes __________ or  No _________________ 
 
Is the x-ray unit equipped with an anti scatter grid: Yes ________ or No _____________ 
 
If an antiscatter grid is present, please state the Grid Ratio; “r” _______________ 
 
Number of Lead (Pb) strips per cm:  _________________ 
  
Image plate sensitivity: 
Screen Manufacturer:   _____________________  
Type of screen (CR or DR):  ______________________ 
  
 
Adapted and from (European Commission 1996, Johnston & Brennan 2000, Abdelhalim 2009) 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 69 
 
APPENDIX 6: 
 
Patient related data to be completed by the researcher / research assistant for each patient 
 
 
Demographic data of patient 
A1 Hospital:   _______________________ 
A2.  Age:    __________in years 
A3. Gender:   __________ 
A4. Weight:   __________ in (kilograms) 
A5. X-ray number:  ____________________ 
A6. Height:   ______________ in centimetres (cm) 
 
B.  Dose related data AP/PA projection 
B1. Name of projection:  ______________________ (i.e PA chest) 
B2. Patient thickness in the centre of the beam: ___________ in centimetres 
B3. Additional filtration used: _______________ 
B4. Applied Voltage:  ____________ kV 
B5. Applied focal spot size: _______________ 
B6. SID:    _______________cm 
B7. Film size:   _______________ cm x ________________ cm 
B8. Automatic Exposure Control (AEC) used. Please state yes or no __________ 
B9. If (AEC) was used please state the selected chamber: (i.e left, right, central) 
 ___________ 
B10. Exposure time:  ___________ milliseconds (ms) 
B11.  Tube current used:  __________ mA or  ____________ mAs 
B12. Type -of screen (DR or CR) __________________________ 
B13. Total dose area product __________________________Gycm
2 
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C. Dose related data Lateral (LAT) projection 
C1. Name of projection:  ______________________ (i.e LAT chest)
 
 
C2. Patient thickness in the centre of the beam: ___________ in centimetres 
C3. Additional filtration used: _______________  
 
C4. Applied Voltage:  ____________ kV 
C5. Applied focal spot size: _______________ 
C6. FFD:    _______________cm 
C7. Film size:   _______________ cm x ________________ cm 
C8. Automatic Exposure Control (AEC) used. Please state yes or no __________ 
C9. If (AEC) was used please state the selected chamber: (i.e left, right, central) 
 ___________ 
C10. Exposure time:  ___________ milliseconds (ms) 
C11.  Tube current used:  __________ mA or  ____________ mAs 
C12. Type of screen ( CR or DR): __________________________ 
C13. Total dose area product: __________________________Gycm
2 
 
 
 
Adapted and from (European Commission 1996, Johnston & Brennan 2000, Abdelhalim 2009) 
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APPENDIX 7: CALIBRATION CERTIFICATE VACUDAP 
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APPENDIX 8: INPUT DATA PA CHEST HOSPITAL 1 
 
 
 
 
 
Hospital 1 Chest PA
Patient
DAP value 
(cGy.cm
2
) - 
X-axis
PCXMC Skin 
dose (mGy) - 
Y-axis
PCXMC 
Effective dose 
(mSv) - 
ICRP103
PCXMC 
Incident air 
kerma (mGy)
Skin dose 
(mGy) - 
calculated 
linear fit
Skin dose 
(mGy) - 
calculated 
power fit
% Diff 
linear fit
% Diff 
power fit
Chauvenet 
criterion
31A 23.7 0.03117 0.04473 0.23546 0.03096 0.03077 -0.66 -1.27 2.99
29A 24.4 0.03314 0.05119 0.22936 0.03184 0.03168 -3.89 -4.40 3.59
39A 25.3 0.03194 0.05007 0.21960 0.03287 0.03273 2.92 2.48 4.40
41A 25.5 0.03267 0.05222 0.23668 0.03317 0.03303 1.51 1.10 4.66
46A 26.2 0.03567 0.05718 0.24766 0.03405 0.03393 -4.56 -4.87 5.48
45A 26.6 0.03384 0.05358 0.24278 0.03449 0.03438 1.91 1.60 5.93
27A 26.7 0.03299 0.06270 0.24766 0.03463 0.03453 4.99 4.68 6.09
28A 29.8 0.03555 0.06772 0.27084 0.03831 0.03827 7.75 7.66 10.80
42A 30.9 0.04107 0.07370 0.29524 0.03963 0.03961 -3.50 -3.53 12.85
44A 31.8 0.04086 0.06539 0.30012 0.04080 0.04080 -0.14 -0.13 14.81
33A 32.0 0.04319 0.06911 0.29646 0.04095 0.04095 -5.19 -5.17 15.06
34A 32.0 0.04293 0.06832 0.29646 0.04095 0.04095 -4.62 -4.61 15.06
38A 33.4 0.03967 0.07009 0.28670 0.04271 0.04274 7.65 7.72 18.15
30A 36.8 0.04452 0.08255 0.34160 0.04682 0.04688 5.17 5.30 14.56
35A 37.7 0.04982 0.06981 0.35502 0.04785 0.04791 -3.97 -3.84 12.85
43A 39.9 0.05263 0.07322 0.36966 0.05049 0.05056 -4.06 -3.93 8.92
36A 40.6 0.04951 0.09032 0.42822 0.05137 0.05144 3.77 3.91 7.78
37A 42.7 0.05186 0.08619 0.36722 0.05387 0.05394 3.87 4.00 5.06
32A 52.7 0.07120 0.11396 0.48922 0.06591 0.06589 -7.43 -7.45 0.25
40A 67.0 0.08052 0.14551 0.63074 0.08309 0.08276 3.19 2.79 0.00
Mean: 34.3 0.0437 0.0724
DRL: 38.2 0.0496 0.0759
Median: 31.9 0.0410 0.0687
n: 20
Population standard deviation: 10.4
Chauvenet criterion value: 0.5
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APPENDIX 9: INPUT DATA LAT CHEST HOSPITAL 1 
 
 
 
 
 
 
Hospital 1 Chest LAT
Patient
DAP value 
(cGy.cm
2
) - 
X-axis
PCXMC Skin 
dose (mGy) - 
Y-axis
PCXMC 
Effective dose 
(mSv) - 
ICRP103
PCXMC 
Incident air 
kerma (mGy)
Skin dose 
(mGy) - 
calculated 
linear fit
Skin dose 
(mGy) - 
calculated 
power fit
% Diff 
linear fit
% Diff 
power fit
Chauvenet 
criterion
39B 22.6 0.03101 0.04845 0.27938 0.03075 0.03293 -0.83 6.17 1.09
29B 27.7 0.04757 0.04946 0.27816 0.03900 0.04053 -18.01 -14.80 2.76
31B 30.7 0.04403 0.06059 0.31964 0.04391 0.04506 -0.27 2.34 4.45
41B 32.7 0.04403 0.06872 0.34526 0.04705 0.04797 6.86 8.94 5.86
42B 33.8 0.05656 0.06528 0.36356 0.04882 0.04960 -13.69 -12.30 6.77
46B 34.2 0.04623 0.07065 0.33672 0.04941 0.05015 6.88 8.48 7.10
34B 34.3 0.05690 0.06123 0.37454 0.04960 0.05033 -12.82 -11.55 7.21
30B 34.8 0.05522 0.06389 0.37454 0.05039 0.05106 -8.74 -7.54 7.66
28B 37.7 0.05738 0.07052 0.39162 0.05510 0.05542 -3.96 -3.41 10.70
45B 38.7 0.05263 0.08074 0.41602 0.05667 0.05688 7.68 8.07 11.84
27B 38.8 0.06111 0.07778 0.40870 0.05687 0.05706 -6.94 -6.63 11.99
33B 41.4 0.05274 0.08592 0.42822 0.06099 0.06089 15.65 15.45 15.21
35B 46.4 0.06692 0.09299 0.48922 0.06904 0.06837 3.18 2.17 17.98
38B 50.8 0.06708 0.11089 0.58316 0.07611 0.07495 13.47 11.74 12.26
36B 51.1 0.06631 0.10380 0.53924 0.07670 0.07550 15.67 13.86 11.83
37B 52.9 0.08373 0.09416 0.57950 0.07965 0.07824 -4.88 -6.55 9.74
44B 59.2 0.07968 0.12351 0.62464 0.08966 0.08758 12.53 9.92 4.36
32B 65.5 0.09484 0.13568 0.73078 0.09987 0.09712 5.30 2.40 1.51
40B 76.5 0.12266 0.14287 0.82350 0.11754 0.11366 -4.17 -7.33 0.13
43B 88.2 0.14692 0.14518 0.86010 0.13639 0.13135 -7.17 -10.60 0.00
Mean: 44.9 0.0667 0.0876
DRL: 51.6 0.0702 0.1056
Median: 38.7 0.0571 0.0793
n: 20
Population standard deviation: 16.4
Chauvenet criterion value: 0.5
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APPENDIX 10: INPUT DATA PA CHEST HOSPITAL 2 
 
 
 
 
Hospital 2 Chest PA
Patient
DAP value 
(cGy.cm2) - 
X-axis
PCXMC Skin 
dose (mGy) - 
Y-axis
PCXMC 
Effective dose 
(mSv) - 
ICRP103
PCXMC 
Incident air 
kerma (mGy)
Skin dose 
(mGy) - 
calculated 
linear fit
Skin dose 
(mGy) - 
calculated 
power fit
% Diff 
linear fit
% Diff 
power 
fit
Chauvenet 
criterion
100A 4.1 0.00590 0.01019 0.06466 0.00554 0.00551 -6.18 -6.62 0.55
98A 4.8 0.00642 0.01127 0.06710 0.00633 0.00632 -1.37 -1.52 1.05
95A 5.7 0.00750 0.01342 0.04758 0.00753 0.00754 0.34 0.43 2.53
105A 7.0 0.00893 0.01692 0.06222 0.00914 0.00915 2.32 2.48 6.57
93A 7.1 0.00861 0.01649 0.06466 0.00920 0.00921 6.79 6.96 6.78
97A 8.3 0.01015 0.01925 0.07564 0.01072 0.01073 5.58 5.67 13.32
88A 8.4 0.00985 0.01987 0.07930 0.01087 0.01088 10.39 10.48 14.10
86A 8.5 0.01176 0.01956 0.07564 0.01102 0.01103 -6.30 -6.23 14.89
87A 8.8 0.01133 0.01863 0.07564 0.01132 0.01133 -0.09 -0.05 16.53
102A 8.8 0.01252 0.02083 0.07808 0.01132 0.01133 -9.53 -9.50 16.53
84A 9.0 0.01261 0.02045 0.07808 0.01163 0.01163 -7.83 -7.81 18.20
89A 9.3 0.01092 0.02264 0.10126 0.01193 0.01193 9.27 9.25 19.91
106A 9.4 0.01232 0.02100 0.08906 0.01208 0.01208 -1.94 -1.97 20.77
103A 9.5 0.01087 0.02222 0.08418 0.01223 0.01223 12.55 12.50 20.37
101A 9.8 0.01153 0.02206 0.08296 0.01254 0.01253 8.75 8.67 18.66
91A 10.4 0.01399 0.02303 0.09028 0.01330 0.01328 -4.97 -5.12 14.52
85A 10.6 0.01408 0.02288 0.09394 0.01360 0.01358 -3.39 -3.58 12.97
104A 12.0 0.01547 0.02517 0.10736 0.01527 0.01521 -1.28 -1.67 6.03
90A 12.9 0.01688 0.02933 0.12932 0.01649 0.01640 -2.37 -2.89 2.95
99A 12.9 0.01736 0.02688 0.11346 0.01649 0.01640 -5.04 -5.55 2.95
94A 20.6 0.02557 0.03859 0.18544 0.02605 0.02561 1.87 0.15 0.00
Mean: 9.4 0.0121 0.0210
DRL: 10.4 0.0140 0.0229
Median: 9.0 0.0115 0.0208
n: 21
Population standard deviation: 3.4
Chauvenet criterion value: 0.5
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APPENDIX 11: INPUT DATA LAT CHEST HOSPITAL 2 
 
 
 
 
 
Hospital 2 Chest LAT
Patient
DAP value 
(cGy.cm
2
) - 
X-axis
PCXMC Skin 
dose (mGy) - 
Y-axis
PCXMC 
Effective dose 
(mSv) - 
ICRP103
PCXMC 
Incident air 
kerma (mGy)
Skin dose 
(mGy) - 
calculated 
linear fit
Skin dose 
(mGy) - 
calculated 
power fit
% Diff 
linear fit
% Diff 
power fit
Chauvenet 
criterion
100B 8.8 0.01190 0.02148 0.15006 0.01358 0.01287 14.19 8.24 0.20
98B 11.0 0.01840 0.02441 0.17080 0.01640 0.01590 -10.85 -13.59 0.31
86B 27.5 0.04447 0.04792 0.26596 0.03742 0.03758 -15.85 -15.48 4.57
97B 27.5 0.03470 0.05995 0.27694 0.03742 0.03758 7.85 8.32 4.57
95B 30.4 0.03721 0.06454 0.27816 0.04116 0.04134 10.61 11.09 6.47
88B 32.0 0.03897 0.06909 0.32696 0.04318 0.04336 10.82 11.28 7.70
85B 32.7 0.04587 0.06562 0.32086 0.04412 0.04429 -3.83 -3.44 8.31
93B 37.0 0.04616 0.07941 0.36234 0.04957 0.04970 7.37 7.67 12.42
103B 39.4 0.04608 0.08553 0.38186 0.05268 0.05278 14.33 14.54 15.12
87B 40.6 0.05499 0.08030 0.38918 0.05424 0.05431 -1.36 -1.23 16.54
104B 41.5 0.05805 0.08330 0.40138 0.05533 0.05538 -4.69 -4.59 17.56
105B 46.0 0.05234 0.09934 0.44896 0.06106 0.06099 16.66 16.54 18.97
99B 46.6 0.06593 0.09761 0.43432 0.06187 0.06178 -6.16 -6.29 18.20
92B 47.0 0.06378 0.09381 0.44896 0.06233 0.06224 -2.27 -2.42 17.76
84B 50.0 0.08320 0.08795 0.49044 0.06623 0.06603 -20.40 -20.64 14.20
102B 52.9 0.06889 0.10862 0.49898 0.06996 0.06965 1.55 1.10 11.08
94B 59.5 0.07986 0.11198 0.57706 0.07837 0.07776 -1.87 -2.63 5.57
106B 65.9 0.09027 0.13669 0.67466 0.08647 0.08552 -4.21 -5.26 2.41
89B 71.1 0.08506 0.14429 0.66856 0.09316 0.09189 9.53 8.04 1.05
101B 79.9 0.09456 0.17106 0.77348 0.10437 0.10251 10.38 8.41 0.19
90B 83.3 0.11697 0.17733 0.86864 0.10873 0.10662 -7.04 -8.85 0.09
Mean: 44.3 0.0589 0.0910
DRL: 52.9 0.0799 0.1086
Median: 41.5 0.0550 0.0855
n: 21
Population standard deviation: 19.3
Chauvenet criterion value: 0.5
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APPENDIX 12: INPUT DATA PA CHEST HOSPITAL 3 
 
 
 
 
 
 
Hospital 3 Chest PA
Patient
DAP value 
(cGy.cm2) - 
X-axis
PCXMC Skin 
dose (mGy) - 
Y-axis
PCXMC 
Effective dose 
(mSv) - 
ICRP103
PCXMC 
Incident air 
kerma (mGy)
Skin dose 
(mGy) - 
calculated 
linear fit
Skin dose 
(mGy) - 
calculated 
power fit
% Diff 
linear fit
% Diff 
power fit
Chauvenet 
criterion
180A 4.1 0.00575 0.00921 0.04636 0.00590 0.00571 2.60 -0.66 0.33
171A 5.4 0.00721 0.01488 0.06100 0.00740 0.00732 2.70 1.46 3.06
166A 6.0 0.00789 0.01495 0.05490 0.00814 0.00809 3.09 2.44 6.74
168A 6.0 0.00836 0.01424 0.05368 0.00814 0.00809 -2.63 -3.24 6.74
172A 6.2 0.00808 0.01577 0.07198 0.00843 0.00839 4.38 3.92 8.78
169A 6.3 0.00882 0.01368 0.05856 0.00858 0.00855 -2.76 -3.12 9.92
174A 6.5 0.00946 0.01403 0.07442 0.00872 0.00870 -7.74 -8.00 11.13
173A 6.6 0.00792 0.01693 0.05978 0.00887 0.00885 12.02 11.79 12.41
175A 6.6 0.00850 0.01665 0.07564 0.00887 0.00885 4.31 4.09 12.41
178A 7.1 0.00895 0.02070 0.07930 0.00946 0.00946 5.60 5.64 17.96
179A 7.1 0.00910 0.01886 0.08052 0.00946 0.00946 3.90 3.94 17.96
181A 7.1 0.00905 0.01718 0.08174 0.00946 0.00946 4.46 4.50 17.96
176A 7.3 0.01048 0.01565 0.06832 0.00971 0.00972 -7.39 -7.28 17.59
167A 7.4 0.01050 0.01726 0.06954 0.00990 0.00991 -5.79 -5.62 15.74
170A 7.7 0.01028 0.02013 0.08784 0.01019 0.01022 -0.93 -0.67 12.99
180AB 7.7 0.01108 0.02023 0.08906 0.01019 0.01022 -8.03 -7.78 12.99
165A 7.7 0.01031 0.02036 0.08906 0.01022 0.01025 -0.88 -0.61 12.73
215A 10.7 0.01459 0.02195 0.08174 0.01387 0.01396 -4.97 -4.35 0.10
177A 12.7 0.01534 0.03227 0.14762 0.01620 0.01629 5.61 6.20 0.00
Mean: 7.2 0.0096 0.0176
DRL: 7.6 0.0104 0.0202
Median: 7.1 0.0091 0.0169
n: 19
Population standard deviation: 1.8
Chauvenet criterion value: 0.5
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APPENDIX 13: INPUT DATA LAT CHEST HOSPITAL 3 
 
 
 
 
 
Hospital 3 Chest LAT
Patient
DAP value 
(cGy.cm2) - 
X-axis
PCXMC Skin 
dose (mGy) - 
Y-axis
PCXMC 
Effective dose 
(mSv) - 
ICRP103
PCXMC 
Incident air 
kerma (mGy)
Skin dose 
(mGy) - 
calculated 
linear fit
Skin dose 
(mGy) - 
calculated 
power fit
% Diff 
linear fit
% Diff 
power fit
Chauvenet 
criterion
215A 10.7 0.01459 0.02195 0.08174 0.01318 0.01179 -9.67 -19.21 1.21
178B 11.5 0.01663 0.03303 0.14518 0.01438 0.01282 -13.51 -22.88 1.56
167B 15.6 0.00314 0.00316 0.16836 0.02131 0.01915 579.57 510.77 5.41
165B 16.1 0.02496 0.03974 0.20008 0.02212 0.01993 -11.37 -20.15 6.11
174B 16.1 0.02769 0.03678 0.20618 0.02212 0.01993 -20.12 -28.03 6.11
175B 18.1 0.02733 0.04319 0.22326 0.02538 0.02312 -7.12 -15.38 9.51
171B 18.3 0.02847 0.04780 0.24278 0.02579 0.02353 -9.43 -17.36 9.99
215B 20.0 0.02600 0.04013 0.19154 0.02866 0.02644 10.24 1.71 13.76
180B 20.1 0.03305 0.04457 0.24888 0.02884 0.02663 -12.73 -19.42 14.02
182B 20.7 0.03122 0.04712 0.25254 0.02980 0.02762 -4.54 -11.52 15.40
166B 20.9 0.02799 0.04762 0.21716 0.03007 0.02790 7.43 -0.32 15.79
172B 20.9 0.02510 0.04139 0.20374 0.03007 0.02790 19.81 11.16 15.79
176B 23.2 0.03518 0.04868 0.23668 0.03402 0.03208 -3.32 -8.83 18.26
173B 23.9 0.03010 0.06055 0.25742 0.03516 0.03331 16.82 10.66 16.55
170B 26.5 0.04091 0.06499 0.33916 0.03944 0.03801 -3.60 -7.07 10.63
168B 27.3 0.03787 0.06127 0.27938 0.04086 0.03962 7.90 4.61 8.92
179B 28.4 0.04347 0.07337 0.36966 0.04269 0.04170 -1.78 -4.08 6.98
180BC 29.4 0.05752 0.06277 0.39528 0.04432 0.04356 -22.94 -24.27 5.50
169B 29.6 0.04488 0.06301 0.31232 0.04473 0.04403 -0.34 -1.89 5.16
177B 53.4 0.08130 0.13142 0.71858 0.08445 0.09466 3.88 16.43 0.00
Mean: 22.5 0.0329 0.0506
DRL: 26.7 0.0386 0.0616
Median: 20.8 0.0293 0.0474
n: 20
Population standard deviation: 8.9
Chauvenet criterion value: 0.5
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APPENDIX 14: INPUT DATA AP LUMBAR SPINE HOSPITAL 1 
 
 
 
 
 
Hospital 1 Lumbar spine AP
Patient
DAP value 
(cGy.cm2) - 
X-axis
PCXMC Skin 
dose (mGy) - 
Y-axis
PCXMC 
Effective dose 
(mSv) - 
ICRP103
PCXMC 
Incident air 
kerma (mGy)
Skin dose 
(mGy) - 
calculated 
linear fit
Skin dose 
(mGy) - 
calculated 
power fit
% Diff 
linear fit
% Diff 
power fit
Chauvenet 
criterion
75A 70.5 0.07799 0.13041 0.78934 0.07898 0.07777 1.27 -0.29 5.73
72A 70.8 0.07546 0.13287 0.88084 0.07926 0.07804 5.04 3.43 5.78
67A 80.3 0.08438 0.15950 0.87718 0.08992 0.08885 6.57 5.30 7.98
80A 80.9 0.08685 0.13963 0.83936 0.09060 0.08954 4.32 3.10 8.13
65A 82.8 0.08983 0.15244 0.86010 0.09279 0.09176 3.29 2.16 8.64
71A 85.4 0.09578 0.17651 0.90646 0.09566 0.09468 -0.13 -1.15 9.35
66A 88.1 0.09864 0.18204 0.98576 0.09866 0.09774 0.03 -0.91 10.11
73A 88.6 0.09816 0.16952 0.94062 0.09921 0.09830 1.07 0.14 10.25
64A 90.4 0.10797 0.21793 1.09800 0.10126 0.10039 -6.22 -7.02 10.80
69A 91.3 0.09895 0.18446 1.07482 0.10221 0.10136 3.29 2.43 11.06
78A 95.0 0.10932 0.19688 1.03944 0.10645 0.10568 -2.63 -3.33 12.24
68A 99.1 0.11370 0.20652 1.10898 0.11096 0.11029 -2.41 -3.01 13.56
74A 119.7 0.12649 0.23411 1.45302 0.13405 0.13394 5.98 5.89 19.13
81A 124.7 0.14240 0.24528 1.43350 0.13966 0.13970 -1.93 -1.90 17.32
70A 127.4 0.14220 0.28948 1.46400 0.14266 0.14279 0.32 0.41 16.36
76A 136.9 0.14834 0.25239 1.66164 0.15332 0.15377 3.36 3.66 13.10
63A 142.9 0.16519 0.31270 1.64212 0.16002 0.16067 -3.13 -2.73 11.19
83A 143.1 0.16942 0.35135 1.68482 0.16029 0.16096 -5.39 -5.00 11.12
82A 166.8 0.19677 0.41357 2.02520 0.18680 0.18838 -5.07 -4.27 5.18
79A 361.1 0.39937 0.82058 4.89708 0.40447 0.41675 1.28 4.35 0.00
Mean: 117.3 0.1314 0.2484
DRL: 129.7 0.1439 0.2617
Median: 93.1 0.1086 0.2017
n: 20
Population standard deviation: 62.0
Chauvenet criterion value: 0.5
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APPENDIX 15: INPUT DATA LAT LUMBAR SPINE HOSPITAL 1 
 
 
 
 
Hospital 1 Lumbar spine LAT
Patient
DAP value 
(cGy.cm2) - 
X-axis
PCXMC Skin 
dose (mGy) - 
Y-axis
PCXMC 
Effective dose 
(mSv) - 
ICRP103
PCXMC 
Incident air 
kerma (mGy)
Skin dose 
(mGy) - 
calculated 
linear fit
Skin dose 
(mGy) - 
calculated 
power fit
% Diff 
linear fit
% Diff 
power fit
Chauvenet 
criterion
75B 95.4 0.11264 0.08594 1.18706 0.08064 0.09218 -28.41 -18.17 1.79
80B 104.3 0.11383 0.07588 1.16754 0.09463 0.10284 -16.87 -9.66 2.46
67B 115.0 0.14502 0.12420 1.51524 0.11149 0.11596 -23.12 -20.04 3.52
73B 115.2 0.12753 0.09566 1.35542 0.11168 0.11611 -12.43 -8.95 3.53
69B 129.8 0.15939 0.12312 1.76046 0.13467 0.13445 -15.51 -15.65 5.48
68B 137.5 0.06000 0.15970 1.86416 0.14674 0.14427 144.57 140.46 6.76
72B 146.6 0.18583 0.13078 2.11060 0.16111 0.15613 -13.30 -15.98 8.51
78B 148.1 0.17835 0.14264 1.83976 0.16341 0.15804 -8.38 -11.39 8.81
66B 178.5 0.21528 0.18478 2.34972 0.21112 0.19865 -1.93 -7.72 16.25
70B 180.8 0.23439 0.19270 11.27158 0.21476 0.20182 -8.37 -13.89 16.89
74B 182.4 0.23315 0.17372 2.85724 0.21725 0.20399 -6.82 -12.51 17.33
64B 182.9 0.06559 0.03592 0.50386 0.21801 0.20466 232.40 212.05 17.46
81B 188.2 0.22561 0.15767 2.53638 0.22645 0.21205 0.37 -6.01 18.96
63B 197.2 0.23339 0.15884 2.74256 0.24043 0.22441 3.02 -3.84 18.54
77B 231.6 0.32390 0.25940 3.33182 0.29446 0.27332 -9.09 -15.61 9.72
71B 232.3 0.27718 0.22087 2.97314 0.29561 0.27438 6.65 -1.01 9.56
65B 239.7 0.27409 0.21445 2.98290 0.30730 0.28520 12.12 4.05 8.01
82B 284.1 0.40541 0.37779 4.08822 0.37704 0.35125 -7.00 -13.36 2.10
83B 310.5 0.45083 0.44395 4.46764 0.41843 0.39159 -7.19 -13.14 0.74
79B 439.0 0.62399 0.54716 7.12602 0.62018 0.59864 -0.61 -4.06 0.00
Mean: 192.0 0.2323 0.1953
DRL: 231.7 0.2749 0.2161
Median: 181.6 0.2204 0.1593
n: 20
Population standard deviation: 80.4
Chauvenet criterion value: 0.5
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APPENDIX 16: INPUT DATA AP LUMBAR SPINE HOSPITAL 2 
 
 
 
 
Hospital 2 Lumbar spine AP
Patient
DAP value 
(cGy.cm2) - 
X-axis
PCXMC Skin 
dose (mGy) - 
Y-axis
PCXMC 
Effective dose 
(mSv) - 
ICRP103
PCXMC 
Incident air 
kerma (mGy)
Skin dose 
(mGy) - 
calculated 
linear fit
Skin dose 
(mGy) - 
calculated 
power fit
% Diff 
linear fit
% Diff 
power fit
Chauvenet 
criterion
122A 57.0 0.06206 0.11984 1.04920 0.07127 0.06557 14.84 5.66 1.00
114A 124.0 0.14065 0.30480 1.86050 0.14033 0.13849 -0.23 -1.54 3.92
121A 125.1 0.13808 0.21315 4.65430 0.14148 0.13970 2.47 1.17 4.00
111A 139.8 0.17161 0.38938 2.25822 0.15669 0.15552 -8.69 -9.37 5.11
119A 154.6 0.16774 0.28871 1.60796 0.17192 0.17130 2.49 2.12 6.41
117A 166.8 0.17613 0.29594 3.70514 0.18451 0.18430 4.76 4.64 7.63
120A 168.6 0.19779 0.36803 3.49530 0.18641 0.18626 -5.75 -5.83 7.82
116A 175.1 0.19296 0.34729 2.12280 0.19307 0.19312 0.06 0.08 8.52
123A 175.6 0.19879 0.35307 3.95524 0.19366 0.19373 -2.58 -2.54 8.59
113A 180.0 0.19313 0.37710 3.44284 0.19810 0.19830 2.58 2.68 9.08
109A 238.1 0.27280 0.57832 3.54532 0.25814 0.25972 -5.37 -4.80 16.69
118A 275.7 0.29573 0.49503 3.00364 0.29694 0.29909 0.41 1.14 12.17
115A 307.1 0.31980 0.54984 5.22038 0.32926 0.33175 2.96 3.74 8.37
107A 346.5 0.38674 0.65477 6.94668 0.36992 0.37265 -4.35 -3.64 4.67
112A 355.6 0.35387 0.61140 6.67462 0.37936 0.38212 7.20 7.98 4.00
108A 538.1 0.55964 1.00163 9.74292 0.56767 0.56941 1.44 1.75 0.04
110A 558.8 0.60017 1.07621 9.32202 0.58894 0.59040 -1.87 -1.63 0.02
Mean: 240.4 0.2605 0.4720
DRL: 307.1 0.3198 0.5783
Median: 175.6 0.1978 0.3771
n: 17
Population standard deviation: 137.4
Chauvenet criterion value: 0.5
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APPENDIX 17: INPUT DATA LAT LUMBAR SPINE HOSPITAL 2 
 
 
 
Hospital 2 Lumbar spine LAT
Patient
DAP value 
(cGy.cm2) - 
X-axis
PCXMC Skin 
dose (mGy) - 
Y-axis
PCXMC 
Effective dose 
(mSv) - 
ICRP103
PCXMC 
Incident air 
kerma (mGy)
Skin dose 
(mGy) - 
calculated 
linear fit
Skin dose 
(mGy) - 
calculated 
power fit
% Diff 
linear fit
% Diff 
power fit
Chauvenet 
criterion
122B 85.7 0.05952 0.13058 1.87636 0.12126 0.07721 103.72 29.71 0.29
119B 145.1 0.16557 0.13503 1.78608 0.16299 0.13243 -1.56 -20.01 2.18
121B 198.9 0.14394 0.26658 8.28624 0.20072 0.18286 39.45 27.04 7.78
117B 199.1 0.18583 0.23717 4.72750 0.20092 0.18312 8.12 -1.46 7.82
113B 202.5 0.11851 0.32733 4.53840 0.20329 0.18630 71.54 57.20 8.34
120B 203.2 0.23658 0.28692 4.73116 0.20376 0.18692 -13.88 -20.99 8.44
112B 214.1 0.20736 0.28669 3.77102 0.21143 0.19723 1.96 -4.89 10.23
109B 222.4 0.27400 0.36648 3.60998 0.21725 0.20505 -20.71 -25.16 11.70
115B 234.1 0.19616 0.33139 4.66040 0.22548 0.21612 14.94 10.17 13.88
118B 248.3 0.28237 0.22643 3.12198 0.23544 0.22955 -16.62 -18.71 16.65
107B 251.8 0.14555 0.47214 6.07560 0.23789 0.23285 63.45 59.98 16.67
116B 261.2 0.32412 0.28017 3.16712 0.24449 0.24175 -24.57 -25.41 14.83
114B 279.7 0.36751 0.32845 3.45504 0.25751 0.25933 -29.93 -29.44 11.35
111B 283.5 0.35905 0.49614 4.59574 0.26016 0.26292 -27.54 -26.77 10.68
123B 288.6 0.27133 0.42848 7.33464 0.26370 0.26771 -2.81 -1.33 9.82
108B 382.1 0.30068 0.58107 8.11544 0.32936 0.35686 9.54 18.68 0.95
110B 551.6 0.38591 0.82866 10.14308 0.44832 0.51965 16.17 34.66 0.00
Mean: 250.1 0.2367 0.3535
DRL: 279.7 0.3007 0.4285
Median: 234.1 0.2366 0.3273
n: 17
Population standard deviation: 97.6
Chauvenet criterion value: 0.5
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APPENDIX 18: INPUT DATA AP LUMBAR SPINE HOSPITAL 3 
 
 
 
 
Hospital 3 Lumbar spine AP
Patient
DAP value 
(cGy.cm
2
) - 
X-axis
PCXMC Skin 
dose (mGy) - 
Y-axis
PCXMC 
Effective dose 
(mSv) - 
ICRP103
PCXMC 
Incident air 
kerma (mGy)
Skin dose 
(mGy) - 
calculated 
linear fit
Skin dose 
(mGy) - 
calculated 
power fit
% Diff 
linear fit
% Diff 
power fit
Chauvenet 
criterion
211A 33.9 0.03720 0.07586 0.56974 0.03557 0.03655 -4.38 -1.74 1.91
187A 36.6 0.04159 0.08058 0.47702 0.03856 0.03944 -7.29 -5.18 2.15
192A 37.6 0.04324 0.08910 0.52948 0.03971 0.04055 -8.15 -6.21 2.24
185A 51.9 0.05987 0.11758 0.74786 0.05555 0.05583 -7.20 -6.74 3.88
186A 59.8 0.06814 0.11322 1.99104 0.06446 0.06442 -5.40 -5.46 5.07
189A 68.8 0.04748 0.09960 0.61976 0.07441 0.07401 56.71 55.87 6.62
183A 76.7 0.08366 0.15999 1.07848 0.08325 0.08253 -0.49 -1.35 8.14
184A 83.6 0.09509 0.18466 1.20536 0.09094 0.08994 -4.36 -5.41 9.55
190A 165.6 0.20041 0.38552 2.77184 0.18228 0.17788 -9.04 -11.24 0.79
188A 176.0 0.18786 0.35614 2.13744 0.19391 0.18906 3.22 0.64 0.44
191A 205.1 0.22048 0.40669 2.97436 0.22635 0.22027 2.66 -0.10 0.06
Mean: 90.5 0.0986 0.1881
DRL: 124.6 0.1415 0.2704
Median: 68.8 0.0681 0.1176
n: 11
Population standard deviation: 58.9
Chauvenet criterion value: 0.5
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APPENDIX 19: INPUT DATA LAT LUMBAR SPINE HOSPITAL 3 
 
 
 
Hospital 3 Lumbar spine LAT
Patient
DAP value 
(cGy.cm
2
) - 
X-axis
PCXMC Skin 
dose (mGy) - 
Y-axis
PCXMC 
Effective dose 
(mSv) - 
ICRP103
PCXMC 
Incident air 
kerma (mGy)
Skin dose 
(mGy) - 
calculated 
linear fit
Skin dose 
(mGy) - 
calculated 
power fit
% Diff 
linear fit
% Diff 
power fit
Chauvenet 
criterion
211B 31.8 0.03185 0.04699 0.59414 0.04921 0.03746 54.47 17.61 0.43
187B 54.7 0.07848 0.06891 0.85522 0.06842 0.06086 -12.82 -22.46 2.09
192B 62.3 0.09509 0.08527 0.97356 0.07482 0.06841 -21.31 -28.06 3.18
186B 70.2 0.04121 0.12455 2.05936 0.08149 0.07617 97.74 84.83 4.65
185B 74.7 0.10153 0.08650 1.27002 0.08527 0.08053 -16.01 -20.68 5.64
190B 80.1 0.06588 0.14573 1.69824 0.08985 0.08578 36.39 30.21 6.98
184B 81.3 0.09410 0.11808 1.50792 0.09082 0.08689 -3.48 -7.67 7.28
189B 122.0 0.14442 0.17986 2.10450 0.12517 0.12519 -13.33 -13.32 4.05
188B 137.9 0.17845 0.17845 1.91784 0.13854 0.13972 -22.37 -21.70 1.71
183B 146.5 0.17414 0.18793 2.64008 0.14575 0.14749 -16.30 -15.31 0.98
191B 179.3 0.11755 0.27441 3.25496 0.17336 0.17682 47.48 50.42 0.06
Mean: 94.6 0.1021 0.1361
DRL: 130.0 0.1310 0.1792
Median: 80.1 0.0951 0.1245
n: 11
Population standard deviation: 43.1
Chauvenet criterion value: 0.5
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APPENDIX 20: INPUT DATA AP PELVIS HOSPITAL 1 
 
 
Hospital 1 Pelvis
Patient
DAP value 
(cGy.cm2) - 
X-axis
PCXMC Skin 
dose (mGy) - 
Y-axis
PCXMC 
Effective dose 
(mSv) - 
ICRP103
PCXMC 
Incident air 
kerma (mGy)
Skin dose 
(mGy) - 
calculated 
linear fit
Skin dose 
(mGy) - 
calculated 
power fit
% Diff 
linear fit
% Diff 
power fit
Chauvenet 
criterion
16 53.9 0.06911 0.07093 0.47702 0.06438 0.06458 -6.85 -6.55 0.18
20 74.7 0.09324 0.11966 0.85888 0.08849 0.08886 -5.10 -4.70 0.82
15 77.3 0.08597 0.10893 0.82106 0.09156 0.09194 6.50 6.94 0.97
11 93.3 0.10258 0.13314 1.09922 0.11020 0.11060 7.43 7.83 2.54
19 99.8 0.11256 0.14936 1.43594 0.11772 0.11812 4.58 4.94 3.58
13 111.1 0.13154 0.16267 1.17974 0.13091 0.13127 -0.48 -0.20 6.16
18 111.8 0.13965 0.18160 1.51646 0.13169 0.13205 -5.70 -5.45 6.35
17 124.3 0.15346 0.19748 1.32004 0.14623 0.14652 -4.71 -4.53 10.53
14 135.2 0.15866 0.19599 1.43472 0.15886 0.15906 0.12 0.25 15.25
10 138.6 0.15326 0.18544 1.55062 0.16283 0.16300 6.25 6.36 16.91
25 147.3 0.17012 0.20017 1.48962 0.17290 0.17299 1.64 1.69 21.41
7 147.9 0.17254 0.21452 1.69946 0.17361 0.17369 0.62 0.66 21.74
6 149.1 0.16705 0.19932 1.71410 0.17503 0.17509 4.77 4.81 22.40
12 161.2 0.19073 0.25120 2.18502 0.18907 0.18900 -0.87 -0.91 22.98
9 167.9 0.19884 0.24373 1.87880 0.19688 0.19671 -0.99 -1.07 19.39
2 168.4 0.20009 0.23727 1.78730 0.19744 0.19727 -1.32 -1.41 19.13
23 169.0 0.20524 0.24511 1.79462 0.19815 0.19797 -3.45 -3.54 18.81
22 173.1 0.19408 0.22940 1.93736 0.20298 0.20274 4.59 4.46 16.71
21 178.2 0.21367 0.25611 1.94956 0.20894 0.20862 -2.22 -2.36 14.26
5 200.4 0.22820 0.26190 2.56566 0.23475 0.23408 2.87 2.58 6.09
8 206.2 0.24296 0.28284 2.42658 0.24142 0.24064 -0.63 -0.95 4.67
24 209.5 0.24973 0.28283 2.34362 0.24525 0.24441 -1.79 -2.13 3.97
26 213.5 0.25544 0.30615 2.51320 0.24993 0.24902 -2.16 -2.51 3.23
3 225.3 0.26469 0.32389 2.46440 0.26369 0.26255 -0.38 -0.81 1.67
4 231.7 0.28058 0.34530 2.66326 0.27107 0.26980 -3.39 -3.84 1.13
102163 278.5 0.31553 0.40829 3.56484 0.32555 0.32321 3.17 2.43 0.03
Mean: 155.7 0.1827 0.2228
DRL: 194.9 0.2246 0.2605
Median: 155.1 0.1816 0.2220
n: 26
Population standard deviation: 53.2
Chauvenet criterion value: 0.5
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APPENDIX 21: INPUT DATA AP PELVIS HOSPITAL 2 
 
 
 
 
 
 
Hospital 2 Pelvis
Patient
DAP value 
(cGy.cm
2
) - 
X-axis
PCXMC Skin 
dose (mGy) - 
Y-axis
PCXMC 
Effective dose 
(mSv) - 
ICRP103
PCXMC 
Incident air 
kerma (mGy)
Skin dose 
(mGy) - 
calculated 
linear fit
Skin dose 
(mGy) - 
calculated 
power fit
% Diff 
linear fit
% Diff 
power fit
Chauvenet 
criterion
137 112.4 0.13413 0.19038 1.14680 0.14205 0.13774 5.90 2.69 1.19
138 131.4 0.14516 0.16408 1.76412 0.16267 0.15962 12.07 9.96 1.84
140 146.6 0.18402 0.26291 1.77998 0.17921 0.17702 -2.62 -3.80 2.53
144 170.7 0.21415 0.25380 1.48352 0.20527 0.20425 -4.14 -4.62 3.99
145 184.5 0.22946 0.29878 1.91540 0.22022 0.21977 -4.02 -4.22 5.03
143 209.5 0.26678 0.33551 2.12646 0.24735 0.24776 -7.28 -7.13 7.31
141 223.4 0.24945 0.33857 3.15492 0.26243 0.26324 5.20 5.53 8.77
146 251.6 0.31258 0.43367 2.78770 0.29299 0.29444 -6.27 -5.80 11.98
148 295.4 0.35103 0.47448 3.35012 0.34049 0.34254 -3.00 -2.42 8.94
139 328.8 0.34355 0.48319 3.56118 0.37674 0.37897 9.66 10.31 5.63
136 330.6 0.37741 0.54856 3.60144 0.37867 0.38091 0.33 0.93 5.47
142 446.8 0.49337 0.57325 4.63844 0.50468 0.50599 2.29 2.56 0.43
147 550.6 0.62896 0.74469 5.71570 0.61727 0.61616 -1.86 -2.03 0.01
Mean: 260.2 0.3023 0.3925
DRL: 328.8 0.3510 0.4832
Median: 223.4 0.2668 0.3386
n: 13
Population standard deviation: 123.8
Chauvenet criterion value: 0.5
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APPENDIX 22: INPUT DATA AP PELVIS HOSPITAL 3 
 
 
 
Hospital 3 Pelvis
Patient
DAP value 
(cGy.cm2) - 
X-axis
PCXMC Skin 
dose (mGy) - 
Y-axis
PCXMC 
Effective dose 
(mSv) - 
ICRP103
PCXMC 
Incident air 
kerma (mGy)
Skin dose 
(mGy) - 
calculated 
linear fit
Skin dose 
(mGy) - 
calculated 
power fit
% Diff 
linear fit
% Diff 
power fit
Chauvenet 
criterion
205 61.7 0.07830 0.10647 0.60146 0.07333 0.07487 -6.34 -4.38 2.52
204 75.3 0.09575 0.12556 0.78202 0.08977 0.09102 -6.24 -4.94 4.55
207 76.5 0.09570 0.12991 1.11996 0.09128 0.09249 -4.62 -3.35 4.79
208 78.0 0.09656 0.12801 0.69174 0.09312 0.09430 -3.57 -2.35 5.08
202 83.5 0.10053 0.12453 1.08702 0.09968 0.10072 -0.84 0.19 6.22
196 84.3 0.10337 0.13158 0.94306 0.10067 0.10169 -2.61 -1.63 6.41
210 92.5 0.10795 0.15471 0.88694 0.11061 0.11140 2.46 3.20 8.47
201 93.3 0.11561 0.15711 1.36884 0.11152 0.11229 -3.53 -2.87 8.67
199 94.1 0.10230 0.15185 1.71044 0.11254 0.11328 10.01 10.74 8.90
200 99.8 0.12110 0.20397 2.68034 0.11941 0.11999 -1.39 -0.92 10.55
193 100.1 0.11852 0.21856 1.40666 0.11978 0.12034 1.06 1.54 10.65
195 115.5 0.13034 0.17140 1.29320 0.13838 0.13846 6.17 6.22 15.70
198 115.8 0.13393 0.17308 1.36274 0.13871 0.13877 3.57 3.61 15.80
209 141.0 0.15537 0.15537 1.60918 0.16917 0.16832 8.88 8.34 11.60
206 168.1 0.20886 0.23745 1.27246 0.20199 0.20003 -3.29 -4.23 4.69
197 225.1 0.27391 0.36865 2.64984 0.27084 0.26625 -1.12 -2.80 0.21
203 242.7 0.28825 0.42990 3.61730 0.29208 0.28659 1.33 -0.58 0.06
194 250.1 0.30759 0.44038 2.45830 0.30105 0.29518 -2.12 -4.03 0.03
Mean: 122.1 0.1463 0.2005
DRL: 134.7 0.1500 0.2149
Median: 96.9 0.1171 0.1562
n: 18
Population standard deviation: 57.9
Chauvenet criterion value: 0.5
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APPENDIX 23: INPUT DATA PA SKULL HOSPITAL 1 
 
 
Hospital 1 Skull PA
Patient
DAP value 
(cGy.cm2) - 
X-axis
PCXMC Skin 
dose (mGy) - 
Y-axis
PCXMC 
Effective dose 
(mSv) - 
ICRP103
PCXMC 
Incident air 
kerma (mGy)
Skin dose 
(mGy) - 
calculated 
linear fit
Skin dose 
(mGy) - 
calculated 
power fit
% Diff 
linear fit
% Diff 
power fit
Chauvenet 
criterion
51A 21.8 0.01731 0.00460 0.26718 0.02146 0.01967 23.94 13.59 1.08
62A 24.8 0.01920 0.00506 0.32330 0.02431 0.02249 26.61 17.11 1.57
53A 27.6 0.03159 0.00903 0.50996 0.02705 0.02522 -14.36 -20.17 2.20
65A 31.6 0.02808 0.00811 0.42456 0.03098 0.02916 10.30 3.83 3.45
61A 36.1 0.03029 0.00800 0.47092 0.03538 0.03362 16.79 10.99 5.40
50A 37.3 0.03346 0.00808 0.47580 0.03657 0.03483 9.28 4.09 6.04
64A 38.6 0.03283 0.00894 0.50264 0.03776 0.03605 15.01 9.81 6.73
55A 41.2 0.04099 0.01030 0.91622 0.04038 0.03873 -1.50 -5.51 8.42
48A 42.6 0.03586 0.00904 0.58438 0.04169 0.04008 16.26 11.77 9.35
57A 47.0 0.05984 0.01610 1.04310 0.04597 0.04450 -23.18 -25.64 12.78
59A 50.1 0.06260 0.01803 1.08824 0.04906 0.04771 -21.62 -23.78 15.56
47A 58.0 0.04891 0.01556 0.73932 0.05668 0.05567 15.88 13.83 19.06
54A 58.6 0.05908 0.01734 1.14436 0.05727 0.05630 -3.06 -4.72 18.49
60A 62.1 0.07364 0.02212 0.79178 0.06072 0.05993 -17.54 -18.61 15.21
58A 70.2 0.05603 0.01637 0.91378 0.06858 0.06825 22.39 21.80 8.74
56A 70.9 0.07973 0.02261 0.75396 0.06935 0.06907 -13.01 -13.36 8.20
63A 73.7 0.05441 0.01458 0.93940 0.07203 0.07193 32.38 32.19 6.51
59AB 74.2 0.10210 0.03138 1.64700 0.07251 0.07244 -28.99 -29.05 6.23
52A 97.6 0.07508 0.01946 1.29076 0.09535 0.09706 27.00 29.28 0.36
49A 101.1 0.08558 0.02403 1.31760 0.09880 0.10082 15.45 17.80 0.20
62AB 109.4 0.12216 0.03462 1.42618 0.10690 0.10966 -12.49 -10.23 0.05
Mean: 55.9 0.0547 0.0154
DRL: 70.9 0.0736 0.0195
Median: 50.1 0.0544 0.0156
n: 21
Population standard deviation: 24.7
Chauvenet criterion value: 0.5
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APPENDIX 24: INPUT DATA LAT SKULL HOSPITAL 1 
 
 
 
Hospital 1 Skull LAT
Patient
DAP value 
(cGy.cm
2
) - 
X-axis
PCXMC Skin 
dose (mGy) - 
Y-axis
PCXMC 
Effective dose 
(mSv) - 
ICRP103
PCXMC 
Incident air 
kerma (mGy)
Skin dose 
(mGy) - 
calculated 
linear fit
Skin dose 
(mGy) - 
calculated 
power fit
% Diff 
linear fit
% Diff 
power fit
Chauvenet 
criterion
51B 25.3 0.02025 0.00952 0.29036 0.02711 0.02324 33.85 14.75 1.17
62B 27.9 0.03231 0.03231 0.41968 0.02912 0.02559 -9.87 -20.79 1.68
61B 33.4 0.02545 0.01169 0.37698 0.03323 0.03037 30.56 19.33 3.31
50B 36.4 0.03198 0.01646 0.42090 0.03542 0.03290 10.76 2.90 4.56
55B 38.1 0.03010 0.00761 0.74786 0.03670 0.03438 21.93 14.22 5.43
53B 44.8 0.04459 0.01585 0.78812 0.04172 0.04014 -6.44 -9.99 9.93
65B 45.3 0.03799 0.01835 0.52338 0.04208 0.04056 10.78 6.75 10.32
64B 47.7 0.03920 0.01759 0.56364 0.04391 0.04264 12.02 8.78 12.39
48B 48.2 0.03599 0.01508 0.55754 0.04428 0.04306 23.02 19.63 12.83
58B 49.2 0.04931 0.01708 0.96624 0.04501 0.04389 -8.73 -11.00 13.72
54B 49.4 0.04391 0.01330 0.99186 0.04519 0.04410 2.92 0.43 13.95
59BA 55.0 0.06268 0.02274 1.08092 0.04939 0.04886 -21.21 -22.05 19.49
58B 57.3 0.04035 0.02070 0.54046 0.05113 0.05083 26.72 25.98 20.13
56B 61.6 0.06821 0.03207 0.60512 0.05434 0.05445 -20.33 -20.17 15.81
62BA 62.1 0.06561 0.03326 0.73322 0.05469 0.05484 -16.65 -16.41 15.36
47B 62.8 0.05309 0.02685 0.72712 0.05524 0.05546 4.03 4.46 14.65
57B 67.8 0.07139 0.02505 1.33224 0.05898 0.05967 -17.39 -16.43 10.23
60B 77.5 0.09074 0.04525 0.91500 0.06619 0.06773 -27.05 -25.36 4.17
49B 80.8 0.06385 0.02832 0.93452 0.06866 0.07048 7.53 10.37 2.88
63B 84.9 0.05849 0.02044 0.95038 0.07176 0.07393 22.70 26.40 1.71
52B 130.9 0.09483 0.03439 1.58966 0.10619 0.11175 11.98 17.84 0.00
Mean: 56.5 0.0505 0.0221
DRL: 62.8 0.0639 0.0283
Median: 49.4 0.0446 0.0204
n: 21
Population standard deviation: 23.1
Chauvenet criterion value: 0.5
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APPENDIX 25: INPUT DATA PA SKULL HOSPITAL 2 
 
 
 
 
 
 
 
Hospital 2 Skull PA
Patient
DAP value 
(cGy.cm
2
) - 
X-axis
PCXMC Skin 
dose (mGy) - 
Y-axis
PCXMC 
Effective dose 
(mSv) - 
ICRP103
PCXMC 
Incident air 
kerma (mGy)
Skin dose 
(mGy) - 
calculated 
linear fit
Skin dose 
(mGy) - 
calculated 
power fit
% Diff 
linear fit
% Diff 
power fit
Chauvenet 
criterion
130A 24.7 0.02807 0.00803 0.48556 0.02714 0.02705 -3.31 -3.65 0.09
135A 34.6 0.03398 0.00914 0.64050 0.03902 0.03848 14.85 13.25 0.32
133A 44.2 0.05218 0.01610 0.75030 0.05053 0.04970 -3.15 -4.75 0.93
128A 72.5 0.10530 0.03087 1.49694 0.08447 0.08334 -19.78 -20.86 7.88
127A 84.4 0.09389 0.02623 1.47620 0.09881 0.09774 5.24 4.10 10.91
129A 92.0 0.10950 0.02795 1.82756 0.10788 0.10690 -1.48 -2.37 7.68
131A 93.1 0.09905 0.02551 1.79096 0.10919 0.10823 10.24 9.26 7.25
125A 93.6 0.08440 0.02102 1.44692 0.10978 0.10882 30.07 28.93 7.06
124A 100.8 0.13660 0.03893 1.98738 0.11841 0.11757 -13.32 -13.93 4.56
126A 112.5 0.11904 0.02866 1.58356 0.13245 0.13187 11.27 10.78 1.85
132A 114.9 0.13603 0.03876 2.45708 0.13538 0.13486 -0.48 -0.86 1.49
134A 116.8 0.15261 0.04324 2.00812 0.13757 0.13710 -9.85 -10.16 1.25
Mean: 82.0 0.0959 0.0262
DRL: 103.7 0.1233 0.0328
Median: 92.5 0.1022 0.0271
n: 12
Population standard deviation: 30.3
Chauvenet criterion value: 0.5
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APPENDIX 26: INPUT DATA LAT SKULL HOSPITAL 2 
 
 
 
 
 
Hospital 2 Skull LAT
Patient
DAP value 
(cGy.cm
2
) - 
X-axis
PCXMC Skin 
dose (mGy) - 
Y-axis
PCXMC 
Effective dose 
(mSv) - 
ICRP103
PCXMC 
Incident air 
kerma (mGy)
Skin dose 
(mGy) - 
calculated 
linear fit
Skin dose 
(mGy) - 
calculated 
power fit
% Diff 
linear fit
% Diff 
power fit
Chauvenet 
criterion
135B 12.7 0.01152 0.00387 0.21838 0.01495 0.01267 29.79 10.02 0.48
130B 19.2 0.02037 0.00691 0.33550 0.01957 0.01814 -3.94 -10.97 0.99
133B 21.8 0.02383 0.01330 0.33428 0.02143 0.02026 -10.07 -14.96 1.29
134B 35.3 0.02786 0.01669 0.59780 0.03099 0.03074 11.23 10.32 4.09
129B 36.1 0.02650 0.00946 0.43676 0.03160 0.03138 19.25 18.44 4.35
132B 44.7 0.03056 0.01484 0.45628 0.03767 0.03773 23.27 23.45 7.46
124B 60.9 0.07132 0.03819 0.81252 0.04921 0.04936 -31.01 -30.79 9.18
126B 74.3 0.07282 0.03784 0.83692 0.05875 0.05867 -19.33 -19.44 4.08
131B 79.1 0.05840 0.03061 0.64904 0.06213 0.06191 6.39 6.01 2.83
125B 84.3 0.05586 0.02735 0.79178 0.06586 0.06546 17.89 17.18 1.79
128B 87.7 0.06600 0.03706 0.79178 0.06829 0.06775 3.47 2.65 1.29
127B 101.1 0.07322 0.03270 1.10532 0.07783 0.07665 6.29 4.68 0.28
Mean: 54.8 0.0449 0.0224
DRL: 80.4 0.0673 0.0338
Median: 52.8 0.0432 0.0220
n: 12
Population standard deviation: 29.0
Chauvenet criterion value: 0.5
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APPENDIX 27: INPUT DATA PA SKULL HOSPITAL 3 
 
 
 
Hospital 3 Skull PA
Patient
DAP value 
(cGy.cm2) - 
X-axis
PCXMC Skin 
dose (mGy) - 
Y-axis
PCXMC 
Effective dose 
(mSv) - 
ICRP103
PCXMC 
Incident air 
kerma (mGy)
Skin dose 
(mGy) - 
calculated 
linear fit
Skin dose 
(mGy) - 
calculated 
power fit
% Diff 
linear fit
% Diff 
power fit
Chauvenet 
criterion
155A 21.5 0.01941 0.00570 0.30134 0.02938 0.02602 51.35 34.07 1.31
160A 23.2 0.03765 0.01298 0.88572 0.03116 0.02792 -17.25 -25.83 1.54
214A 25.4 0.02695 0.00777 0.55388 0.03359 0.03051 24.62 13.21 1.90
151A 32.3 0.03709 0.01146 0.43188 0.04090 0.03823 10.29 3.07 3.39
212A 34.1 0.03967 0.01230 0.63318 0.04280 0.04021 7.87 1.35 3.89
213A 41.4 0.05231 0.02057 0.89426 0.05069 0.04842 -3.10 -7.45 6.55
157A 42.3 0.03993 0.01133 0.43920 0.05161 0.04936 29.24 23.62 6.92
163A 52.0 0.06811 0.02262 0.67710 0.06199 0.06004 -8.98 -11.85 11.96
162A 56.4 0.07780 0.02796 1.25416 0.06679 0.06494 -14.15 -16.53 14.72
158A 60.7 0.04863 0.01391 0.81130 0.07134 0.06956 46.70 43.05 17.49
161A 63.6 0.14140 0.02230 0.14140 0.07450 0.07277 -47.31 -48.54 18.55
150A 70.5 0.09159 0.03009 1.27124 0.08183 0.08017 -10.65 -12.47 14.09
156A 71.2 0.09637 0.02855 1.58234 0.08261 0.08096 -14.27 -15.99 13.64
164A 72.6 0.08716 0.02483 0.94550 0.08410 0.08245 -3.50 -5.40 12.78
153A 81.5 0.08185 0.02612 1.08824 0.09363 0.09200 14.39 12.40 7.91
152A 85.0 0.08312 0.02614 1.19316 0.09733 0.09569 17.10 15.13 6.37
159A 96.6 0.07336 0.01985 1.35786 0.10985 0.10813 49.74 47.40 2.66
154A 122.7 0.10734 0.03227 1.72508 0.13776 0.13560 28.34 26.34 0.17
149A 143.4 0.19209 0.05441 3.45748 0.15996 0.15723 -16.73 -18.14 0.01
Mean: 63.0 0.0738 0.0216
DRL: 77.1 0.0894 0.0271
Median: 60.7 0.0734 0.0223
n: 19
Population standard deviation: 32.3
Chauvenet criterion value: 0.5
 92 
 
 
APPENDIX 28: INPUT DATA LAT SKULL HOSPITAL 3 
 
 
 
 
 
Hospital 3 Skull LAT
Patient
DAP value 
(cGy.cm2) - 
X-axis
PCXMC Skin 
dose (mGy) - 
Y-axis
PCXMC 
Effective dose 
(mSv) - 
ICRP103
PCXMC 
Incident air 
kerma (mGy)
Skin dose 
(mGy) - 
calculated 
linear fit
Skin dose 
(mGy) - 
calculated 
power fit
% Diff 
linear fit
% Diff 
power fit
Chauvenet 
criterion
157B 20.5 0.01775 0.00974 0.19276 0.02380 0.02205 34.09 24.20 1.84
214B 21.4 0.01868 0.00669 0.33550 0.02441 0.02278 30.68 21.95 2.13
163B 24.3 0.03306 0.01549 0.28670 0.02646 0.02521 -19.96 -23.76 3.38
160B 25.6 0.03407 0.01337 0.73322 0.02738 0.02627 -19.65 -22.91 4.09
151B 26.4 0.02934 0.01534 0.31110 0.02789 0.02686 -4.93 -8.46 4.53
212B 30.7 0.02597 0.01059 0.40138 0.03095 0.03030 19.15 16.67 7.84
213B 32.0 0.02795 0.01810 0.45506 0.03187 0.03133 14.04 12.08 9.08
162B 32.4 0.04397 0.01909 0.39284 0.03216 0.03164 -26.87 -28.05 9.47
155B 32.9 0.02758 0.01286 0.40626 0.03246 0.03196 17.66 15.88 9.90
164B 36.2 0.04072 0.02046 0.41602 0.03478 0.03448 -14.61 -15.34 13.54
158B 40.7 0.03063 0.01107 0.49288 0.03799 0.03788 24.02 23.67 18.83
159B 43.8 0.03081 0.00986 0.51728 0.04012 0.04009 30.23 30.13 15.09
156B 45.2 0.03749 0.01732 0.53314 0.04110 0.04110 9.63 9.62 13.42
152B 47.6 0.04518 0.02438 0.57584 0.04281 0.04284 -5.23 -5.17 10.69
150B 47.6 0.05744 0.03057 0.62098 0.04283 0.04286 -25.43 -25.39 10.67
154B 47.8 0.03771 0.01487 0.57828 0.04292 0.04294 13.80 13.88 10.54
153B 53.3 0.05261 0.02834 0.62952 0.04677 0.04679 -11.10 -11.05 5.63
149B 76.0 0.05479 0.02828 0.74664 0.06271 0.06195 14.46 13.06 0.07
161B 87.4 0.07435 0.03390 1.05652 0.07070 0.06916 -4.91 -6.98 0.00
Mean: 40.6 0.0379 0.0179
DRL: 47.6 0.0446 0.0224
Median: 36.2 0.0341 0.0155
n: 19
Population standard deviation: 17.1
Chauvenet criterion value: 0.5
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APPENDIX 29: UNCERTAINTY OF KAP METER 
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APPENDIX 30: CORRECTION CURVE KAP METER 
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APPENDIX 31: CORRECTION FACTORS ACROSS DIFFERENT kVp’s 
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APPENDIX 32: ETHICS CERTIFICATE CPUT 
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APPENDIX 33: ETHICS CERTIFICATE CPUT 
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APPENDIX 34: ETHICS CERTIFICATE CPUT 
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APPENDIX 35: APPROVAL LETTER PERMANENT SECRETARY MOHSS 
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APPENDIX 36: SUPPORT LETTER NRPA 
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APPENDIX 37: APPROVAL LETTER MEDICAL IMAGING 
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APPENDIX 38: PATIENT INFORMATION LEAFLET AND CONSENT FORM 
PARTICIPANT INFORMATION LEAFLET AND CONSENT FORM 
TITLE OF THE RESEARCH PROJECT: Measurement of radiation doses to patients 
undergoing routine x-ray examinations in Windhoek Namibia to develop diagnostic reference 
levels. 
 
PRINCIPAL INVESTIGATOR:  Edwin Ralph Daniels. 
     Registered for: M Tech Radiography at the Cape   
     Peninsula University of Technology. 
      
ADDRESS:  P.O.Box 20323, Windhoek, Namibia. 
   
Contact number: +27 0721374566 or + 00264 812575787 
 
Dear Participant, 
 
As a radiographer it is part of our goal to continuously improve the quality of our services as well 
as striving into research ventures that will bring new knowledge, enabling us to improve our 
patient management service. 
 
On this note we request your participation in a project titled: “Measurement of radiation doses 
to patients undergoing routine x-ray examinations in Windhoek Namibia to develop 
diagnostic reference levels. 
 
 Please take some time to read the information presented here which will explain the details of 
this project. Please ask the principal investigator about any part of the project that you do not 
fully understand. It is very important that you are fully satisfied as to what the research entails. 
Your participation is entirely voluntary and you are free to withdraw at any stage if you say no, 
this will not affect you negatively in any way whatsoever. 
 
The research study has been approved by the Permanent Secretary (Ministry of Health and Social 
Services as well as the Cape Peninsula University of Technology research Ethics committee of 
the Faculty of Health and Wellness Sciences. The study has also been approved by the heads of 
the various radiology departments and is supported by the National Radiation Protection 
Authority of Namibia. 
 
Purpose of research study: 
 
The study aims to measure radiation to patients undergoing routine x-ray examinations in 
Windhoek Namibia and develop diagnostic reference levels. 
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What is the study about? 
 
The study will explore whether radiographers optimise the radiation delivered to patients during 
four selected radiography procedures, namely chest, skull, lumbar spine and pelvis. These 
examinations have been selected because they are frequently performed in these hospitals. 
 
In a global effort to minimise the harmful effects of ionising radiation and an effort to keep 
radiation doses as low as reasonably achievable (ALARA) the researcher decided to measure 
radiation doses that patients receive during the above mentioned procedures and establish 
diagnostic reference levels for these procedures. The diagnostic reference levels will be compared 
with international reference levels and determine whether our radiation protection measures 
conform to international levels or not.  
 
The results will also be forwarded to the National Radiation Protection Authority of Namibia and 
propose that these values be used as provisional diagnostic reference levels until such a time 
when National reference values are established. Once these reference values have been 
established x-ray departments can compare their radiation practices against these values and 
investigate the cause of the dose variation if the values are exceeded. 
 
Why have you been invited to participate? 
 
You have been chosen to participate because the Doctor have referred you for one of the x-ray 
procedures we are interested in monitoring. 
 
What will your responsibilities be? 
 
To allow us to measure your weight, height, and anatomical thickness for the body part under 
examination. You will be asked to stand on a digital scale and your weight bill be recorded. You 
will also stand against the wall of the x-ray room and your height will be measured.  The 
radiographer will then position you as per departmental protocol and measure the distance from 
the x-ray source to your skin. This measurement will be used to determine the thickness of your 
body part in the centre of the x-ray source. The radiographer will then record the dose area 
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product displayed on the DAP meter after exposure. This is normally not part of an x-ray 
procedure. 
 
Will you benefit from this research? 
 
There are no direct benefits to you as a volunteer. There will be no results that can tell us 
anything about your health or possible diseases. Your radiographs will be reported by radiologist 
as per normal routine. This study will not interfere with your results or management of your 
health. However the study will help us determine whether we are conforming to international 
norm and whether or nor not our radiation protection practices are optimised.  
 
Are there any risks from taking part in this research? 
X-rays usually involve radiation which poses a small risk. The risk of this study is however 
negligible. We will only perform the normal radiographic views that the Doctor requested 
without any alteration in the positioning technique procedure, or reading of the image. 
 
If you do not agree what alternatives do you have? 
 
Whether or not you participate in this study will not affect your clinical care in any way. 
 
Who will have access to the data? 
 
All information collected will be treated as confidential. In order to assure anonymity and protect 
your identity you will be assigned a study code. Access to the information will only be limited to 
the principal investigator and immediate supervisors. There will be no means to trace the data to 
the participant as the study will only record data related to radiation exposure received during the 
x-ray examination procedure. 
 
Data to be collected 
The following data will be collected from each participant: 
- Age 
- Gender (male/female) 
- Weight 
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- Height 
- Thickness of anatomical part under examination  
No other data will be collected. 
 
Will you be paid to take part in this study? 
You will not be paid to take part in this study, and you will not incur any cost either. 
 
 
(Declaration by participant, Principal investigator and Translator.) 
NB...!  
(Consent form must be signed by Participant, Principal Researcher & Language 
Translator) 
 
Declaration by participant: 
 
By signing below, I………………………………………………….agree to take part in a 
research study titled: Measurement of radiation doses to patients undergoing routine x-ray 
examinations in Windhoek Namibia to develop diagnostic reference levels. 
 
 
I declare that: 
 
 I have read or had read to me this information and consent form and it is written in a 
language with which I am fluent and comfortable. I have had a chance to ask questions 
and all my questions have been adequately answered. 
 I understand that taking part in this study is voluntary and I have not been pressurized to 
take part. 
 I understand that all data collected in this research will be handled confidentially. 
 
 
Signed at (place)…………………………………………………on (date)………………… 
 
 
………………………………………  …………………………………………. 
Signature of participant     Signature of witness 
 
 
Declaration by principal investigator: 
 
I (name) ………………………………………………declare that: 
 
 I explained the information in this document to …………………………………. 
 I encouraged him/her to ask questions and took adequate time to answer them.  
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 I am satisfied that he/she adequately understands all aspects of the research as discussed 
above. 
 I did/did not use a translator.  
 
 
Signed at (place)…………………………………………………on (date)………………… 
 
 
………………………………………  …………………………………………. 
Signature of investigator     Signature of witness 
 
Declaration by language translator 
 
I (name) ………………………………………………declare that: 
 
 I assisted the investigator (name)  ………………………………..to explain the 
Information in this document to (name of participant) 
……………………………………..using the medium of …………………………... 
 
 We encouraged him/her to ask questions and took adequate time to answer them. 
 I conveyed a factually correct version of what was related to me. 
 I am satisfied that the participant fully understands the content of this informed consent 
document and has had all his/her question satisfactorily answered. 
 
 
 
Signed at (place)…………………………………………………on (date)………………… 
 
 
………………………………………  …………………………………………. 
Signature of translator    Signature of witness 
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APPENDIX 39: LINEAR & EXPONENTIAL FIT PA CHEST HOSPITAL 1 
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APPENDIX 40: LINEAR & EXPONENTIAL FIT LAT CHEST HOSPITAL 1 
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APPENDIX 41: LINEAR & EXPONENTIAL FIT PA CHEST HOSPITAL 2 
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APPENDIX 42: LINEAR & EXPONENTIAL FIT LAT CHEST HOSPITAL 2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
y = 0.001276263109528x + 0.002387854542503 
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APPENDIX 43: LINEAR & EXPONENTIAL FIT PA CHEST HOSPITAL 3 
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APPENDIX 44: LINEAR & EXPONENTIAL FIT LAT CHEST HOSPITAL 3 
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APPENDIX 45: LINEAR & EXPONENTIAL FIT AP LUMBAR SPINE HOSPITAL 1 
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APPENDIX 46: LINEAR & EXPONENTIAL FIT LAT LUMBAR SPINE HOSPITAL 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
y = 0.001570470404782x - 0.069189632455926 
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APPENDIX 47: LINEAR & EXPONENTIAL FIT AP LUMBAR SPINE HOSPITAL 2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
y = 0.001031758880508x + 0.012436947266405 
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APPENDIX 48: LINEAR & EXPONENTIAL FIT LAT LUMBAR SPINE HOSPITAL 2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
y = 0.000701999723376x + 0.061124911070004 
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APPENDIX 49: LINEAR & EXPONENTIAL FIT AP LUMBAR SPINE HOSPITAL 3 
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APPENDIX 50: LINEAR & EXPONENTIAL FIT LAT LUMBAR SPINE HOSPITAL 3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
y = 0.000842212490206x + 0.022388997719903 
R² = 0.612659844285810 
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APPENDIX 51: LINEAR & EXPONENTIAL FIT AP PELVIS HOSPITAL 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
y = 0.001162810073248x + 0.001673676515911 
R² = 0.991106438876810 
0.00000
0.05000
0.10000
0.15000
0.20000
0.25000
0.30000
0.35000
0.0 25.0 50.0 75.0 100.0 125.0 150.0 175.0 200.0 225.0 250.0 275.0 300.0
Sk
in
 d
o
se
 (
m
G
y)
 
DAP value (cGy.cm2) 
Skin dose (mGy) as a function of DAP for Hospital 1 Pelvis 
y = 0.001293183261929x0.980757926935273 
R² = 0.989445413371738 
0.00000
0.05000
0.10000
0.15000
0.20000
0.25000
0.30000
0.35000
0.0 25.0 50.0 75.0 100.0 125.0 150.0 175.0 200.0 225.0 250.0 275.0 300.0
Sk
in
 d
o
se
 (
m
G
y)
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APPENDIX 52: LINEAR & EXPONENTIAL FIT AP PELVIS HOSPITAL 2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
y = 0.001084456387100x + 0.020180915045682 
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APPENDIX 53: LINEAR & EXPONENTIAL FIT AP PELVIS HOSPITAL 3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
y = 0.001208523877759x - 0.001182483710759 
R² = 0.992961280231385 
0.00000
0.05000
0.10000
0.15000
0.20000
0.25000
0.30000
0.35000
0.0 25.0 50.0 75.0 100.0 125.0 150.0 175.0 200.0 225.0 250.0 275.0 300.0
Sk
in
 d
o
se
 (
m
G
y)
 
DAP value (cGy.cm2) 
Skin dose (mGy) as a function of DAP for Hospital 3 Pelvis 
y = 0.001319733849013x0.979781905375766 
R² = 0.988172979379749 
0.00000
0.05000
0.10000
0.15000
0.20000
0.25000
0.30000
0.35000
0.0 25.0 50.0 75.0 100.0 125.0 150.0 175.0 200.0 225.0 250.0 275.0 300.0
Sk
in
 d
o
se
 (
m
G
y)
 
DAP value (cGy.cm2) 
Skin dose (mGy) as a function of DAP for Hospital 3 Pelvis 
 122 
 
 
 
APPENDIX 54: LINEAR & EXPONENTIAL FIT PA SKULL HOSPITAL 1 
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APPENDIX 55: LINEAR & EXPONENTIAL FIT LAT SKULL HOSPITAL 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
y = 0.000748553110676x + 0.008203743839149 
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APPENDIX 56: LINEAR & EXPONENTIAL FIT PA SKULL HOSPITAL 2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
y = 0.001199035868445x - 0.002419716051110 
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APPENDIX 57: LINEAR & EXPONENTIAL FIT LAT SKULL HOSPITAL 2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
y = 0.000710940562396x + 0.005926903664513 
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APPENDIX 58: LINEAR & EXPONENTIAL FIT PA SKULL HOSPITAL 3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
y = 0.001071104823012x + 0.006326870800791 
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APPENDIX 59: LINEAR & EXPONENTIAL FIT LAT SKULL HOSPITAL 3 
 
 
 
 
 
 
 
 
  
y = 0.000701600779850x + 0.009404688402129 
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APPENDIX 60: INPUT DATA PA CHEST ALL THREE HOSPITALS COMBINED 
 
 
 
 
 
 
All three hospitals Chest PA
Patient
DAP value 
(cGy.cm2) - 
X-axis
PCXMC Skin 
dose (mGy) - 
Y-axis
PCXMC 
Effective dose 
(mSv) - 
ICRP103
PCXMC 
Incident air 
kerma (mGy)
Skin dose 
(mGy) - 
calculated 
linear fit
Skin dose 
(mGy) - 
calculated 
power fit
% Diff 
linear fit
% Diff 
power 
fit
Chauvenet 
criterion
180A 4.1 0.00575 0.00921 0.04636 0.00571 0.00550 -0.66 -4.21 11.27
100A 4.1 0.00590 0.01019 0.06466 0.00574 0.00554 -2.81 -6.25 11.32
98A 4.8 0.00642 0.01127 0.06710 0.00653 0.00636 1.81 -0.86 12.69
171A 5.4 0.00721 0.01488 0.06100 0.00728 0.00714 1.00 -1.00 14.08
95A 5.7 0.00750 0.01342 0.04758 0.00774 0.00761 3.17 1.45 14.98
166A 6.0 0.00789 0.01495 0.05490 0.00805 0.00793 1.94 0.44 15.61
168A 6.0 0.00836 0.01424 0.05368 0.00805 0.00793 -3.71 -5.14 15.61
172A 6.2 0.00808 0.01577 0.07198 0.00835 0.00824 3.42 2.06 16.25
169A 6.3 0.00882 0.01368 0.05856 0.00851 0.00840 -3.58 -4.76 16.58
174A 6.5 0.00946 0.01403 0.07442 0.00866 0.00856 -8.43 -9.49 16.91
173A 6.6 0.00792 0.01693 0.05978 0.00881 0.00872 11.28 10.07 17.24
175A 6.6 0.00850 0.01665 0.07564 0.00881 0.00872 3.62 2.49 17.24
105A 7.0 0.00893 0.01692 0.06222 0.00936 0.00928 4.82 3.93 18.49
93A 7.1 0.00861 0.01649 0.06466 0.00942 0.00934 9.39 8.49 18.64
178A 7.1 0.00895 0.02070 0.07930 0.00942 0.00934 5.22 4.35 18.64
179A 7.1 0.00910 0.01886 0.08052 0.00942 0.00934 3.53 2.67 18.64
181A 7.1 0.00905 0.01718 0.08174 0.00942 0.00934 4.09 3.22 18.64
176A 7.3 0.01048 0.01565 0.06832 0.00968 0.00961 -7.61 -8.29 19.25
167A 7.4 0.01050 0.01726 0.06954 0.00988 0.00981 -5.93 -6.56 19.73
170A 7.7 0.01028 0.02013 0.08784 0.01019 0.01013 -0.95 -1.52 20.48
180AB 7.7 0.01108 0.02023 0.08906 0.01019 0.01013 -8.04 -8.57 20.48
165A 7.7 0.01031 0.02036 0.08906 0.01022 0.01016 -0.89 -1.45 20.55
97A 8.3 0.01015 0.01925 0.07564 0.01095 0.01091 7.89 7.50 22.43
88A 8.4 0.00985 0.01987 0.07930 0.01110 0.01107 12.78 12.41 22.84
86A 8.5 0.01176 0.01956 0.07564 0.01126 0.01122 -4.29 -4.56 23.25
87A 8.8 0.01133 0.01863 0.07564 0.01156 0.01154 2.02 1.79 24.08
102A 8.8 0.01252 0.02083 0.07808 0.01156 0.01154 -7.63 -7.83 24.08
84A 9.0 0.01261 0.02045 0.07808 0.01187 0.01185 -5.92 -6.07 24.92
89A 9.3 0.01092 0.02264 0.10126 0.01217 0.01216 11.49 11.37 25.79
106A 9.4 0.01232 0.02100 0.08906 0.01233 0.01232 0.04 -0.04 26.23
103A 9.5 0.01087 0.02222 0.08418 0.01248 0.01247 14.80 14.74 26.67
101A 9.8 0.01153 0.02206 0.08296 0.01279 0.01278 10.90 10.89 27.57
91A 10.4 0.01399 0.02303 0.09028 0.01355 0.01356 -3.17 -3.08 29.90
85A 10.6 0.01408 0.02288 0.09394 0.01386 0.01387 -1.59 -1.46 30.85
215A 10.7 0.01459 0.02195 0.08174 0.01402 0.01404 -3.89 -3.75 31.39
104A 12.0 0.01547 0.02517 0.10736 0.01554 0.01558 0.43 0.72 36.39
177A 12.7 0.01534 0.03227 0.14762 0.01645 0.01651 7.29 7.66 39.58
90A 12.9 0.01688 0.02933 0.12932 0.01676 0.01682 -0.74 -0.39 40.67
99A 12.9 0.01736 0.02688 0.11346 0.01676 0.01682 -3.46 -3.12 40.67
94A 20.6 0.02557 0.03859 0.18544 0.02639 0.02650 3.20 3.64 42.67
31A 23.7 0.03117 0.04473 0.23546 0.03021 0.03032 -3.08 -2.74 29.71
29A 24.4 0.03314 0.05119 0.22936 0.03113 0.03123 -6.06 -5.74 26.95
39A 25.3 0.03194 0.05007 0.21960 0.03220 0.03230 0.81 1.12 23.91
41A 25.5 0.03267 0.05222 0.23668 0.03250 0.03260 -0.51 -0.22 23.09
46A 26.2 0.03567 0.05718 0.24766 0.03342 0.03351 -6.31 -6.05 20.71
45A 26.6 0.03384 0.05358 0.24278 0.03388 0.03397 0.11 0.37 19.58
27A 26.7 0.03299 0.06270 0.24766 0.03403 0.03412 3.16 3.43 19.22
28A 29.8 0.03555 0.06772 0.27084 0.03785 0.03791 6.48 6.64 11.50
42A 30.9 0.04107 0.07370 0.29524 0.03923 0.03927 -4.47 -4.36 9.37
44A 31.8 0.04086 0.06539 0.30012 0.04045 0.04048 -0.99 -0.91 7.75
33A 32.0 0.04319 0.06911 0.29646 0.04060 0.04064 -5.98 -5.91 7.56
34A 32.0 0.04293 0.06832 0.29646 0.04060 0.04064 -5.42 -5.35 7.56
38A 33.4 0.03967 0.07009 0.28670 0.04244 0.04245 6.97 6.99 5.58
30A 36.8 0.04452 0.08255 0.34160 0.04672 0.04667 4.94 4.84 2.55
35A 37.7 0.04982 0.06981 0.35502 0.04779 0.04773 -4.09 -4.21 2.06
43A 39.9 0.05263 0.07322 0.36966 0.05054 0.05044 -3.97 -4.17 1.15
36A 40.6 0.04951 0.09032 0.42822 0.05146 0.05134 3.94 3.70 0.94
37A 42.7 0.05186 0.08619 0.36722 0.05406 0.05389 4.23 3.91 0.52
32A 52.7 0.07120 0.11396 0.48922 0.06659 0.06616 -6.47 -7.07 0.02
40A 67.0 0.08052 0.14551 0.63074 0.08447 0.08358 4.91 3.80 0.00
Mean: 17.0 0.0219 0.0371
DRL: 26.3 0.0333 0.0545
Median: 9.5 0.0124 0.0220
n: 60
Population standard deviation: 13.8
Chauvenet criterion value: 0.5
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APPENDIX 61: INPUT DATA LAT CHEST ALL THREE HOSPITALS COMBINED 
 
 
 
 
All three hospitals Chest LAT
Patient
DAP value 
(cGy.cm2) - 
X-axis
PCXMC Skin 
dose (mGy) - 
Y-axis
PCXMC 
Effective dose 
(mSv) - 
ICRP103
PCXMC 
Incident air 
kerma (mGy)
Skin dose 
(mGy) - 
calculated 
linear fit
Skin dose 
(mGy) - 
calculated 
power fit
% Diff 
linear fit
% Diff 
power 
fit
Chauvenet 
criterion
100B 8.8 0.01190 0.02148 0.15006 0.01248 0.01096 4.88 -7.90 1.87
215A 10.7 0.01459 0.02195 0.08174 0.01527 0.01370 4.67 -6.14 2.70
98B 11.0 0.01840 0.02441 0.17080 0.01560 0.01402 -15.20 -23.79 2.81
178B 11.5 0.01663 0.03303 0.14518 0.01629 0.01471 -2.03 -11.56 3.07
167B 15.6 0.00314 0.00316 0.16836 0.02216 0.02064 606.76 558.42 6.11
165B 16.1 0.02496 0.03974 0.20008 0.02285 0.02135 -8.46 -14.45 6.59
174B 16.1 0.02769 0.03678 0.20618 0.02285 0.02135 -17.49 -22.89 6.59
175B 18.1 0.02733 0.04319 0.22326 0.02561 0.02421 -6.28 -11.40 8.81
171B 18.3 0.02847 0.04780 0.24278 0.02596 0.02457 -8.84 -13.70 9.13
215B 20.0 0.02600 0.04013 0.19154 0.02839 0.02712 9.20 4.32 11.58
180B 20.1 0.03305 0.04457 0.24888 0.02855 0.02729 -13.63 -17.44 11.76
182B 20.7 0.03122 0.04712 0.25254 0.02936 0.02814 -5.96 -9.86 12.68
166B 20.9 0.02799 0.04762 0.21716 0.02958 0.02838 5.70 1.40 12.95
172B 20.9 0.02510 0.04139 0.20374 0.02958 0.02838 17.88 13.08 12.95
39B 22.6 0.03101 0.04845 0.27938 0.03200 0.03064 3.18 -1.20 16.07
176B 23.2 0.03518 0.04868 0.23668 0.03293 0.03193 -6.41 -9.24 17.41
173B 23.9 0.03010 0.06055 0.25742 0.03390 0.03297 12.63 9.53 18.87
170B 26.5 0.04091 0.06499 0.33916 0.03752 0.03687 -8.27 -9.88 25.04
168B 27.3 0.03787 0.06127 0.27938 0.03873 0.03817 2.28 0.81 27.34
86B 27.5 0.04447 0.04792 0.26596 0.03890 0.03836 -12.52 -13.73 27.68
97B 27.5 0.03470 0.05995 0.27694 0.03890 0.03836 12.12 10.56 27.68
29B 27.7 0.04757 0.04946 0.27816 0.03925 0.03874 -17.49 -18.57 28.36
179B 28.4 0.04347 0.07337 0.36966 0.04028 0.03986 -7.33 -8.29 30.46
180BC 29.4 0.05752 0.06277 0.39528 0.04167 0.04137 -27.57 -28.08 33.39
169B 29.6 0.04488 0.06301 0.31232 0.04201 0.04175 -6.40 -6.99 34.14
95B 30.4 0.03721 0.06454 0.27816 0.04305 0.04288 15.68 15.24 36.45
31B 30.7 0.04403 0.06059 0.31964 0.04356 0.04345 -1.06 -1.32 37.63
88B 32.0 0.03897 0.06909 0.32696 0.04529 0.04535 16.23 16.37 41.68
41B 32.7 0.04403 0.06872 0.34526 0.04633 0.04649 5.21 5.58 44.18
85B 32.7 0.04587 0.06562 0.32086 0.04633 0.04649 0.99 1.34 44.18
42B 33.8 0.05656 0.06528 0.36356 0.04788 0.04821 -15.35 -14.77 48.03
46B 34.2 0.04623 0.07065 0.33672 0.04840 0.04878 4.70 5.52 49.33
34B 34.3 0.05690 0.06123 0.37454 0.04857 0.04897 -14.64 -13.94 49.77
30B 34.8 0.05522 0.06389 0.37454 0.04926 0.04974 -10.79 -9.93 51.52
93B 37.0 0.04616 0.07941 0.36234 0.05237 0.05320 13.44 15.24 59.54
28B 37.7 0.05738 0.07052 0.39162 0.05340 0.05436 -6.93 -5.26 59.76
45B 38.7 0.05263 0.08074 0.41602 0.05478 0.05590 4.09 6.22 56.18
27B 38.8 0.06111 0.07778 0.40870 0.05496 0.05610 -10.07 -8.20 55.73
103B 39.4 0.04608 0.08553 0.38186 0.05582 0.05707 21.14 23.85 53.51
87B 40.6 0.05499 0.08030 0.38918 0.05755 0.05901 4.66 7.32 49.11
33B 41.4 0.05274 0.08592 0.42822 0.05858 0.06018 11.07 14.11 46.52
104B 41.5 0.05805 0.08330 0.40138 0.05875 0.06038 1.22 4.01 46.09
105B 46.0 0.05234 0.09934 0.44896 0.06511 0.06759 24.40 29.14 31.43
35B 46.4 0.06692 0.09299 0.48922 0.06566 0.06822 -1.88 1.95 30.28
99B 46.6 0.06593 0.09761 0.43432 0.06600 0.06862 0.11 4.08 29.57
92B 47.0 0.06378 0.09381 0.44896 0.06652 0.06921 4.30 8.51 28.53
84B 50.0 0.08320 0.08795 0.49044 0.07084 0.07416 -14.86 -10.87 20.66
38B 50.8 0.06708 0.11089 0.58316 0.07187 0.07535 7.15 12.34 19.00
36B 51.1 0.06631 0.10380 0.53924 0.07239 0.07595 9.17 14.54 18.20
37B 52.9 0.08373 0.09416 0.57950 0.07498 0.07894 -10.45 -5.72 14.56
102B 52.9 0.06889 0.10862 0.49898 0.07498 0.07894 8.83 14.59 14.56
177B 53.4 0.08130 0.13142 0.71858 0.07567 0.07974 -6.93 -1.92 13.68
44B 59.2 0.07968 0.12351 0.62464 0.08378 0.08919 5.15 11.94 6.05
94B 59.5 0.07986 0.11198 0.57706 0.08430 0.08980 5.56 12.44 5.72
32B 65.5 0.09484 0.13568 0.73078 0.09276 0.09975 -2.20 5.17 2.03
106B 65.9 0.09027 0.13669 0.67466 0.09328 0.10036 3.33 11.18 1.90
89B 71.1 0.08506 0.14429 0.66856 0.10070 0.10917 18.39 28.35 0.65
40B 76.5 0.12266 0.14287 0.82350 0.10829 0.11826 -11.71 -3.59 0.19
101B 79.9 0.09456 0.17106 0.77348 0.11313 0.12407 19.63 31.21 0.08
90B 83.3 0.11697 0.17733 0.86864 0.11796 0.12991 0.84 11.06 0.03
43B 88.2 0.14692 0.14518 0.86010 0.12487 0.13829 -15.01 -5.88 0.01
Mean: 37.4 0.0529 0.0766
DRL: 47.0 0.0663 0.0942
Median: 33.8 0.0462 0.0687
n: 61
Population standard deviation: 18.7
Chauvenet criterion value: 0.5
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APPENDIX 62: INPUT DATA AP LUMBAR SPINE ALL THREE HOSPITALS COMBINED 
 
 
 
 
 
 
All three hospitals Lumbar spine AP
Patient
DAP value 
(cGy.cm2) - 
X-axis
PCXMC Skin 
dose (mGy) - 
Y-axis
PCXMC 
Effective dose 
(mSv) - 
ICRP103
PCXMC 
Incident air 
kerma (mGy)
Skin dose 
(mGy) - 
calculated 
linear fit
Skin dose 
(mGy) - 
calculated 
power fit
% Diff 
linear fit
% Diff 
power 
fit
Chauvenet 
criterion
211A 33.9 0.03720 0.07586 0.56974 0.04176 0.03748 12.26 0.75 6.58
187A 36.6 0.04159 0.08058 0.47702 0.04460 0.04043 7.23 -2.79 7.01
192A 37.6 0.04324 0.08910 0.52948 0.04569 0.04157 5.69 -3.85 7.18
185A 51.9 0.05987 0.11758 0.74786 0.06073 0.05720 1.45 -4.45 9.86
122A 57.0 0.06206 0.11984 1.04920 0.06620 0.06289 6.67 1.33 11.00
186A 59.8 0.06814 0.11322 1.99104 0.06918 0.06599 1.54 -3.16 11.66
189A 68.8 0.04748 0.09960 0.61976 0.07863 0.07579 65.60 59.63 13.93
75A 70.5 0.07799 0.13041 0.78934 0.08048 0.07771 3.18 -0.36 14.40
72A 70.8 0.07546 0.13287 0.88084 0.08074 0.07798 7.00 3.34 14.47
183A 76.7 0.08366 0.15999 1.07848 0.08702 0.08450 4.02 1.01 16.17
67A 80.3 0.08438 0.15950 0.87718 0.09080 0.08842 7.62 4.80 17.26
80A 80.9 0.08685 0.13963 0.83936 0.09145 0.08909 5.29 2.58 17.45
65A 82.8 0.08983 0.15244 0.86010 0.09351 0.09124 4.10 1.57 18.06
184A 83.6 0.09509 0.18466 1.20536 0.09433 0.09208 -0.80 -3.16 18.31
71A 85.4 0.09578 0.17651 0.90646 0.09622 0.09405 0.46 -1.81 18.89
66A 88.1 0.09864 0.18204 0.98576 0.09906 0.09699 0.43 -1.67 19.78
73A 88.6 0.09816 0.16952 0.94062 0.09958 0.09753 1.44 -0.65 19.95
64A 90.4 0.10797 0.21793 1.09800 0.10152 0.09954 -5.98 -7.81 20.57
69A 91.3 0.09895 0.18446 1.07482 0.10242 0.10047 3.50 1.53 20.87
78A 95.0 0.10932 0.19688 1.03944 0.10642 0.10462 -2.66 -4.30 22.20
68A 99.1 0.11370 0.20652 1.10898 0.11068 0.10904 -2.66 -4.11 23.68
74A 119.7 0.12649 0.23411 1.45302 0.13249 0.13164 4.74 4.07 31.98
114A 124.0 0.14065 0.30480 1.86050 0.13701 0.13632 -2.59 -3.08 33.83
81A 124.7 0.14240 0.24528 1.43350 0.13778 0.13712 -3.24 -3.71 34.15
121A 125.1 0.13808 0.21315 4.65430 0.13820 0.13755 0.08 -0.39 34.32
70A 127.4 0.14220 0.28948 1.46400 0.14062 0.14006 -1.11 -1.51 35.34
76A 136.9 0.14834 0.25239 1.66164 0.15069 0.15048 1.58 1.45 39.65
111A 139.8 0.17161 0.38938 2.25822 0.15379 0.15369 -10.38 -10.44 41.00
63A 142.9 0.16519 0.31270 1.64212 0.15701 0.15703 -4.95 -4.94 42.42
83A 143.1 0.16942 0.35135 1.68482 0.15727 0.15730 -7.17 -7.15 42.54
119A 154.6 0.16774 0.28871 1.60796 0.16940 0.16986 0.99 1.26 47.92
190A 165.6 0.20041 0.38552 2.77184 0.18103 0.18189 -9.67 -9.24 42.91
82A 166.8 0.19677 0.41357 2.02520 0.18231 0.18321 -7.35 -6.89 42.35
117A 166.8 0.17613 0.29594 3.70514 0.18231 0.18321 3.51 4.02 42.35
120A 168.6 0.19779 0.36803 3.49530 0.18426 0.18523 -6.84 -6.35 41.49
116A 175.1 0.19296 0.34729 2.12280 0.19109 0.19229 -0.97 -0.34 38.52
123A 175.6 0.19879 0.35307 3.95524 0.19169 0.19292 -3.57 -2.95 38.26
188A 176.0 0.18786 0.35614 2.13744 0.19207 0.19331 2.24 2.90 38.10
113A 180.0 0.19313 0.37710 3.44284 0.19625 0.19763 1.62 2.33 36.31
191A 205.1 0.22048 0.40669 2.97436 0.22286 0.22515 1.08 2.12 25.70
109A 238.1 0.27280 0.57832 3.54532 0.25781 0.26128 -5.50 -4.23 14.63
118A 275.7 0.29573 0.49503 3.00364 0.29759 0.30237 0.63 2.25 6.55
115A 307.1 0.31980 0.54984 5.22038 0.33073 0.33659 3.42 5.25 2.92
107A 346.5 0.38674 0.65477 6.94668 0.37242 0.37962 -3.70 -1.84 0.88
112A 355.6 0.35387 0.61140 6.67462 0.38210 0.38960 7.98 10.10 0.65
79A 361.1 0.39937 0.82058 4.89708 0.38791 0.39560 -2.87 -0.94 0.53
108A 538.1 0.55964 1.00163 9.74292 0.57518 0.58866 2.78 5.19 0.00
110A 558.8 0.60017 1.07621 9.32202 0.59699 0.61113 -0.53 1.83 0.00
Mean: 154.7 0.1696 0.3138
DRL: 175.2 0.1970 0.3792
Median: 124.9 0.1414 0.2488
n: 48
Population standard deviation: 114.9
Chauvenet criterion value: 0.5
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APPENDIX 63: INPUT DATA LAT LUMBAR SPINE ALL THREE HOSPITALS COMBINED 
 
 
 
 
 
 
 
All three hospitals Lumbar spine LAT
Patient
DAP value 
(cGy.cm2) - 
X-axis
PCXMC Skin 
dose (mGy) - 
Y-axis
PCXMC 
Effective dose 
(mSv) - 
ICRP103
PCXMC 
Incident air 
kerma (mGy)
Skin dose 
(mGy) - 
calculated 
linear fit
Skin dose 
(mGy) - 
calculated 
power fit
% Diff 
linear fit
% Diff 
power 
fit
Chauvenet 
criterion
211B 31.8 0.03185 0.04699 0.59414 0.04491 0.03401 40.97 6.76 1.15
187B 54.7 0.07848 0.06891 0.85522 0.06782 0.05770 -13.59 -26.48 2.57
192B 62.3 0.09509 0.08527 0.97356 0.07545 0.06554 -20.65 -31.08 3.28
186B 70.2 0.04121 0.12455 2.05936 0.08341 0.07368 102.39 78.79 4.19
185B 74.7 0.10153 0.08650 1.27002 0.08792 0.07829 -13.41 -22.89 4.79
190B 80.1 0.06588 0.14573 1.69824 0.09338 0.08387 41.74 27.31 5.60
184B 81.3 0.09410 0.11808 1.50792 0.09453 0.08504 0.46 -9.62 5.79
122B 85.7 0.05952 0.13058 1.87636 0.09897 0.08957 66.27 50.47 6.55
75B 95.4 0.11264 0.08594 1.18706 0.10875 0.09951 -3.46 -11.66 8.48
80B 104.3 0.11383 0.07588 1.16754 0.11769 0.10859 3.40 -4.60 10.61
67B 115.0 0.14502 0.12420 1.51524 0.12847 0.11952 -11.41 -17.59 13.64
73B 115.2 0.12753 0.09566 1.35542 0.12860 0.11964 0.84 -6.18 13.68
189B 122.0 0.14442 0.17986 2.10450 0.13550 0.12662 -6.18 -12.33 15.90
69B 129.8 0.15939 0.12312 1.76046 0.14330 0.13450 -10.10 -15.61 18.69
68B 137.5 0.06000 0.15970 1.86416 0.15102 0.14229 151.70 137.15 21.72
188B 137.9 0.17845 0.17845 1.91784 0.15144 0.14271 -15.14 -20.03 21.89
119B 145.1 0.16557 0.13503 1.78608 0.15867 0.15000 -4.17 -9.40 24.97
183B 146.5 0.17414 0.18793 2.64008 0.16004 0.15138 -8.10 -13.07 25.58
72B 146.6 0.18583 0.13078 2.11060 0.16021 0.15155 -13.79 -18.45 25.66
78B 148.1 0.17835 0.14264 1.83976 0.16168 0.15303 -9.35 -14.20 26.32
66B 178.5 0.21528 0.18478 2.34972 0.19219 0.18368 -10.72 -14.68 41.62
191B 179.3 0.11755 0.27441 3.25496 0.19297 0.18445 64.16 56.92 42.03
70B 180.8 0.23439 0.19270 11.27158 0.19452 0.18601 -17.01 -20.64 42.87
74B 182.4 0.23315 0.17372 2.85724 0.19611 0.18761 -15.89 -19.53 43.73
64B 182.9 0.06559 0.03592 0.50386 0.19660 0.18810 199.76 186.80 43.99
81B 188.2 0.22561 0.15767 2.53638 0.20200 0.19350 -10.47 -14.23 46.91
63B 197.2 0.23339 0.15884 2.74256 0.21094 0.20246 -9.62 -13.25 44.24
121B 198.9 0.14394 0.26658 8.28624 0.21266 0.20417 47.74 41.85 43.31
117B 199.1 0.18583 0.23717 4.72750 0.21294 0.20445 14.59 10.02 43.16
113B 202.5 0.11851 0.32733 4.53840 0.21633 0.20785 82.54 75.38 41.34
120B 203.2 0.23658 0.28692 4.73116 0.21699 0.20851 -8.28 -11.87 40.98
112B 214.1 0.20736 0.28669 3.77102 0.22797 0.21948 9.94 5.84 35.23
109B 222.4 0.27400 0.36648 3.60998 0.23631 0.22780 -13.76 -16.86 31.05
77B 231.6 0.32390 0.25940 3.33182 0.24550 0.23696 -24.21 -26.84 26.70
71B 232.3 0.27718 0.22087 2.97314 0.24623 0.23770 -11.17 -14.25 26.36
115B 234.1 0.19616 0.33139 4.66040 0.24807 0.23953 26.46 22.11 25.54
65B 239.7 0.27409 0.21445 2.98290 0.25371 0.24514 -7.44 -10.56 23.08
118B 248.3 0.28237 0.22643 3.12198 0.26233 0.25373 -7.10 -10.14 19.59
107B 251.8 0.14555 0.47214 6.07560 0.26584 0.25722 82.65 76.73 18.27
116B 261.2 0.32412 0.28017 3.16712 0.27527 0.26661 -15.07 -17.74 14.98
114B 279.7 0.36751 0.32845 3.45504 0.29390 0.28512 -20.03 -22.42 9.71
111B 283.5 0.35905 0.49614 4.59574 0.29770 0.28889 -17.09 -19.54 8.83
82B 284.1 0.40541 0.37779 4.08822 0.29831 0.28949 -26.42 -28.59 8.69
123B 288.6 0.27133 0.42848 7.33464 0.30276 0.29391 11.58 8.32 7.75
83B 310.5 0.45083 0.44395 4.46764 0.32478 0.31574 -27.96 -29.96 4.16
108B 382.1 0.30068 0.58107 8.11544 0.39670 0.38683 31.94 28.65 0.30
79B 439.0 0.62399 0.54716 7.12602 0.45381 0.44306 -27.27 -29.00 0.02
110B 551.6 0.38591 0.82866 10.14308 0.56691 0.55399 46.90 43.56 0.00
Mean: 190.2 0.2040 0.2377
DRL: 235.5 0.2740 0.2970
Median: 182.6 0.1821 0.1864
n: 48
Population standard deviation: 99.3
Chauvenet criterion value: 0.5
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APPENDIX 64: INPUT DATA AP PELVIS ALL THREE HOSPITALS COMBINED 
 
 
 
 
All three hospitals Pelvis
Patient
DAP value 
(cGy.cm2) - 
X-axis
PCXMC Skin 
dose (mGy) - 
Y-axis
PCXMC 
Effective dose 
(mSv) - 
ICRP103
PCXMC 
Incident air 
kerma (mGy)
Skin dose 
(mGy) - 
calculated 
linear fit
Skin dose 
(mGy) - 
calculated 
power fit
% Diff 
linear fit
% Diff 
power 
fit
Chauvenet 
criterion
16 53.9 0.06911 0.07093 0.47702 0.06892 0.06569 -0.28 -4.96 4.45
205 61.7 0.07830 0.10647 0.60146 0.07764 0.07482 -0.84 -4.44 5.72
20 74.7 0.09324 0.11966 0.85888 0.09230 0.09010 -1.02 -3.37 8.48
204 75.3 0.09575 0.12556 0.78202 0.09297 0.09080 -2.90 -5.17 8.63
207 76.5 0.09570 0.12991 1.11996 0.09437 0.09226 -1.38 -3.59 8.94
15 77.3 0.08597 0.10893 0.82106 0.09527 0.09319 10.81 8.39 9.15
208 78.0 0.09656 0.12801 0.69174 0.09609 0.09404 -0.49 -2.61 9.34
202 83.5 0.10053 0.12453 1.08702 0.10221 0.10039 1.67 -0.14 10.86
196 84.3 0.10337 0.13158 0.94306 0.10313 0.10135 -0.23 -1.96 11.10
210 92.5 0.10795 0.15471 0.88694 0.11240 0.11093 4.12 2.77 13.78
201 93.3 0.11561 0.15711 1.36884 0.11325 0.11181 -2.04 -3.28 14.05
11 93.3 0.10258 0.13314 1.09922 0.11333 0.11190 10.49 9.09 14.08
199 94.1 0.10230 0.15185 1.71044 0.11420 0.11279 11.64 10.26 14.35
200 99.8 0.12110 0.20397 2.68034 0.12061 0.11941 -0.40 -1.40 16.51
19 99.8 0.11256 0.14936 1.43594 0.12062 0.11942 7.16 6.10 16.52
193 100.1 0.11852 0.21856 1.40666 0.12095 0.11976 2.05 1.04 16.63
13 111.1 0.13154 0.16267 1.17974 0.13341 0.13258 1.42 0.79 21.45
18 111.8 0.13965 0.18160 1.51646 0.13416 0.13336 -3.93 -4.51 21.76
137 112.4 0.13413 0.19038 1.14680 0.13480 0.13401 0.50 -0.09 22.03
195 115.5 0.13034 0.17140 1.29320 0.13830 0.13761 6.11 5.58 23.55
198 115.8 0.13393 0.17308 1.36274 0.13861 0.13792 3.49 2.98 23.69
17 124.3 0.15346 0.19748 1.32004 0.14826 0.14782 -3.39 -3.68 28.20
138 131.4 0.14516 0.16408 1.76412 0.15623 0.15599 7.63 7.46 32.24
14 135.2 0.15866 0.19599 1.43472 0.16050 0.16034 1.16 1.06 34.51
10 138.6 0.15326 0.18544 1.55062 0.16435 0.16428 7.24 7.19 36.62
209 141.0 0.15537 0.15537 1.60918 0.16701 0.16700 7.50 7.49 38.12
140 146.6 0.18402 0.26291 1.77998 0.17342 0.17354 -5.76 -5.70 41.80
25 147.3 0.17012 0.20017 1.48962 0.17411 0.17424 2.35 2.42 42.20
7 147.9 0.17254 0.21452 1.69946 0.17480 0.17494 1.30 1.39 42.60
6 149.1 0.16705 0.19932 1.71410 0.17617 0.17634 5.46 5.56 43.41
12 161.2 0.19073 0.25120 2.18502 0.18978 0.19020 -0.50 -0.28 51.63
9 167.9 0.19884 0.24373 1.87880 0.19735 0.19788 -0.75 -0.48 56.30
206 168.1 0.20886 0.23745 1.27246 0.19762 0.19816 -5.38 -5.12 56.47
2 168.4 0.20009 0.23727 1.78730 0.19790 0.19844 -1.10 -0.82 56.64
23 169.0 0.20524 0.24511 1.79462 0.19858 0.19914 -3.24 -2.97 56.94
144 170.7 0.21415 0.25380 1.48352 0.20051 0.20109 -6.37 -6.10 55.75
22 173.1 0.19408 0.22940 1.93736 0.20326 0.20389 4.73 5.05 54.05
21 178.2 0.21367 0.25611 1.94956 0.20903 0.20974 -2.17 -1.84 50.50
145 184.5 0.22946 0.29878 1.91540 0.21604 0.21685 -5.85 -5.49 46.24
5 200.4 0.22820 0.26190 2.56566 0.23406 0.23507 2.57 3.01 35.83
8 206.2 0.24296 0.28284 2.42658 0.24052 0.24160 -1.01 -0.56 32.35
24 209.5 0.24973 0.28283 2.34362 0.24423 0.24535 -2.20 -1.76 30.43
143 209.5 0.26678 0.33551 2.12646 0.24423 0.24535 -8.45 -8.03 30.43
26 213.5 0.25544 0.30615 2.51320 0.24877 0.24992 -2.61 -2.16 28.17
141 223.4 0.24945 0.33857 3.15492 0.25991 0.26115 4.19 4.69 23.01
197 225.1 0.27391 0.36865 2.64984 0.26183 0.26309 -4.41 -3.95 22.18
3 225.3 0.26469 0.32389 2.46440 0.26211 0.26336 -0.98 -0.50 22.06
4 231.7 0.28058 0.34530 2.66326 0.26926 0.27056 -4.03 -3.57 19.15
203 242.7 0.28825 0.42990 3.61730 0.28163 0.28301 -2.30 -1.82 14.72
194 250.1 0.30759 0.44038 2.45830 0.29001 0.29142 -5.72 -5.26 12.16
146 251.6 0.31258 0.43367 2.78770 0.29167 0.29309 -6.69 -6.24 11.69
102163 278.5 0.31553 0.40829 3.56484 0.32206 0.32354 2.07 2.54 5.30
148 295.4 0.35103 0.47448 3.35012 0.34103 0.34252 -2.85 -2.42 3.00
139 328.8 0.34355 0.48319 3.56118 0.37871 0.38010 10.23 10.64 0.81
136 330.6 0.37741 0.54856 3.60144 0.38071 0.38210 0.88 1.24 0.75
142 446.8 0.49337 0.57325 4.63844 0.51167 0.51193 3.71 3.76 0.00
147 550.6 0.62896 0.74469 5.71570 0.62868 0.62709 -0.04 -0.30 0.00
Mean: 168.9 0.1985 0.2544
DRL: 209.5 0.2497 0.3061
Median: 147.9 0.1725 0.2186
n: 57
Population standard deviation: 92.3
Chauvenet criterion value: 0.5
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APPENDIX 65: INPUT DATA PA SKULL ALL THREE HOSPITALS COMBINED 
 
 
 
All three hospitals Skull PA
Patient
DAP value 
(cGy.cm2) - 
X-axis
PCXMC Skin 
dose (mGy) - 
Y-axis
PCXMC 
Effective dose 
(mSv) - 
ICRP103
PCXMC 
Incident air 
kerma (mGy)
Skin dose 
(mGy) - 
calculated 
linear fit
Skin dose 
(mGy) - 
calculated 
power fit
% Diff 
linear fit
% Diff 
power 
fit
Chauvenet 
criterion
155A 21.5 0.01941 0.00570 0.30134 0.02128 0.02178 9.61 12.23 2.46
51A 21.8 0.01731 0.00460 0.26718 0.02163 0.02212 24.96 27.76 2.55
160A 23.2 0.03765 0.01298 0.88572 0.02314 0.02353 -38.53 -37.50 2.94
130A 24.7 0.02807 0.00803 0.48556 0.02481 0.02509 -11.63 -10.63 3.43
62A 24.8 0.01920 0.00506 0.32330 0.02493 0.02520 29.83 31.25 3.47
214A 25.4 0.02695 0.00777 0.55388 0.02570 0.02593 -4.64 -3.80 3.72
53A 27.6 0.03159 0.00903 0.50996 0.02809 0.02817 -11.07 -10.80 4.59
65A 31.6 0.02808 0.00811 0.42456 0.03262 0.03246 16.16 15.56 6.70
151A 32.3 0.03709 0.01146 0.43188 0.03339 0.03318 -9.96 -10.53 7.13
212A 34.1 0.03967 0.01230 0.63318 0.03539 0.03507 -10.81 -11.60 8.32
135A 34.6 0.03398 0.00914 0.64050 0.03596 0.03562 5.84 4.84 8.69
61A 36.1 0.03029 0.00800 0.47092 0.03771 0.03728 24.48 23.07 9.89
50A 37.3 0.03346 0.00808 0.47580 0.03908 0.03859 16.78 15.31 10.91
64A 38.6 0.03283 0.00894 0.50264 0.04046 0.03990 23.23 21.53 12.01
55A 41.2 0.04099 0.01030 0.91622 0.04348 0.04278 6.06 4.37 14.71
213A 41.4 0.05231 0.02057 0.89426 0.04368 0.04298 -16.50 -17.84 14.91
157A 42.3 0.03993 0.01133 0.43920 0.04465 0.04390 11.81 9.95 15.85
48A 42.6 0.03586 0.00904 0.58438 0.04499 0.04423 25.47 23.36 16.20
133A 44.2 0.05218 0.01610 0.75030 0.04677 0.04594 -10.36 -11.95 18.09
57A 47.0 0.05984 0.01610 1.04310 0.04993 0.04898 -16.55 -18.16 21.75
59A 50.1 0.06260 0.01803 1.08824 0.05351 0.05241 -14.52 -16.27 26.38
163A 52.0 0.06811 0.02262 0.67710 0.05557 0.05440 -18.42 -20.13 29.27
162A 56.4 0.07780 0.02796 1.25416 0.06061 0.05927 -22.09 -23.81 36.91
47A 58.0 0.04891 0.01556 0.73932 0.06230 0.06091 27.38 24.53 39.62
54A 58.6 0.05908 0.01734 1.14436 0.06299 0.06157 6.60 4.21 40.74
158A 60.7 0.04863 0.01391 0.81130 0.06539 0.06391 34.47 31.41 44.73
60A 62.1 0.07364 0.02212 0.79178 0.06697 0.06544 -9.06 -11.14 47.38
161A 63.6 0.06420 0.02230 0.14140 0.06872 0.06713 7.03 4.57 50.34
58A 70.2 0.05603 0.01637 0.91378 0.07604 0.07427 35.70 32.54 41.34
150A 70.5 0.09159 0.03009 1.27124 0.07642 0.07464 -16.56 -18.50 40.71
56A 70.9 0.07973 0.02261 0.75396 0.07693 0.07514 -3.51 -5.75 39.88
156A 71.2 0.09637 0.02855 1.58234 0.07725 0.07545 -19.84 -21.71 39.36
128A 72.5 0.10530 0.03087 1.49694 0.07865 0.07682 -25.31 -27.05 37.11
164A 72.6 0.08716 0.02483 0.94550 0.07881 0.07698 -9.57 -11.68 36.85
63A 73.7 0.05441 0.01458 0.93940 0.08002 0.07816 47.07 43.64 34.95
59AB 74.2 0.10210 0.03138 1.64700 0.08057 0.07870 -21.09 -22.92 34.11
153A 81.5 0.08185 0.02612 1.08824 0.08883 0.08679 8.53 6.03 22.52
127A 84.4 0.09389 0.02623 1.47620 0.09211 0.09001 -1.89 -4.13 18.64
152A 85.0 0.08312 0.02614 1.19316 0.09272 0.09060 11.55 9.01 17.97
129A 92.0 0.10950 0.02795 1.82756 0.10063 0.09839 -8.10 -10.14 10.66
131A 93.1 0.09905 0.02551 1.79096 0.10187 0.09961 2.84 0.57 9.75
125A 93.6 0.08440 0.02102 1.44692 0.10242 0.10016 21.35 18.67 9.37
159A 96.6 0.07336 0.01985 1.35786 0.10588 0.10357 44.33 41.19 7.19
52A 97.6 0.07508 0.01946 1.29076 0.10695 0.10463 42.45 39.36 6.60
124A 100.8 0.13660 0.03893 1.98738 0.11052 0.10816 -19.09 -20.82 4.91
49A 101.1 0.08558 0.02403 1.31760 0.11093 0.10857 29.62 26.86 4.74
62AB 109.4 0.12216 0.03462 1.42618 0.12028 0.11783 -1.54 -3.54 1.99
126A 112.5 0.11904 0.02866 1.58356 0.12371 0.12124 3.93 1.85 1.40
132A 114.9 0.13603 0.03876 2.45708 0.12646 0.12397 -7.04 -8.87 1.04
134A 116.8 0.15261 0.04324 2.00812 0.12852 0.12602 -15.79 -17.42 0.83
154A 122.7 0.10734 0.03227 1.72508 0.13522 0.13270 25.98 23.63 0.38
149A 143.4 0.19209 0.05441 3.45748 0.15857 0.15603 -17.45 -18.77 0.01
Mean: 64.5 0.0697 0.0202
DRL: 86.7 0.0922 0.0267
Median: 61.4 0.0634 0.0197
n: 52
Population standard deviation: 30.7
Chauvenet criterion value: 0.5
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APPENDIX 66: INPUT DATA LAT SKULL ALL THREE HOSPITALS COMBINED 
 
 
 
 
 
 
All three hospitals Skull LAT
Patient
DAP value 
(cGy.cm2) - 
X-axis
PCXMC Skin 
dose (mGy) - 
Y-axis
PCXMC 
Effective dose 
(mSv) - 
ICRP103
PCXMC 
Incident air 
kerma (mGy)
Skin dose 
(mGy) - 
calculated 
linear fit
Skin dose 
(mGy) - 
calculated 
power fit
% Diff 
linear fit
% Diff 
power 
fit
Chauvenet 
criterion
135B 12.7 0.01152 0.00387 0.21838 0.01738 0.01352 50.95 17.42 1.35
130B 19.2 0.02037 0.00691 0.33550 0.02209 0.01934 8.42 -5.06 3.40
157B 20.5 0.01775 0.00974 0.19276 0.02305 0.02050 29.86 15.47 4.05
214B 21.4 0.01868 0.00669 0.33550 0.02368 0.02124 26.77 13.73 4.52
133B 21.8 0.02383 0.01330 0.33428 0.02398 0.02160 0.64 -9.35 4.76
163B 24.3 0.03306 0.01549 0.28670 0.02580 0.02374 -21.98 -28.20 6.44
51B 25.3 0.02025 0.00952 0.29036 0.02648 0.02453 30.73 21.12 7.18
160B 25.6 0.03407 0.01337 0.73322 0.02674 0.02484 -21.52 -27.11 7.49
151B 26.4 0.02934 0.01534 0.31110 0.02727 0.02545 -7.06 -13.27 8.12
62B 27.9 0.03231 0.03231 0.41968 0.02842 0.02677 -12.03 -17.14 9.65
212B 30.7 0.02597 0.01059 0.40138 0.03042 0.02905 17.12 11.84 12.80
213B 32.0 0.02795 0.01810 0.45506 0.03138 0.03012 12.25 7.78 14.52
162B 32.4 0.04397 0.01909 0.39284 0.03167 0.03045 -27.98 -30.74 15.08
155B 32.9 0.02758 0.01286 0.40626 0.03198 0.03080 15.92 11.65 15.69
61B 33.4 0.02545 0.01169 0.37698 0.03239 0.03126 27.27 22.84 16.53
134B 35.3 0.02786 0.01669 0.59780 0.03371 0.03274 20.99 17.49 19.41
129B 36.1 0.02650 0.00946 0.43676 0.03433 0.03342 29.56 26.13 20.85
164B 36.2 0.04072 0.02046 0.41602 0.03437 0.03346 -15.61 -17.83 20.94
50B 36.4 0.03198 0.01646 0.42090 0.03451 0.03362 7.92 5.13 21.28
55B 38.1 0.03010 0.00761 0.74786 0.03574 0.03498 18.76 16.22 24.39
158B 40.7 0.03063 0.01107 0.49288 0.03769 0.03710 23.02 21.12 29.74
159B 43.8 0.03081 0.00986 0.51728 0.03988 0.03947 29.44 28.14 36.37
132B 44.7 0.03056 0.01484 0.45628 0.04051 0.04016 32.56 31.41 38.40
53B 44.8 0.04459 0.01585 0.78812 0.04060 0.04025 -8.95 -9.73 38.68
156B 45.2 0.03749 0.01732 0.53314 0.04089 0.04057 9.07 8.21 39.62
65B 45.3 0.03799 0.01835 0.52338 0.04095 0.04063 7.79 6.96 39.82
152B 47.6 0.04518 0.02438 0.57584 0.04266 0.04246 -5.58 -6.02 45.46
150B 47.6 0.05744 0.03057 0.62098 0.04267 0.04247 -25.71 -26.05 45.51
64B 47.7 0.03920 0.01759 0.56364 0.04272 0.04252 8.98 8.48 45.66
154B 47.8 0.03771 0.01487 0.57828 0.04276 0.04257 13.40 12.88 45.81
48B 48.2 0.03599 0.01508 0.55754 0.04307 0.04290 19.67 19.19 46.85
58B 49.2 0.04931 0.01708 0.96624 0.04378 0.04365 -11.23 -11.49 49.24
54B 49.4 0.04391 0.01330 0.99186 0.04395 0.04384 0.10 -0.16 49.84
153B 53.3 0.05261 0.02834 0.62952 0.04673 0.04677 -11.16 -11.09 44.76
59BA 55.0 0.06268 0.02274 1.08092 0.04801 0.04811 -23.40 -23.25 40.52
58B 57.3 0.04035 0.02070 0.54046 0.04969 0.04986 23.16 23.58 35.17
124B 60.9 0.07132 0.03819 0.81252 0.05225 0.05251 -26.74 -26.37 27.59
56B 61.6 0.06821 0.03207 0.60512 0.05280 0.05307 -22.60 -22.19 26.09
62BA 62.1 0.06561 0.03326 0.73322 0.05313 0.05342 -19.02 -18.58 25.19
47B 62.8 0.05309 0.02685 0.72712 0.05366 0.05396 1.07 1.64 23.80
57B 67.8 0.07139 0.02505 1.33224 0.05728 0.05766 -19.77 -19.24 15.54
126B 74.3 0.07282 0.03784 0.83692 0.06196 0.06239 -14.92 -14.33 8.06
149B 76.0 0.05479 0.02828 0.74664 0.06318 0.06361 15.31 16.09 6.66
60B 77.5 0.09074 0.04525 0.91500 0.06425 0.06468 -29.19 -28.72 5.59
131B 79.1 0.05840 0.03061 0.64904 0.06540 0.06583 11.99 12.72 4.60
49B 80.8 0.06385 0.02832 0.93452 0.06664 0.06706 4.36 5.01 3.70
125B 84.3 0.05586 0.02735 0.79178 0.06920 0.06959 23.87 24.57 2.29
63B 84.9 0.05849 0.02044 0.95038 0.06964 0.07003 19.07 19.73 2.10
161B 87.4 0.07435 0.03390 1.05652 0.07141 0.07177 -3.95 -3.46 1.46
128B 87.7 0.06600 0.03706 0.79178 0.07167 0.07202 8.59 9.12 1.39
127B 101.1 0.07322 0.03270 1.10532 0.08138 0.08146 11.14 11.25 0.14
52B 130.9 0.09483 0.03439 1.58966 0.10292 0.10183 8.53 7.38 0.00
Mean: 50.3 0.0446 0.0206
DRL: 62.3 0.0584 0.0283
Median: 46.4 0.0398 0.0178
n: 52
Population standard deviation: 23.9
Chauvenet criterion value: 0.5
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APPENDIX 68: PERMISSION TO USE MAP IN DISSERTATION 
 
 
 
